Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3026725	s-e2	nmol/l (nmol/l)	5946	8441	3.15%
3026725	s-e2	— (—)	1746	2097	100.00%	Distribution not available
3026725	s-estradioli	nmol/l (nmol/l)	7	8	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Female infertility, associated with anovulation

573

593

11.13

307.65

2.1

1.3

0.58

0.36

nmol/l

2.16

493

453

Malignant neoplasm of breast, HER2-negative

1063

1472

4.92

307.65

1.3

0.27

0.41

nmol/l

7.05

656

1129

Malignant neoplasm of breast, HER2-negative, including Hilmo

1106

1594

4.67

307.65

1.3

0.28

0.42

nmol/l

6.06

689

1225

Malignant neoplasm of breast, HER-positive

933

1043

7.35

307.65

1.4

1.3

0.25

0.36

nmol/l

3.92

576

768

L02BA Anti-estrogens

574

908

6.78

307.65

1.5

1.3

0.28

0.37

nmol/l

1.90

408

638

L02BG Aromatase inhibitors

774

1070

7.60

307.65

1.7

1.3

0.31

0.35

nmol/l

0.39

462

749

Female infertility, cervical, vaginal, other or unspecified origin

1633

1136

10.37

307.65

1.6

1.3

0.67

0.34

nmol/l

14.55

1435

794

Malignant neoplasm of breast, ER-positive, including Hilmo

951

1066

7.25

307.65

1.4

1.3

0.25

0.37

nmol/l

3.98

590

787

Medical treatment for female infertility

1587

2819

6.44

307.65

1.8

1.3

0.74

0.38

nmol/l

15.14

1401

2187

Malignant neoplasm of breast, including Hilmo

1106

1594

4.67

307.65

1.3

0.28

0.42

nmol/l

6.06

689

1225

Amenorrhoea

561

424

15.74

307.65

2.0

1.4

0.22

0.35

nmol/l

3.09

453

320

Exclusions for E4_PCOS_BROAD

736

1128

7.08

307.65

1.8

1.4

0.28

0.42

nmol/l

4.34

537

896

Medicines for HER+ breast cancer

1110

1522

7.32

307.65

1.6

1.3

0.32

0.37

nmol/l

0.74

725

1111

Female infertility

1730

1157

10.02

307.65

1.6

1.3

0.65

0.34

nmol/l

12.75

1507

812

Malignant neoplasm of breast

1095

1532

4.85

307.65

1.3

0.27

0.41

nmol/l

6.38

681

1178

Disorders of other endocrine glands

1279

2941

4.47

307.65

1.7

1.4

0.34

0.43

nmol/l

1.81

1005

2322

Noninflammatory disorders of female genital tract

1143

1311

4.53

307.65

1.6

1.3

0.49

0.32

nmol/l

4.41

960

938

Hypopituitarism

346

293

13.23

307.65

1.9

1.4

0.24

0.35

nmol/l

2.18

251

234

Malignant neoplasm

1516

3119

2.93

275.70

1.5

1.4

0.29

0.42

nmol/l

8.34

1034

2506

Malignant neoplasm, wide definition for exclusion

1583

3364

2.81

266.92

1.5

1.4

0.29

0.42

nmol/l

8.28

1094

2723

Solid cancers, helper endpoint

1473

3046

2.91

264.40

1.4

0.29

0.42

nmol/l

7.79

996

2446

Polycystic ovarian syndrome, broad definition

653

1683

4.29

228.64

1.9

1.4

0.56

0.52

nmol/l

0.23

571

1405

Personal history of malignant neoplasm

275

355

8.48

202.47

1.5

1.4

0.27

0.34

nmol/l

0.87

210

262

Any event in cancer register

1634

4146

2.36

195.33

1.5

1.4

0.32

0.46

nmol/l

8.48

1135

3405

Ovarian dysfunction

462

1070

4.83

187.12

1.8

1.4

0.45

0.55

nmol/l

0.66

394

905

Endometriosis

711

1153

3.72

184.40

1.4

1.3

0.55

0.33

nmol/l

6.15

590

805

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

717

2229

3.32

184.04

1.8

1.4

0.31

0.44

nmol/l

4.77

530

1719

Benign neoplasm: Pituitary gland, craniopharyngeal duct

237

293

9.00

181.53

1.9

1.5

0.31

0.37

nmol/l

0.71

169

238

Hypogonadotropic hypogonadism

136

21.07

175.13

2.0

1.7

0.13

0.27

nmol/l

1.07

107

Irregular menses

1346

4617

2.37

172.24

1.6

1.4

0.32

0.48

nmol/l

11.25

1091

3614

Exclusions for E4_PCOS_CONSORTIUM

1571

4581

2.19

160.16

1.6

1.4

0.34

0.46

nmol/l

5.48

1192

3652

Genitourinary diseases

748

1172

3.24

152.28

1.6

1.4

0.35

0.26

nmol/l

2.30

616

889

Hypothyroidism, levothyroxine purchases

737

1355

3.17

148.92

1.7

1.4

0.46

0.54

nmol/l

0.67

614

1165

Hypothyroidism and >3 levothyroxin purchases

737

1355

3.17

148.92

1.7

1.4

0.46

0.54

nmol/l

0.67

614

1165

Hypothyroidism (congenital or acquired)

737

1357

3.16

148.29

1.7

1.4

0.45

0.54

nmol/l

0.82

612

1166

Testicular dysfunction

106

23.29

144.56

1.8

1.6

0.12

0.13

nmol/l

0.17

Hyperfunction of pituitary gland

244

403

6.73

144.05

1.5

1.3

0.29

0.46

nmol/l

2.45

181

327

Procreative management

720

2151

2.87

138.08

1.6

1.5

0.62

0.29

nmol/l

6.59

606

1604

Polycystic ovarian syndrome, consortium definition

1601

4718

2.05

135.97

1.6

1.4

0.36

0.48

nmol/l

4.11

1299

3683

Endometriosis of ovary

369

875

4.26

135.68

1.5

1.4

0.61

0.33

nmol/l

5.30

316

598

Disorders of the thyroid gland

1552

5054

2.03

131.95

1.6

1.4

0.44

0.41

nmol/l

0.41

1234

4021

Endocrine, nutritional and metabolic diseases

1482

3611

2.11

130.79

1.6

1.4

0.39

0.42

nmol/l

0.47

1198

2905

Testicular hypofunction

23.27

129.44

1.9

1.6

0.12

0.13

nmol/l

0.15

Hypothyroidism, other/unspecified

1507

4946

2.03

129.29

1.6

1.4

0.45

0.42

nmol/l

0.51

1196

3926

Behavioural syndromes associated with physiological disturbances and physical factors

1507

5389

2.01

127.66

1.5

1.4

0.35

0.42

nmol/l

2.26

1206

4240

Endometriosis of pelvic peritoneum

376

922

4.03

127.23

1.4

1.3

0.55

0.32

nmol/l

4.73

314

636

Hypothyreosis and Thyroxine purchase for inclusion criteria

1540

5113

2.00

126.98

1.6

1.4

0.45

0.42

nmol/l

0.49

1218

4041

Excessive, frequent and irregular menstruation

683

1272

3.00

126.49

1.5

1.3

0.40

0.32

nmol/l

1.75

557

904

Complications associated with artificial fertilization

121

14.50

126.15

2.1

1.3

1.76

0.33

nmol/l

5.17

116

Ovarian cyst

632

1209

3.08

124.12

1.5

1.3

0.47

0.33

nmol/l

2.39

500

854

Neoplasms

1450

3791

2.06

121.56

1.6

1.5

0.38

0.46

nmol/l

2.29

1163

3203

Unspecified/other endometriosis

278

610

4.79

118.14

1.4

1.3

0.59

0.35

nmol/l

3.28

237

451

Pain and other conditions associated with female genital organs and menstrual cycle

439

1207

3.44

117.52

1.4

1.3

0.44

0.33

nmol/l

1.33

373

869

Benign neoplasm of other and unspecified endocrine glands

272

601

4.71

114.16

1.8

1.4

0.33

0.36

nmol/l

0.36

195

465

Endometriosis diagnosis and infertility diagnosis occurring together

434

1354

3.43

113.19

1.5

0.68

0.48

nmol/l

2.69

380

1082

Hyperprolactinaemia

195

335

6.58

111.27

1.5

1.3

0.30

0.48

nmol/l

2.28

150

277

Neurotic, stress-related and somatoform disorders

1435

5378

1.89

101.69

1.5

1.4

0.38

0.42

nmol/l

0.71

1136

4221

Anxiety disorders

1437

5382

1.88

100.69

1.5

1.4

0.38

0.42

nmol/l

0.73

1137

4224

Polycystic ovarian syndrome

306

834

4.04

99.38

1.9

1.4

0.55

0.59

nmol/l

0.12

271

711

Recurrent or chronic depression

719

2092

2.46

98.98

1.5

1.4

0.39

0.46

nmol/l

0.82

545

1663

Sleep disorders

1367

5328

1.88

95.46

1.5

1.4

0.37

0.43

nmol/l

1.52

1099

4189

Anxiety disorders, excluding more controls

1269

4320

1.93

95.01

1.5

1.4

0.38

0.43

nmol/l

1.02

995

3399

Depression

1457

5425

1.84

94.65

1.5

1.4

0.39

0.41

nmol/l

0.23

1138

4292

Primary ovarian failure

137

200

8.15

92.48

1.8

1.3

0.23

0.50

nmol/l

2.55

109

166

Hypothyroidism, strict autoimmune

1191

4069

1.95

91.44

1.5

1.4

0.48

0.43

nmol/l

0.61

950

3263

Female infertility, tubal origin

165

290

6.07

90.65

1.6

1.3

0.74

0.33

nmol/l

3.30

150

203

Mood disorders

1487

5446

1.78

86.74

1.5

1.4

0.39

0.41

nmol/l

0.25

1153

4308

Mood [affective] disorders

1485

5446

1.78

86.73

1.5

1.4

0.39

0.41

nmol/l

0.25

1152

4308

Anxiety (asthma-related co-morbidities)

1145

4681

1.92

86.71

1.5

1.4

0.41

0.43

nmol/l

0.33

930

3713

All anxiety disorders

1175

5065

1.86

81.04

1.5

1.4

0.40

0.43

nmol/l

0.42

960

4013

Insomnia

1350

5567

1.79

80.89

1.5

0.36

0.42

nmol/l

1.68

1085

4379

Polyp of the female genital tract

449

903

2.91

80.58

1.5

1.3

0.47

0.32

nmol/l

3.66

357

603

Oligomenorrhoea

116

160

7.76

80.48

1.7

1.4

0.26

0.31

nmol/l

0.71

123

Used for control exclusion in common control thyroid runs

1496

4354

1.75

77.62

1.6

1.4

0.39

0.41

nmol/l

0.24

1179

3517

Other antidepressants

1366

3941

1.79

76.74

1.5

0.34

0.45

nmol/l

3.45

1042

3184

Endometriosis of rectovaginal septum and vagina

154

305

5.24

73.77

1.6

1.4

0.54

0.34

nmol/l

2.24

128

224

Mood disorders, excluding more controls

1285

4354

1.78

73.06

1.5

1.4

0.38

0.43

nmol/l

0.86

991

3426

Ovarian hyperstimulation (induction)

114

176

7.55

72.85

2.2

1.3

1.84

0.32

nmol/l

5.16

109

144

Other menopausal disorders

397

788

2.89

70.17

1.4

1.3

0.32

0.30

nmol/l

0.20

298

518

Depression medications

627

1383

2.32

69.44

1.5

1.4

0.39

0.53

nmol/l

1.76

485

1188

Gender identity disorders

100

150

7.83

65.77

2.2

1.7

0.26

0.34

nmol/l

0.86

132

Use of cabergoline

9.74

65.27

1.6

0.36

0.39

nmol/l

0.15

Dysplasia of cervi uteri

389

1095

2.62

61.70

1.5

1.3

0.48

0.34

nmol/l

2.15

320

764

Habitual aborter

129

7.45

58.17

1.6

1.3

0.71

0.37

nmol/l

1.16

106

Headache

1006

4644

1.75

57.27

1.4

0.33

0.46

nmol/l

6.06

792

3715

Hypothyroidism, strict autoimmune, 3 medication purchases required

1221

4986

1.67

57.02

1.5

1.4

0.47

0.42

nmol/l

0.57

972

3932

GASTRO-related operations

1259

3835

1.66

54.15

1.5

1.4

0.41

0.43

nmol/l

0.22

1002

3116

Any gastric operation

1259

3835

1.66

54.15

1.5

1.4

0.41

0.43

nmol/l

0.22

1002

3116

Any reimbursement code in KELA

1091

3211

1.72

53.32

1.5

0.37

0.48

nmol/l

3.12

853

2708

Other anxiety disorders

901

4508

1.76

52.60

1.5

1.4

0.39

0.45

nmol/l

0.89

756

3630

KRA_PSY_EATING, excluding more controls

318

1265

2.62

52.47

1.7

1.5

0.25

0.50

nmol/l

9.16

255

1079

Hypertrophy of breast in women and men

396

1770

2.29

50.15

1.4

0.31

0.42

nmol/l

1.15

304

1340

Panhypopituitarism

9.39

49.85

2.4

1.5

0.30

0.28

nmol/l

0.10

Liquid cancers, helper endpoint

282

930

2.67

49.31

1.6

1.4

0.27

0.34

nmol/l

1.04

217

727

Thyrotropin deficiency

9.19

48.68

1.6

1.4

0.41

0.42

nmol/l

0.04

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

143

371

3.92

48.49

1.6

1.4

0.26

0.31

nmol/l

0.59

114

300

Adrenocortical insufficiency

170

5.72

48.00

1.8

1.4

0.34

0.46

nmol/l

0.59

141

Menorrhagia

418

1025

2.29

46.99

1.4

1.3

0.37

0.33

nmol/l

0.48

327

698

Other disorders of adrenal gland

107

231

4.86

46.66

1.8

1.4

0.32

0.41

nmol/l

0.54

184

General symptoms and signs

1457

4765

1.54

46.50

1.5

1.4

0.30

0.45

nmol/l

11.71

1129

3818

Anorexia (incl.atypical)

207

711

3.06

45.89

1.8

1.5

0.25

0.52

nmol/l

5.21

163

597

Sleep disorders (combined)

1418

4862

1.54

45.55

1.5

1.4

0.35

0.44

nmol/l

2.59

1113

3856

Depression or dysthymia

728

2230

1.81

44.03

1.5

1.4

0.34

0.44

nmol/l

1.54

564

1767

Selective serotonin reuptake inhibitors

1190

3954

1.58

42.84

1.5

0.35

0.45

nmol/l

2.40

911

3191

Endometriosis of intestine

100

7.20

42.37

1.5

1.4

0.57

0.29

nmol/l

1.73

Eating disorder

319

1423

2.34

41.25

1.7

1.5

0.25

0.48

nmol/l

9.26

256

1207

Medical observation and evaluation for suspected diseases and conditions

886

2702

1.69

41.18

1.6

1.4

0.35

0.43

nmol/l

1.15

698

2150

Endometriosis ASRM stages 3,4

444

2255

2.01

40.35

1.5

1.4

0.61

0.48

nmol/l

1.64

377

1761

Adenomyosis (Endometriosis of uterus)

164

527

3.17

40.16

1.5

1.4

0.49

0.34

nmol/l

1.05

133

356

Eating disorders

327

1495

2.27

39.65

1.7

1.5

0.26

0.48

nmol/l

7.41

260

1266

Primary amenorrhea

111

7.25

38.37

2.1

1.7

0.21

0.40

nmol/l

2.04

Benign neoplasms

1336

4965

1.49

37.58

1.5

1.4

0.40

0.43

nmol/l

0.49

1071

4010

Pain in joint

748

2864

1.68

35.73

1.5

0.33

0.43

nmol/l

2.16

572

2313

Malignant neoplasm of ovary, including Hilmo

207

4.37

34.34

3.0

1.4

0.18

0.34

nmol/l

2.84

163

Deep endometriosis

213

862

2.55

34.19

1.6

1.4

0.56

0.47

nmol/l

0.77

183

712

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

154

516

2.98

34.15

1.6

1.3

0.17

0.26

nmol/l

3.14

390

Supervision of high-risk pregnancy

520

1731

1.85

33.30

1.4

0.49

0.33

nmol/l

2.23

418

1290

Anaemias

383

1251

2.03

33.25

1.5

1.4

0.39

0.55

nmol/l

2.83

315

1076

Dentofacial anomalies [including malocclusion]

1054

5674

1.50

32.90

1.5

1.4

0.45

0.42

nmol/l

0.41

825

4486

Primary_lymphoid and hematopoietic malignant neoplasms

183

698

2.65

32.69

1.7

1.4

0.29

0.28

nmol/l

0.13

152

526

Diabetes insipidus

10.80

32.68

2.5

1.4

0.25

0.29

nmol/l

0.26

Any mental disorder

1275

4375

1.47

32.43

1.5

1.4

0.38

0.43

nmol/l

0.91

975

3443

Psychiatric diseases

1115

3757

1.49

31.11

1.5

1.4

0.37

0.43

nmol/l

1.23

870

2944

Other diseases of blood and blood-forming organs, wide

236

1044

2.29

30.64

1.4

0.26

0.37

nmol/l

2.39

160

798

Ovarian dysfunction, other/unspecified

9.66

30.48

1.5

1.4

0.26

0.52

nmol/l

1.27

Diarrhoea and gastroenteritis of presumed infectious origin

1214

5586

1.44

29.70

1.5

1.4

0.41

0.40

nmol/l

0.09

955

4401

Hodgkin lymphoma, hilmo

140

4.95

29.54

1.7

1.5

0.39

0.34

nmol/l

0.24

114

Migraine, single triptan purchase ok & required. ICD-code if available is included

1121

5250

1.46

29.12

1.4

1.5

0.46

0.40

nmol/l

0.71

873

4147

Triptan medication for migraine, single purchase ok

1121

5250

1.46

29.12

1.4

1.5

0.46

0.40

nmol/l

0.71

873

4147

Rare circulating lymphoid malignancy, including Hilmo

6.49

28.41

2.0

1.4

0.24

0.38

nmol/l

0.91

Agranulocytosis

144

525

2.80

28.35

1.4

0.27

0.36

nmol/l

1.23

407

Pregnancy examination and test

454

1582

1.83

28.22

1.6

1.4

0.62

0.34

nmol/l

5.23

383

1208

Complications of procedures, not elsewhere classified

916

5107

1.49

28.01

1.4

0.35

0.43

nmol/l

2.40

693

4005

Opioids

1318

4868

1.41

27.87

1.5

0.39

0.44

nmol/l

0.79

1026

3923

Corticotropin deficiency

8.64

27.40

1.5

0.31

nmol/l

0.00

Migraine

877

4780

1.50

27.28

1.4

1.5

0.38

0.46

nmol/l

1.23

696

3853

Episodal and paroxysmal disorders

1402

5143

1.39

27.27

1.5

0.35

0.43

nmol/l

2.34

1093

4138

Drug-induced neutropenia

298

3.41

27.26

1.4

1.5

0.28

0.31

nmol/l

0.27

221

Other noninflammatory disorders of vulva and perineum

126

437

2.94

27.23

1.4

0.37

0.35

nmol/l

0.15

101

308

Hypertrichosis

289

3.61

27.16

1.5

0.38

0.51

nmol/l

0.47

247

Family history of malignant neoplasm

214

961

2.28

27.14

1.5

1.4

0.35

0.44

nmol/l

1.05

161

750

First line medication for Crohn's disease

1380

5385

1.39

26.91

1.5

1.4

0.34

0.43

nmol/l

5.15

1044

4344

Complications of medical and surgical care

789

4797

1.52

26.85

1.4

0.35

0.40

nmol/l

1.52

597

3718

Endometriosis ASRM stages 1,2

382

2119

1.84

26.81

1.4

0.54

0.48

nmol/l

0.65

318

1662

Hirsutism in women

259

3.76

26.61

1.5

0.40

0.50

nmol/l

0.31

223

Fever of other and unknown origin

628

3525

1.60

26.34

1.5

1.4

0.28

0.44

nmol/l

8.87

472

2798

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

627

3924

1.59

26.09

1.4

0.37

0.40

nmol/l

0.56

473

3034

Malignant neoplasm of breast, ER-negative, including Hilmo

175

699

2.41

25.49

1.3

0.37

0.40

nmol/l

0.18

116

521

Cystitis

1154

4880

1.41

25.15

1.5

1.4

0.41

0.43

nmol/l

0.25

908

3843

Other eating disorders

170

720

2.47

25.09

1.7

1.6

0.25

0.51

nmol/l

6.53

141

605

Malaise and fatigue

497

2400

1.68

25.06

1.5

0.27

0.45

nmol/l

8.87

374

1886

Malignant neoplasm of breast, HER-negative

148

571

2.57

24.91

1.2

1.3

0.33

0.41

nmol/l

0.70

420

Malignant neoplasm of ovary

139

4.51

24.88

3.7

1.3

0.16

0.38

nmol/l

3.79

111

Abdominal and pelvic pain

1135

4032

1.42

24.62

1.4

1.5

0.40

0.39

nmol/l

0.12

879

3206

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

578

3655

1.59

24.31

1.4

0.37

0.40

nmol/l

0.49

436

2808

Nonorganic sleeping disorders, excluding more controls

319

1723

1.88

24.26

1.7

1.4

0.40

0.44

nmol/l

0.22

269

1398

Lymphoid leukaemia

126

4.62

24.10

1.8

1.6

0.23

0.29

nmol/l

0.49

Persons encountering health services in circumstances related to reproduction

616

2635

1.59

23.99

1.6

1.4

0.35

0.26

nmol/l

1.21

485

1970

Caries of enamel

1098

5686

1.40

23.49

1.5

1.4

0.51

0.39

nmol/l

2.09

859

4475

Neurological diseases

1199

4346

1.39

23.29

1.5

0.37

0.45

nmol/l

1.66

946

3514

Autoimmune diseases

1331

4973

1.37

23.16

1.5

1.4

0.42

0.40

nmol/l

0.25

1058

3968

Drug-induced adrenocortical insufficiency

5.68

22.41

1.6

1.4

0.39

0.29

nmol/l

0.56

Symptoms and signs involving the digestive system and abdomen

1120

4032

1.40

22.25

1.4

1.5

0.41

0.39

nmol/l

0.17

872

3206

Secondary and unspecified malignant neoplasm of lymph nodes

215

3.54

22.25

1.7

1.4

0.31

0.30

nmol/l

0.11

180

Routine general health check-up of defined subpopulation

193

3.78

21.62

1.9

1.4

0.38

0.39

nmol/l

0.02

150

Benzodiazepine use

1151

5808

1.37

21.54

1.5

1.4

0.36

0.42

nmol/l

1.18

878

4618

Complications of surgical and medical care, not elsewhere classified

1081

5403

1.38

20.79

1.4

0.35

0.42

nmol/l

1.65

817

4258

Parasetamol

1015

3681

1.40

20.76

1.5

0.42

0.41

nmol/l

0.10

804

3023

Persons encountering health services in other circumstances, wide

1288

4934

1.35

20.75

1.6

1.4

0.36

0.42

nmol/l

1.29

1004

3878

Secondary uncertain malignant neoplasm

288

3.05

20.44

1.7

1.4

0.29

0.30

nmol/l

0.05

239

Intestinal infectious diseases

1287

5501

1.34

20.41

1.5

1.4

0.39

0.40

nmol/l

0.05

1011

4329

Examination and observation for other reasons

693

2695

1.50

20.35

1.5

1.4

0.45

0.43

nmol/l

0.16

540

2145

Dermatitis and eczema

1259

5843

1.34

20.19

1.5

1.4

0.37

0.41

nmol/l

1.10

973

4641

Chronic diseases of tonsils and adenoids

1021

4682

1.39

20.16

1.5

1.4

0.41

nmol/l

0.04

827

3699

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1222

4934

1.35

20.13

1.6

1.4

0.35

0.42

nmol/l

1.28

979

3878

Acute lymphocytic leukaemia, helper endpoint

7.39

20.05

1.7

1.5

0.25

0.43

nmol/l

0.81

Acute lymphocytic leukaemia, including Hilmo

7.39

20.05

1.7

1.5

0.25

0.43

nmol/l

0.81

Acute lymphocytic leukaemia

7.39

20.05

1.7

1.5

0.25

0.43

nmol/l

0.81

Other endocrine disorders

296

2.99

19.84

1.7

1.4

0.31

0.40

nmol/l

0.70

238

Postprocedural endocrine and metabolic disorders, not elsewhere classified

197

974

2.06

19.61

1.7

1.4

0.32

0.41

nmol/l

1.46

155

753

Codeine

1183

4774

1.35

19.59

1.5

1.4

0.39

0.44

nmol/l

0.94

922

3842

General examination and investigation of persons without complaint and reported diagnosis

754

2702

1.46

19.49

1.5

1.4

0.36

0.43

nmol/l

0.88

581

2150

Other noninflammatory disorders of uterus, except cervix

165

496

2.26

19.45

1.3

1.4

0.30

0.27

nmol/l

0.26

129

310

Postmenopausal atrophic vaginitis

227

626

2.02

19.16

1.3

1.4

0.23

0.28

nmol/l

0.73

149

386

Endocrine disorders, other/unspecified

100

4.72

19.16

1.6

1.3

0.38

0.40

nmol/l

0.08

Other metabolic disorders

204

1030

2.01

19.15

1.7

1.4

0.32

0.41

nmol/l

1.58

160

793

Postmenopausal bleeding

214

557

2.07

19.08

1.4

0.23

0.26

nmol/l

0.27

145

327

malignant neoplasm of female genital organs

106

404

2.63

18.96

2.7

1.3

0.21

0.35

nmol/l

2.69

300

Other noninflammatory disorders of vagina

329

2.84

18.94

1.8

1.3

0.41

0.31

nmol/l

0.69

235

Acute upper respiratory infections

1173

5412

1.34

18.80

1.4

0.34

0.43

nmol/l

3.24

885

4289

Other reaction to severe stress, and adjustment disorders

588

3967

1.50

18.76

1.6

1.4

0.37

0.46

nmol/l

2.21

471

3169

265

3.16

18.68

1.5

0.46

0.56

nmol/l

0.26

224

Other abnormal uterine and vaginal bleeding

191

669

2.06

18.22

1.3

1.4

0.34

0.33

nmol/l

0.16

140

445

Symptoms and signs involving the circulatory and respiratory systems

1325

5063

1.32

18.06

1.5

0.37

0.43

nmol/l

1.65

1021

4085

Cushing syndrome

6.38

17.55

3.1

1.4

0.23

0.43

nmol/l

0.97

Other other unspecified disorders of the circulatory system

124

4.06

17.54

1.3

0.26

0.28

nmol/l

0.09

Conjunctivitis

966

6002

1.35

17.11

1.5

1.4

0.43

0.41

nmol/l

0.17

792

4718

Other abnormal products of conception

758

3582

1.42

17.04

1.5

1.4

0.55

0.45

nmol/l

1.55

624

2854

Disorders of conjunctiva

1009

6069

1.34

16.93

1.5

1.4

0.42

0.41

nmol/l

0.16

821

4774

Triptan medication for migraine, min. 3 purchases

965

5483

1.35

16.92

1.4

0.43

0.44

nmol/l

0.10

758

4354

Spontaneous abortion

788

3819

1.40

16.91

1.5

1.4

0.54

0.44

nmol/l

1.39

624

3013

Hypothyroidism, drug reimbursement

207

757

1.95

16.89

1.5

1.4

0.35

0.57

nmol/l

3.39

159

654

Use of hypnotics and sedatives

1117

4848

1.33

16.66

1.5

1.4

0.33

0.43

nmol/l

3.82

862

3795

Other diseases of urinary system

1179

5053

1.32

16.51

1.5

1.4

0.42

nmol/l

0.11

933

3996

Primary adrenocortical insufficiency

5.80

16.44

1.7

1.4

0.33

0.37

nmol/l

0.14

Disorders of adult personality and behaviour

468

3121

1.52

15.95

1.6

1.5

0.34

0.43

nmol/l

0.99

371

2523

212

1159

1.86

15.76

1.7

1.5

0.39

0.47

nmol/l

0.55

166

922

Nonorganic sleeping disorders

319

1959

1.65

15.64

1.7

1.5

0.40

0.45

nmol/l

0.27

269

1576

Codeine or tramadol medication

1294

5505

1.29

15.61

1.5

0.38

0.42

nmol/l

0.87

1000

4389

Dental caries

255

1415

1.75

15.56

1.5

0.39

0.43

nmol/l

0.21

204

1129

Diseases of male genital organs

205

535

1.94

15.39

1.6

1.5

0.13

nmol/l

0.55

165

445

Other disorders of lacrimal gland

352

2220

1.60

15.36

1.4

0.29

0.41

nmol/l

3.16

255

1683

Caries of dentine

225

1226

1.80

15.27

1.6

1.5

0.30

0.42

nmol/l

2.01

182

979

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1107

5530

1.31

15.26

1.4

0.33

0.43

nmol/l

2.96

850

4361

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

517

1735

1.50

15.25

1.5

1.4

0.37

0.44

nmol/l

0.86

407

1418

Acromegaly and pituitary gigantism

12.47

15.20

2.0

1.3

0.36

0.34

nmol/l

0.05

Other symptoms and signs involving the digestive system and abdomen

186

989

1.90

15.03

1.7

1.4

0.33

0.39

nmol/l

0.51

151

757

Pain, not elsewhere classified

322

2001

1.62

14.96

1.5

0.39

0.49

nmol/l

1.15

251

1585

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

863

5114

1.34

14.74

1.5

1.4

0.49

0.45

nmol/l

0.53

684

4016

Other special examinations and investigations of persons without complaint or reported diagnosis

739

2703

1.39

14.52

1.5

1.4

0.39

0.43

nmol/l

0.33

580

2150

Oxycodone

230

1193

1.75

14.21

1.4

0.21

0.34

nmol/l

3.35

154

879

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

451

2731

1.48

13.97

1.6

1.4

0.25

0.35

nmol/l

3.94

338

2045

Carcinoma in situ of breast, intraductal

373

2.45

13.91

1.2

1.4

0.49

0.29

nmol/l

1.16

255

Pain (limb, back, neck, head abdominally)

783

2881

1.37

13.89

1.5

0.39

0.43

nmol/l

0.38

610

2327

Irritable bowel syndrome

354

2293

1.56

13.85

1.5

0.37

0.45

nmol/l

1.29

288

1790

Other headache syndromes

534

3751

1.43

13.83

1.4

0.32

0.44

nmol/l

3.99

392

2969

Sleep apnoea, including avohilmo

935

4398

1.32

13.80

1.5

1.4

0.28

0.40

nmol/l

4.58

690

3388

Impotence

4.75

13.78

2.6

1.3

0.13

0.12

nmol/l

0.35

Male infertility

100

3.96

13.71

1.6

1.4

0.13

0.12

nmol/l

0.31

Isolated growth hormone deficiency

6.56

13.65

2.6

1.5

0.22

0.42

nmol/l

0.67

Nausea and vomiting

272

1625

1.65

13.63

1.4

1.5

0.40

0.39

nmol/l

0.05

204

1297

Antihypertensive medication - note that there are other indications

1078

4423

1.30

13.59

1.5

0.39

0.46

nmol/l

1.42

879

3613

Persons encountering health services in other circumstances

467

3208

1.46

13.35

1.5

1.4

0.30

0.45

nmol/l

5.17

374

2542

Symptoms and signs involving the nervous and musculoskeletal systems

544

3860

1.42

13.32

1.4

1.5

0.35

0.40

nmol/l

0.65

405

3000

Abnormalities of heart beat

368

2378

1.53

13.22

1.5

0.30

0.42

nmol/l

3.55

292

1893

Other soft tissue disorders, not elsewhere classified

1105

5056

1.29

13.21

1.4

1.5

0.39

0.43

nmol/l

0.54

834

4112

Neurological diseases, wide definition

527

1834

1.45

13.17

1.6

1.4

0.40

0.46

nmol/l

0.51

419

1506

Disorders of puberty, all

164

3.27

13.02

2.0

1.6

0.33

nmol/l

0.03

138

Disorders of puberty

116

3.71

12.75

1.9

1.4

0.32

0.38

nmol/l

0.25

Hypo-osmolality and hyponatraemia

429

2.26

12.71

1.7

1.5

0.23

0.27

nmol/l

0.33

313

Any operation in hilmo

3.89

12.66

1.7

1.2

0.33

0.26

nmol/l

0.26

Other nutritional deficiencies

817

5865

1.32

12.60

1.5

1.4

0.39

0.43

nmol/l

0.56

657

4625

Torsion of ovary, ovarian pedicle and fallopian tube

103

3.80

12.47

1.3

1.4

0.48

0.28

nmol/l

1.38

Non-selective monoamine reuptake inhibitors

266

1589

1.62

12.47

1.5

1.4

0.33

0.37

nmol/l

0.40

195

1208

Certain infectious and parasitic diseases

1178

4662

1.27

12.43

1.5

1.4

0.35

0.43

nmol/l

2.56

892

3743

Personality disorders, excluding more controls

379

2559

1.49

12.26

1.5

1.4

0.37

0.48

nmol/l

1.11

299

2090

Other disorders of fluid, electrolyte and acid-base balance

183

981

1.79

12.25

1.6

1.4

0.25

0.32

nmol/l

0.88

138

712

Uterine polyps

408

2.28

12.22

1.4

0.50

0.30

nmol/l

1.51

265

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

841

4088

1.32

12.21

1.4

1.5

0.62

0.45

nmol/l

2.43

702

3345

Other CVD

454

2.19

12.06

1.3

1.4

0.26

nmol/l

0.04

349

Other obstetric conditions, not elsewhere classified

851

4161

1.32

11.99

1.4

1.5

0.61

0.45

nmol/l

2.49

708

3391

Special screening examination for infectious and parasitic diseases

438

2234

1.46

11.93

1.6

1.4

0.42

0.47

nmol/l

0.86

389

1831

Other symptoms and signs involving the nervous and musculoskeletal systems

432

3008

1.44

11.87

1.4

1.5

0.37

0.42

nmol/l

0.49

315

2343

Asthma (mode)

902

3721

1.30

11.82

1.5

1.4

0.41

0.42

nmol/l

0.07

687

2976

Certain infectious and parasitic diseases

851

3255

1.31

11.74

1.5

1.4

0.35

0.43

nmol/l

1.52

664

2593

Diabetes, insulin treatment (Kela reimbursement)

558

4610

0.73

11.73

1.4

0.25

0.38

nmol/l

5.52

407

3541

Mycoses

919

6245

1.28

11.66

1.5

1.4

0.37

0.41

nmol/l

0.81

727

4943

Panic disorder

273

1748

1.58

11.45

1.5

0.31

0.45

nmol/l

3.15

219

1438

Disorders of lacrimal system

391

2685

1.46

11.43

1.4

0.31

0.40

nmol/l

1.95

290

2040

Other complications of surgical and medical care, not elsewhere classified

115

574

2.03

11.36

1.6

1.5

0.39

0.36

nmol/l

0.06

456

Allergic conjunctivitis

759

5674

1.31

11.32

1.5

1.4

0.43

0.42

nmol/l

0.10

624

4441

Polyuria

148

804

1.85

11.29

1.5

1.4

0.24

0.34

nmol/l

1.79

119

630

Acute upper respiratory infections of multiple and unspecified sites

900

5209

1.29

11.26

1.5

1.4

0.32

0.43

nmol/l

4.16

701

4144

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

729

5421

1.31

11.11

1.5

1.4

0.44

0.42

nmol/l

0.13

601

4242

Sleep apnoea

808

4031

1.30

10.94

1.5

1.4

0.28

0.38

nmol/l

3.26

587

3072

Congenital malformations, deformations and chromosomal abnormalities

837

6016

1.29

10.92

1.5

0.40

0.42

nmol/l

0.19

695

4765

Other dorsopathies, not elsewhere classified

1205

5091

1.24

10.74

1.4

1.5

0.37

0.43

nmol/l

1.42

942

4092

Diseases of the eye and adnexa

1114

4463

1.26

10.73

1.5

0.41

0.42

nmol/l

0.09

875

3594

Soft tissue disorders

1225

5103

1.24

10.67

1.4

1.5

0.37

0.42

nmol/l

0.92

930

4150

Other diseases of upper respiratory tract

1139

4767

1.25

10.63

1.5

1.4

0.41

nmol/l

0.06

880

3765

Inflammatory diseases of prostate (prostatitis)

161

2.94

10.58

1.4

0.10

0.12

nmol/l

0.83

136

Asthma, excluding more controls

899

3665

1.28

10.55

1.5

1.4

0.42

nmol/l

0.07

685

2933

Symptoms and signs concerning food and fluid intake

440

2.13

10.54

1.7

1.5

0.23

0.40

nmol/l

3.01

352

Asthma

901

3702

1.28

10.38

1.5

1.4

0.42

nmol/l

0.05

686

2963

Intestinal infectious diseases

1005

6100

1.25

10.35

1.5

1.4

0.38

0.41

nmol/l

0.35

800

4839

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

554

4477

0.74

10.30

1.4

0.25

0.38

nmol/l

5.72

404

3440

Asthma, including avohilmo

1284

5902

1.23

10.20

1.4

1.5

0.40

0.41

nmol/l

0.12

999

4695

Other maternal disorders predominantly related to pregnancy

905

4483

1.27

10.19

1.4

0.50

0.41

nmol/l

1.21

719

3473

Dental pulpitis, including avohilmo

1115

5859

1.24

10.10

1.4

1.5

0.41

nmol/l

0.01

869

4663

Factors influencing health status and contact with health services

232

715

1.63

10.08

1.6

1.3

0.25

0.26

nmol/l

0.12

185

555

Coxibs

283

964

1.55

10.06

1.7

1.5

0.29

0.41

nmol/l

1.97

232

810

Cerebral cysts

418

2.15

10.03

1.4

1.5

0.32

0.42

nmol/l

0.91

347

Bronchitis

1165

5970

1.23

10.00

1.5

0.33

0.42

nmol/l

3.62

901

4741

Generalized anxiety disorder

290

1941

1.51

9.99

1.4

1.5

0.37

0.45

nmol/l

0.83

244

1596

Hyperhidrosis

249

2.52

9.96

1.7

1.5

0.30

0.49

nmol/l

1.55

210

Symptoms and signs involving the skin and subcutaneous tissue

709

5370

1.30

9.93

1.4

0.40

0.41

nmol/l

0.09

549

4188

L01XE Protein kinase inhibitors

136

3.06

9.83

1.5

1.4

0.20

0.29

nmol/l

0.70

101

Emotional disorders starting during childhood or adolecense, excluding more controls

100

490

2.04

9.82

1.4

1.5

0.28

0.45

nmol/l

2.44

417

Abnormal results of function studies

455

2.07

9.77

1.7

1.5

0.26

0.37

nmol/l

1.13

360

Chronic periodontitis, including avohilmo

547

4854

0.75

9.45

1.5

1.4

0.36

0.39

nmol/l

0.21

392

3760

Fenamates

176

712

1.69

9.25

1.5

0.33

0.46

nmol/l

1.91

146

589

Periodontitis

552

4864

0.76

9.22

1.5

1.4

0.36

0.39

nmol/l

0.20

394

3772

Dorsopathies

1223

5110

1.22

9.21

1.5

0.37

0.43

nmol/l

1.09

959

4108

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

372

2.13

9.13

1.4

1.3

0.16

0.24

nmol/l

1.92

280

Abnormal findings in secretions and smears from cervix uteri vagina vulva

823

4945

1.27

9.12

1.5

1.4

0.51

0.46

nmol/l

0.57

654

3881

Temporomandibular joint disorders, including avohilmo

687

5295

1.29

9.06

1.5

0.43

0.44

nmol/l

0.05

540

4245

Dorsalgia

1154

5068

1.22

9.02

1.4

1.5

0.34

0.43

nmol/l

3.21

882

4072

Certain disorders involving the immune mechanism

167

1008

1.67

8.96

1.6

1.4

0.28

0.35

nmol/l

0.69

130

763

Hyperkinetic disorders, excluding more controls

222

1378

1.56

8.87

1.6

1.5

0.29

0.49

nmol/l

5.74

190

1179

Bacterial infection, other or unspecified

333

2024

1.43

8.81

1.5

1.4

0.24

0.36

nmol/l

4.45

236

1543

Oedema, not elsewhere classified

232

1499

1.53

8.78

1.4

0.34

0.43

nmol/l

1.30

174

1149

Other specific joint derangements/joint disorders

946

4947

1.24

8.70

1.4

1.5

0.34

0.44

nmol/l

3.70

732

3986

Other functional intestinal disorders

388

2604

1.39

8.64

1.6

1.5

0.37

0.40

nmol/l

0.17

305

1988

Acetic acid derivatives and related substances

272

938

1.51

8.63

1.5

0.45

0.41

nmol/l

0.26

222

786

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

473

3437

1.34

8.57

1.4

0.30

0.38

nmol/l

2.53

357

2669

Asthma (only as main-diagnosis)

804

3702

1.26

8.46

1.4

0.43

0.42

nmol/l

0.04

612

2963

Abnormal findings on diagnostic imaging of central nervous system

303

2.22

8.27

1.4

0.27

0.37

nmol/l

0.80

246

Disease of hard tissues of teeth, NOS

486

1895

1.35

8.19

1.4

0.34

0.41

nmol/l

0.95

368

1501

Malignant neoplasm of mesothelium and soft tissue

3.72

8.19

1.4

1.5

0.17

0.35

nmol/l

1.36

Congenital malformations, deformations and chromosomal abnormalities

765

5842

1.25

8.12

1.5

0.40

0.42

nmol/l

0.28

631

4643

Gastrointestinal diseases

867

3496

1.25

8.07

1.5

0.39

0.44

nmol/l

0.57

692

2819

Tramadol

750

3661

1.26

8.07

1.5

1.4

0.32

0.42

nmol/l

2.51

568

2871

Disorders of parathyroid gland

107

579

1.83

8.07

1.5

1.4

0.31

0.28

nmol/l

0.22

414

Implicit viral Sepsis

208

1358

1.54

8.05

1.5

1.4

0.30

0.39

nmol/l

1.30

159

1061

Somatoform disorder

197

1274

1.56

8.03

1.5

1.4

0.30

0.44

nmol/l

3.26

146

1003

Obesity related asthma

300

2109

1.43

8.03

1.5

1.4

0.35

0.37

nmol/l

0.15

215

1598

Persons encountering health services for examination and investigation

688

2703

1.28

8.01

1.5

1.4

0.38

0.43

nmol/l

0.48

553

2150

Other pulmonary diagnosis

920

3738

1.24

7.96

1.5

1.4

0.44

0.42

nmol/l

0.16

709

2992

Pain associated with micturition

110

612

1.81

7.96

1.4

1.5

0.30

0.39

nmol/l

1.04

480

Asthma (only as main-diagnosis), excluding more controls

799

3665

1.25

7.84

1.4

0.43

0.42

nmol/l

0.02

610

2933

Obesity and other hyperalimentation

749

5800

1.25

7.82

1.5

1.4

0.40

0.43

nmol/l

0.42

602

4570

Other septicaemia

210

1330

1.52

7.77

1.5

1.4

0.25

0.35

nmol/l

2.22

165

1005

Chromosomal abnormalities, not elsewhere classified

186

2.55

7.74

2.0

1.4

0.31

0.40

nmol/l

0.79

151

Follow-up examination after treatment for conditions other than malignant neoplasms

504

2540

1.32

7.71

1.4

0.35

0.45

nmol/l

2.01

401

2015

Obesity

746

5795

1.25

7.68

1.5

1.4

0.40

0.43

nmol/l

0.44

600

4565

Chronic rhinitis, nasopharyngitis and pharyngitis

339

2456

1.39

7.65

1.5

1.4

0.34

0.39

nmol/l

0.74

276

1900

Non-Hodgkin lymphoma, all, including Hilmo

260

2.24

7.65

1.7

1.4

0.26

nmol/l

0.03

208

Excluding asthma or asthma-COPD overlap

916

3738

1.23

7.64

1.5

1.4

0.43

0.42

nmol/l

0.13

708

2992

Secondary polycythaemia

3.54

7.58

1.4

1.5

0.24

0.30

nmol/l

0.35

ILD differential diagnosis

911

3721

1.23

7.53

1.5

1.4

0.44

0.42

nmol/l

0.15

702

2976

Diseases of the skin and subcutaneous tissue

1095

4561

1.21

7.53

1.5

1.4

0.38

0.43

nmol/l

0.80

848

3631

Malignant melanoma, including Hilmo

436

1.94

7.53

1.4

1.3

0.27

0.30

nmol/l

0.22

346

Maternal care for known or suspected fetal abnormality and damage

382

2435

1.37

7.50

1.6

1.4

0.62

0.47

nmol/l

1.20

330

1967

Tonsillectomy and adenotomy

920

5263

1.22

7.50

1.4

1.5

0.44

0.43

nmol/l

0.07

764

4209

Thyroiditis, ILD-related definition

159

996

1.62

7.50

1.6

1.5

0.43

0.45

nmol/l

0.10

127

793

Bacterial infection, other or unspecified

370

2297

1.37

7.48

1.5

1.4

0.25

0.38

nmol/l

5.44

265

1755

Post-traumatic stress disorder

181

1173

1.57

7.45

1.5

0.32

0.47

nmol/l

3.91

146

976

COPD differential diagnosis

910

3723

1.23

7.42

1.5

1.4

0.44

0.42

nmol/l

0.16

701

2978

Antenatal screening

438

1845

1.34

7.34

1.4

0.48

0.32

nmol/l

1.53

349

1383

Monoamine oxidase A inhibitors

497

1.87

7.34

1.3

1.4

0.40

0.38

nmol/l

0.04

384

Other diseases of intestines

1211

5799

1.19

7.33

1.5

0.37

0.42

nmol/l

0.89

951

4615

Personal history of other diseases and conditions

201

1331

1.52

7.30

1.4

1.5

0.45

0.48

nmol/l

0.09

165

1090

Septicaemia

238

1525

1.46

7.26

1.4

0.25

0.37

nmol/l

3.34

180

1159

Inflammatory diseases of female pelvic organs

884

5346

1.22

7.22

1.4

0.46

0.45

nmol/l

0.19

698

4204

Female genital prolapse

206

762

1.53

7.22

1.3

0.36

0.33

nmol/l

0.41

153

492

Osteoporosis

117

636

1.73

7.19

1.9

1.5

0.28

0.26

nmol/l

0.10

430

Malignant neoplasm of endocrine gland

308

2.10

7.14

1.7

1.4

0.24

0.41

nmol/l

1.95

255

Covid-19 confirmed case

305

2198

1.39

7.13

1.5

0.29

0.41

nmol/l

3.51

227

1747

Abnormal findings on diagnostic imaging of other body structures

109

626

1.75

7.12

1.9

1.4

0.27

0.34

nmol/l

0.83

478

Disorders of skin appendages

565

4445

1.28

7.12

1.5

0.38

0.42

nmol/l

0.60

464

3525

Psychotic depression

350

2.03

7.06

1.5

0.45

0.50

nmol/l

0.14

298

Disorders of thyroid, IBD co-morbidities

276

1367

1.43

7.03

1.5

1.4

0.41

0.48

nmol/l

0.95

216

1109

Malignant neoplasm of brain, including Hilmo

170

2.50

7.02

2.0

1.5

0.22

0.34

nmol/l

1.77

147

Atopic dermatitis

808

5426

1.23

6.96

1.5

1.4

0.41

0.43

nmol/l

0.30

649

4333

Visual disturbances and blindness

442

3381

1.31

6.96

1.6

1.5

0.37

0.40

nmol/l

0.26

332

2636

Contraceptive management

427

2266

1.33

6.95

1.5

1.4

0.36

0.28

nmol/l

0.72

323

1688

Other congenital malformations

129

783

1.67

6.94

1.7

1.5

0.56

0.42

nmol/l

0.38

105

626

Cardiovascular diseases

1024

4590

1.20

6.92

1.5

0.44

0.45

nmol/l

0.06

810

3770

Disorders of ocular muscles, binocular movement, accommodation and refraction

555

4348

1.27

6.82

1.4

1.5

0.36

0.42

nmol/l

0.70

428

3465

Autism spe, excluding more controls

198

2.38

6.81

1.7

1.4

0.30

0.46

nmol/l

0.88

168

Obsessive-compulsive disorder

131

805

1.65

6.78

1.7

1.5

0.45

nmol/l

0.03

109

678

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

504

1.82

6.77

1.6

1.5

0.27

0.40

nmol/l

1.74

400

Cluster headache, wide

269

2.16

6.75

1.4

0.25

0.43

nmol/l

1.86

221

Malignant melanoma

349

1.99

6.71

1.4

0.26

0.28

nmol/l

0.19

283

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

127

2.73

6.71

1.3

1.4

0.81

0.26

nmol/l

1.20

Other/unspecified dorsalgia

363

2694

1.34

6.70

1.5

0.34

0.43

nmol/l

1.79

266

2107

Explicit Sepsis

298

2018

1.38

6.66

1.4

0.28

0.41

nmol/l

3.76

228

1584

Gestational diabetes (for exclusion)

811

4647

1.22

6.63

1.5

1.4

0.59

0.45

nmol/l

1.73

665

3727

1191

5216

1.18

6.61

1.4

0.33

0.43

nmol/l

4.13

901

4141

Other general symptoms and signs

349

1.99

6.59

1.6

1.4

0.26

0.48

nmol/l

3.25

288

Hyperparathyroidism

480

1.82

6.58

1.5

1.3

0.32

0.26

nmol/l

0.51

335

Deviated nasal septum

206

1403

1.47

6.57

1.4

0.24

0.35

nmol/l

3.33

163

1093

Disorders of refraction and accommodation

336

2487

1.35

6.57

1.4

1.5

0.36

0.40

nmol/l

0.49

268

1980

Postprocedural disorders of nervous system

127

782

1.65

6.53

1.3

1.5

0.41

0.46

nmol/l

0.31

106

643

Dissociative [conversion] disorders

404

1.92

6.53

1.4

1.5

0.56

0.46

nmol/l

0.11

338

Other joint disorders

1119

4989

1.19

6.47

1.5

0.36

0.44

nmol/l

2.37

889

4016

Misadventures to patients during surgical and medical care

121

738

1.65

6.39

1.5

1.4

0.29

0.38

nmol/l

1.36

581

Visual disturbances

420

3233

1.30

6.39

1.6

1.5

0.38

0.40

nmol/l

0.21

312

2523

Fibromyalgia

140

888

1.60

6.36

1.3

1.4

0.32

0.42

nmol/l

1.25

707

Disorders of mineral metabolism

343

1.97

6.35

1.2

1.5

0.35

0.28

nmol/l

0.38

256

Melanocytic naevi

326

2425

1.35

6.34

1.5

0.39

0.44

nmol/l

0.45

265

1901

Disturbances of skin sensation

338

2531

1.34

6.30

1.4

1.5

0.32

0.46

nmol/l

4.25

263

2008

Myalgia

274

1986

1.39

6.29

1.5

0.33

0.45

nmol/l

2.06

197

1594

Cluster headache, strict

265

2.12

6.22

1.4

0.25

0.43

nmol/l

1.70

217

Haemorrhage from respiratory passages

181

1094

1.50

6.21

1.5

0.22

0.34

nmol/l

3.48

141

846

Brain meningioma, including Hilmo

138

2.56

6.21

1.3

0.21

0.34

nmol/l

1.34

111

Congenital malformations and deformations of the musculoskeletal system

133

834

1.61

6.20

1.5

0.33

0.43

nmol/l

1.16

116

676

Polyneuropathies and other disorders of the peripheral nervous system

109

652

1.68

6.19

1.8

1.4

0.28

0.26

nmol/l

0.11

485

Other and unspecified drugs and medicaments

475

1.81

6.18

1.6

1.5

0.26

0.39

nmol/l

1.55

374

Candidiasis

327

2446

1.34

6.15

1.8

1.5

0.42

0.46

nmol/l

0.37

261

1949

Short stature, not elsewhere classified

145

2.49

6.13

1.9

1.4

0.26

0.39

nmol/l

0.99

122

Other disorders of optic [2nd] nerve and visual pathways

341

1.96

6.13

1.7

1.4

0.26

0.36

nmol/l

0.79

275

Enlarged lymph nodes

140

896

1.57

6.08

1.4

0.25

0.45

nmol/l

4.42

115

699

Bulimia nervosa (incl. atypical)

526

1.78

6.04

1.4

1.6

0.28

0.56

nmol/l

4.00

448

Sleep disorders, other/unspecified

289

2.05

6.02

1.9

1.5

0.61

0.40

nmol/l

0.26

237

Migraine with aura

396

3056

1.30

6.00

1.5

0.40

0.47

nmol/l

0.78

333

2495

Persons with potential health hazards related to communicable diseases

580

4643

1.24

6.00

1.5

0.34

0.46

nmol/l

4.86

430

3813

Congenital malformations and deformations of the musculoskeletal system

158

1038

1.53

5.99

1.6

1.5

0.35

0.43

nmol/l

0.84

137

835

Hard cardiovascular diseases

363

2838

0.76

5.97

1.4

0.24

0.30

nmol/l

1.82

263

2053

Wide developmental disorders, excluding more controls

253

2.10

5.89

1.7

1.5

0.29

0.43

nmol/l

0.96

211

Diseases of liver

232

1654

1.41

5.87

1.4

0.23

0.35

nmol/l

4.21

172

1238

Diseases of the respiratory system

750

3089

1.22

5.87

1.5

1.4

0.45

0.43

nmol/l

0.16

562

2472

Diarrhoea and gastroenteritis of presumed infectious origin

738

5503

1.21

5.86

1.5

1.4

0.38

0.42

nmol/l

0.84

582

4393

Other and unspecified polyneuropathies, also in other diseases

505

1.75

5.83

1.5

1.4

0.29

0.26

nmol/l

0.15

381

Primary hyperparathyroidism

354

1.91

5.81

1.6

1.4

0.35

0.27

nmol/l

0.58

247

Hernia of abdominal wall, postoperative

118

733

1.62

5.81

1.6

1.3

0.32

0.40

nmol/l

0.58

573

Other sleep disorders

103

619

1.68

5.81

1.6

1.5

0.39

0.37

nmol/l

0.08

499

Lower back pain or/and sciatica

1077

6002

1.17

5.80

1.4

1.5

0.33

0.42

nmol/l

2.87

806

4792

Mycoses

225

1600

1.41

5.80

1.5

0.39

0.42

nmol/l

0.16

168

1255

Malignant neoplasm of urinary organs

125

2.57

5.78

1.4

0.24

nmol/l

0.01

102

Abnormalities of breathing

1024

5054

1.18

5.74

1.4

1.5

0.33

0.44

nmol/l

4.03

769

4078

Oter anti-inflammatory and antirheumatic agents, non-steroids

114

378

1.67

5.73

1.6

1.4

0.29

0.48

nmol/l

1.51

298

Malignant neoplasm of testis

5.27

5.73

2.0

1.5

0.14

0.15

nmol/l

0.16

Other disorders of male genital organs

3.36

5.73

1.9

1.4

0.12

nmol/l

0.01

Specific personality disorders

339

2580

1.32

5.72

1.5

0.37

0.44

nmol/l

0.49

270

2097

Personality disorders

379

2928

1.30

5.72

1.5

0.37

0.43

nmol/l

0.52

299

2365

Benign neoplasm of ovary

138

895

1.55

5.69

1.7

1.4

0.48

0.37

nmol/l

0.53

636

Cervical disc disorders

234

1681

1.40

5.68

1.5

1.4

0.27

0.34

nmol/l

1.98

177

1244

Brain meningioma

133

2.51

5.62

1.3

0.22

0.35

nmol/l

1.29

106

Major coronary heart disease event

291

2352

0.74

5.61

1.3

1.4

0.23

0.27

nmol/l

0.51

199

1668

Follow-up examination after treatment for malignant neoplasms

262

2.03

5.57

1.4

0.18

0.26

nmol/l

1.08

194

Other extrapyramidal and movement disorders in other diseases

162

1092

1.49

5.56

1.4

0.30

0.37

nmol/l

0.83

128

824

Mouth breathing

277

2050

1.35

5.56

1.5

1.4

0.30

0.34

nmol/l

0.52

215

1546

Other epidermal thickening

184

2.26

5.53

1.4

0.22

0.35

nmol/l

1.61

145

Pain in limb

868

4895

1.19

5.48

1.4

1.5

0.36

0.43

nmol/l

1.42

656

3975

Premature rupture of membranes

484

2763

1.26

5.47

1.4

0.45

nmol/l

0.03

385

2224

Malignant neoplasm of other connective and soft tissue, including Hilmo

2.84

5.42

1.4

0.17

0.37

nmol/l

2.20

Obesity, other/unspecified

431

3408

1.27

5.42

1.5

1.4

0.44

0.43

nmol/l

0.07

357

2665

Benign paroxysmal vertigo

196

1380

1.43

5.38

1.3

1.4

0.30

0.36

nmol/l

0.82

147

1012

In situ neoplasms

304

2298

1.33

5.36

1.3

1.5

0.47

0.44

nmol/l

0.12

221

1774

Malignant neoplasm of testis, including Hilmo

4.79

5.32

2.0

1.6

0.14

0.15

nmol/l

0.13

Emotional disorders and disorders of social functioning with onset specific to childhood

107

656

1.63

5.32

1.4

1.6

0.27

0.40

nmol/l

2.11

551

Contact with and exposure to communicable diseases

514

4141

1.24

5.30

1.4

1.5

0.34

0.47

nmol/l

4.23

374

3412

Implicit viral Sepsis

127

822

1.55

5.30

1.4

0.22

0.35

nmol/l

3.56

655

Other symptoms and signs involving cognitive functions and awareness

246

1643

1.37

5.22

1.5

1.4

0.28

0.34

nmol/l

1.08

194

1223

Viral Sepsis

127

825

1.55

5.22

1.4

0.22

0.35

nmol/l

3.51

658

Syncope and collapse

315

2052

1.32

5.20

1.4

1.5

0.36

0.45

nmol/l

1.04

233

1635

Low back pain

812

4917

1.19

5.18

1.4

1.5

0.35

0.44

nmol/l

2.11

610

3949

Other complications of labour and delivery, not elsewhere classified

304

2126

1.33

5.17

1.6

1.5

0.64

0.46

nmol/l

2.38

278

1774

Transplanted organ and tissue status

376

1.82

5.17

1.6

1.5

0.24

0.28

nmol/l

0.47

284

Other diseases of hard tissues of teeth

463

1900

1.26

5.11

1.4

0.31

0.40

nmol/l

2.16

363

1505

Radiculopathy

100

619

1.62

5.06

1.3

1.4

0.27

0.33

nmol/l

0.81

458

Postpartum care and examination

306

1470

1.33

5.06

1.3

1.4

0.48

0.35

nmol/l

1.43

243

1131

Other diseases of liver

143

961

1.50

5.04

1.5

1.4

0.23

0.33

nmol/l

1.89

109

716

Malignant neoplasm of thyroid gland, including Hilmo

329

1.87

5.04

1.7

1.4

0.32

0.40

nmol/l

0.42

278

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

147

2.32

5.00

1.4

1.3

0.18

0.27

nmol/l

0.96

117

Percutaneous Coronary Intervention

273

2220

0.75

5.00

1.3

1.4

0.24

0.26

nmol/l

0.40

190

1571

Malignant neoplasm of eye, brain and central nervous system

129

2.43

4.98

1.9

1.6

0.21

0.34

nmol/l

1.39

111

Abrasion of teeth

313

2404

1.31

4.97

1.5

1.4

0.36

0.39

nmol/l

0.35

235

1813

Restless leg syndrome

109

693

1.58

4.97

1.4

1.5

0.35

0.38

nmol/l

0.17

537

Enterocolitis due to Clostridium difficile

352

1.83

4.96

1.6

1.5

0.23

0.33

nmol/l

1.52

282

Unspecified misadventure during surgical and medical care

240

2.02

4.96

1.4

1.5

0.34

0.32

nmol/l

0.15

190

Salpingitis and oophoritis

175

1228

1.43

4.96

1.5

1.4

0.47

0.37

nmol/l

0.66

128

895

Benign neoplasm: Colon

230

1610

1.37

4.95

1.4

0.31

0.28

nmol/l

0.32

170

1149

Disorders of tooth development and eruption

216

1267

1.39

4.94

1.6

1.5

0.53

0.48

nmol/l

0.15

177

1041

Sciatica+with lumbago

466

3454

1.24

4.94

1.5

1.4

0.36

0.41

nmol/l

0.51

338

2685

Malignant melanoma of skin, including Hilmo

360

1.81

4.92

1.4

1.3

0.26

0.30

nmol/l

0.33

292

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

387

2724

1.27

4.87

1.5

0.30

0.44

nmol/l

5.84

321

2307

Anankastic personality disorder

334

1.86

4.87

1.7

1.5

0.27

0.46

nmol/l

2.15

284

Disorders of calcium metabolism

235

2.02

4.85

1.1

1.5

0.42

0.28

nmol/l

0.69

177

454

3630

1.24

4.85

1.5

0.34

0.40

nmol/l

1.05

339

2877

Abnormal weight loss

348

1.82

4.84

1.7

1.5

0.27

0.31

nmol/l

0.38

274

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

379

2984

1.27

4.83

1.4

0.42

0.49

nmol/l

0.77

293

2425

Hypoparathyroidism

119

2.47

4.81

1.6

1.4

0.35

0.36

nmol/l

0.02

Coronary revascularization (ANGIO or CABG)

276

2225

0.76

4.80

1.3

1.4

0.24

0.27

nmol/l

0.46

192

1573

Migraine with aura and triptan purchases

284

2169

1.32

4.79

1.5

0.43

0.46

nmol/l

0.13

237

1761

Emergency coronary revascularization (for ACS)

286

2277

0.76

4.78

1.3

1.4

0.23

0.26

nmol/l

0.49

198

1604

Type 2 diabetes, wide definition

329

2703

0.78

4.74

1.5

1.4

0.22

0.34

nmol/l

5.44

236

2008

Arthropathies

1134

4994

1.15

4.72

1.5

0.36

0.44

nmol/l

2.40

899

4021

Other skin changes

118

773

1.53

4.72

1.4

1.5

0.35

0.36

nmol/l

0.08

599

Benign neoplasm: Cerebral meninges

344

1.82

4.70

1.4

0.27

nmol/l

0.02

248

Other and unspecified dermatitis

465

3772

1.24

4.70

1.5

1.4

0.33

0.40

nmol/l

1.44

358

2928

Implicit fungal Sepsis

266

1.93

4.69

2.0

1.5

0.42

0.33

nmol/l

0.46

218

Implicit fungal Sepsis

115

2.46

4.64

1.4

0.34

0.35

nmol/l

0.05

Dermatographic urticaria

581

1.62

4.63

1.4

0.38

0.45

nmol/l

0.24

470

Malignant neoplasm of kidney, except renal pelvis

121

2.41

4.63

1.4

0.20

0.22

nmol/l

0.21

Bipolar affective disorders

243

1823

1.34

4.62

1.5

0.35

0.46

nmol/l

1.55

200

1480

Crossbite

565

1.61

4.60

1.4

1.5

0.26

0.29

nmol/l

0.22

455

Immunodeficiencies

290

1.89

4.58

1.7

1.5

0.22

0.40

nmol/l

1.95

226

Benign neoplasm of meninges

369

1.77

4.58

1.4

0.27

0.26

nmol/l

0.04

268

Varicose veins

240

2407

0.75

4.57

1.4

0.44

0.32

nmol/l

0.50

169

1704

Other diseases of lip and oral mucosa

324

2531

1.28

4.56

1.4

0.38

0.40

nmol/l

0.08

250

1911

Asthma, hospital admissions , main diagnosis only

829

6265

1.17

4.55

1.4

1.5

0.42

0.40

nmol/l

0.16

633

4976

Migraine without aura

351

2774

1.27

4.55

1.4

1.5

0.40

0.46

nmol/l

0.40

280

2248

COPD/asthma/ILD related infections

1123

4898

1.15

4.54

1.5

1.4

0.36

0.43

nmol/l

2.15

840

3914

COPD/asthma related infections

1123

4898

1.15

4.54

1.5

1.4

0.36

0.43

nmol/l

2.15

840

3914

Other diseases of blood and blood-forming organs

248

1.95

4.54

1.5

0.31

0.30

nmol/l

0.02

191

Asthma-related infections

536

4338

1.21

4.51

1.5

0.35

0.38

nmol/l

0.54

401

3407

Asthma, hospital admission 2, infections

536

4338

1.21

4.51

1.5

0.35

0.38

nmol/l

0.54

401

3407

Non-follicular lymphoma

194

2.07

4.49

1.9

1.5

0.19

0.26

nmol/l

0.90

148

Weight loss

424

1.71

4.47

1.7

1.5

0.25

0.33

nmol/l

1.05

338

Dysphagia

147

1019

1.45

4.47

1.3

1.4

0.50

0.33

nmol/l

0.67

109

771

Hypoplasia of dental enamel , including avohilmo

313

1.83

4.44

1.7

1.6

0.27

0.34

nmol/l

0.68

270

Use of pramipexole

123

825

1.50

4.42

1.5

1.4

0.31

0.30

nmol/l

0.05

603

Osteopathies and chondropathies

408

3059

1.25

4.41

1.6

1.4

0.28

0.38

nmol/l

3.23

307

2333

Haemorrhoids and perianal venous thrombosis

194

1412

1.37

4.40

1.4

0.42

0.39

nmol/l

0.17

147

1070

Maternal care related to the fetus and amniotic cavity and possible delivery problems

727

3615

1.19

4.40

1.4

0.47

0.40

nmol/l

0.86

565

2811

Constipation

710

4161

1.18

4.37

1.5

1.4

0.35

0.37

nmol/l

0.11

524

3165

Major coronary heart disease event excluding revascularizations

107

1079

0.66

4.36

1.1

1.4

0.20

nmol/l

0.12

748

Hypertrophy of breast

230

1729

1.34

4.36

1.3

1.4

0.45

0.42

nmol/l

0.12

172

1308

Melanocytic naevi of trunk

120

805

1.50

4.35

1.4

1.5

0.44

0.43

nmol/l

0.06

643

Cerebrovascular diseases

221

2070

0.75

4.32

1.4

0.27

0.30

nmol/l

0.21

171

1508

Nonalcoholic fatty liver disease

521

1.63

4.31

1.3

1.4

0.26

0.31

nmol/l

0.42

393

Candidiasis

134

921

1.47

4.30

1.4

1.5

0.48

0.44

nmol/l

0.15

742

Diseases of oral cavity, salivary glands and jaws

456

1900

1.24

4.26

1.4

0.34

0.40

nmol/l

1.08

359

1505

Paralytic ileus and intestinal obstruction

128

872

1.47

4.26

1.3

1.4

0.25

0.31

nmol/l

0.92

636

Molar incisor enamel hypoplasia

329

1.79

4.25

1.7

1.6

0.26

0.35

nmol/l

0.85

283

Benign neoplasm of colon, rectum, anus and anal canal

286

1922

1.29

4.25

1.5

1.4

0.31

0.29

nmol/l

0.14

211

1375

Paracetamol or NSAID medication

191

692

1.40

4.25

1.5

1.6

0.36

0.37

nmol/l

0.12

154

596

Emotional disorders starting during childhood or adolescence

100

645

1.56

4.25

1.4

1.6

0.28

0.39

nmol/l

1.52

542

External causes of morbidity and mortality

804

3443

1.17

4.24

1.5

1.4

0.40

0.47

nmol/l

1.31

619

2801

Ectopic pregnancy

232

1757

1.33

4.20

1.5

1.4

0.54

0.46

nmol/l

0.45

188

1348

Malignant neoplasm of skin

182

900

1.39

4.19

1.3

0.27

0.30

nmol/l

0.40

137

680

Sequelae of external causes of morbidity and mortality

174

1261

1.39

4.15

1.4

0.32

0.39

nmol/l

0.80

132

965

Redundant prepuce, phimosis and paraphimosis

406

1.69

4.14

1.3

1.6

0.12

0.14

nmol/l

0.47

337

Influenza and pneumonia

853

6262

0.86

4.14

1.5

1.4

0.35

0.41

nmol/l

1.46

645

4980

Hyperplasia of prostate

265

1.67

4.12

1.7

1.3

0.13

0.12

nmol/l

0.72

222

Fungal Sepsis

122

2.32

4.12

1.4

1.5

0.34

nmol/l

0.01

101

Thyrotoxicosis, other and/or unspecified

192

1419

1.36

4.08

1.5

1.4

0.42

0.45

nmol/l

0.21

145

1090

Oxicams

161

646

1.42

4.08

1.4

1.5

0.37

0.45

nmol/l

0.47

119

533

162

2.14

4.07

1.2

1.5

0.56

0.32

nmol/l

0.64

126

Dermatitis

535

4455

1.20

4.06

1.5

1.4

0.32

0.41

nmol/l

2.27

403

3466

Migraine without aura and triptan purchases

295

2322

1.28

4.03

1.4

1.5

0.42

0.45

nmol/l

0.14

235

1881

Other noninfective disorders of lymphatic vessels and lymph nodes

163

2.11

4.00

1.6

1.4

0.24

0.33

nmol/l

0.77

135

Other anaemias

203

1440

1.34

3.99

1.6

1.4

0.27

0.35

nmol/l

1.44

163

1062

Dermatophytosis

527

4403

1.20

3.98

1.4

1.5

0.32

0.40

nmol/l

1.64

405

3447

Postpartum haemorrhage

492

3442

1.21

3.98

1.4

0.56

0.41

nmol/l

1.57

415

2686

Malignant neoplasm of thyroid gland

282

1.82

3.98

1.8

1.4

0.26

0.42

nmol/l

1.56

237

Diseases of the ear and mastoid process

1271

5659

1.13

3.97

1.5

0.37

0.42

nmol/l

1.11

999

4495

Other congenital malformations

166

1206

1.39

3.95

1.6

1.5

0.53

0.42

nmol/l

0.38

138

966

Other disorders starting during childhood or adolecense, excluding more controls

436

1.65

3.95

1.6

1.4

0.23

0.45

nmol/l

3.88

361

Anti-inflammatory and antirheumatic products, non-steroids

271

1047

1.31

3.94

1.5

0.33

0.39

nmol/l

0.75

222

877

Benign neoplasm: Pancreas

2.75

3.94

1.2

1.5

0.45

0.36

nmol/l

0.14

Excessive attrition of teeth

620

5268

1.18

3.93

1.4

0.47

0.41

nmol/l

0.44

492

4158

Visual field defects

327

1.76

3.93

2.0

1.5

0.25

0.31

nmol/l

0.72

255

Viral infections characterized by skin and mucous membrane lesions

853

6337

1.15

3.93

1.5

1.4

0.37

0.41

nmol/l

0.64

668

5021

All pneumoniae

776

5999

0.86

3.91

1.5

1.4

0.35

0.41

nmol/l

1.14

581

4751

Scar conditions and fibrosis of skin

292

1.81

3.89

1.4

0.41

0.34

nmol/l

0.18

225

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

473

1.62

3.88

1.5

1.4

0.33

0.36

nmol/l

0.18

375

Other and unspecified anaemias

200

1427

1.34

3.87

1.6

1.4

0.27

0.35

nmol/l

1.39

161

1053

Asthma (diagnoses ohter than nonallergic)

862

6225

1.15

3.86

1.5

1.4

0.40

0.41

nmol/l

0.00

651

4951

Injury of muscle and tendon at shoulder and upper arm level

158

1143

1.39

3.83

1.4

0.23

0.27

nmol/l

0.71

121

834

Propionic acid derivatives

270

1047

1.30

3.83

1.6

1.5

0.35

0.39

nmol/l

0.43

225

877

Autism spe

251

1.87

3.81

1.7

1.6

0.30

0.38

nmol/l

0.61

213

Malignant melanoma of skin

264

1.83

3.80

1.5

1.4

0.25

0.28

nmol/l

0.28

217

Outcome of delivery

323

1589

1.27

3.80

1.5

1.4

0.57

0.34

nmol/l

2.32

285

1201

Intestinal stricture

151

1086

1.39

3.80

1.3

1.4

0.26

0.31

nmol/l

0.83

109

798

ILD medications

1192

5732

1.13

3.79

1.5

0.34

0.43

nmol/l

3.77

920

4570

Basal cell carcinoma

133

641

1.44

3.79

1.3

0.26

0.25

nmol/l

0.08

100

473

Hypokalaemia

461

1.61

3.76

1.5

1.4

0.30

0.34

nmol/l

0.23

350

Benign neoplasm: Colon, unspecified

611

1.53

3.75

1.4

0.29

0.22

nmol/l

0.52

430

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

734

5792

0.86

3.75

1.5

1.4

0.35

0.40

nmol/l

0.84

550

4565

Provisional assignment of new diseases of uncertain etiology

521

4374

1.19

3.74

1.5

0.41

0.42

nmol/l

0.12

410

3490

Ischemic heart diseases

342

2547

0.80

3.73

1.4

0.24

0.28

nmol/l

1.07

237

1827

Sequelae with surgical and medical care as external cause

126

882

1.43

3.72

1.4

0.32

0.37

nmol/l

0.36

676

Basal cell carcinoma, including avohilmo

145

710

1.41

3.70

1.3

0.27

0.29

nmol/l

0.14

106

523

Venous thromboembolism

299

2296

1.26

3.70

1.4

0.35

0.34

nmol/l

0.07

208

1722

Hypermetropia

417

1.64

3.69

1.7

1.5

0.29

0.39

nmol/l

0.62

321

Diseases of the musculoskeletal system and connective tissue

746

3219

1.17

3.68

1.5

0.39

0.48

nmol/l

1.04

591

2647

Codes for special purposes

521

4381

1.19

3.68

1.5

0.41

0.42

nmol/l

0.11

410

3496

Unspecified mental disorder

410

3378

1.22

3.67

1.5

0.36

0.42

nmol/l

0.82

315

2680

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

904

5460

1.14

3.65

1.5

1.4

0.35

0.41

nmol/l

0.92

700

4264

Diseases of tongue

268

1.81

3.65

1.2

1.5

0.39

0.42

nmol/l

0.06

210

Ischaemic heart disease, wide definition

225

1809

0.77

3.64

1.4

0.20

0.24

nmol/l

1.30

154

1266

Pneumonias (Asthma/COPD co-morbidities)

772

5962

0.87

3.64

1.5

1.4

0.35

0.41

nmol/l

1.08

577

4718

Polyarthropathies

479

3739

0.83

3.64

1.4

0.33

0.43

nmol/l

2.83

351

2944

Appendectomy

695

5733

1.16

3.63

1.6

1.4

0.45

0.42

nmol/l

0.34

560

4497

Malignant neoplasm of cervix uteri

2.40

3.62

1.3

1.4

0.37

0.42

nmol/l

0.14

Cerebral palsy and other paralytic syndromes

593

1.53

3.62

1.5

0.26

0.38

nmol/l

1.65

471

Extrapyramidal and movement disorders

211

1612

1.31

3.60

1.4

0.30

0.35

nmol/l

0.86

171

1199

Cough

334

2553

1.24

3.60

1.5

0.32

0.38

nmol/l

0.55

239

1998

Iron deficiency

369

1.69

3.59

1.5

0.53

0.47

nmol/l

0.14

313

Other degenerative diseases of the nervous system

950

0.66

3.57

1.4

0.36

0.42

nmol/l

0.26

755

ILD medications: prednisolone, methylprednisolone, prednisone

1129

5610

1.13

3.55

1.5

0.34

0.43

nmol/l

4.58

872

4465

Autoimmune diseases related-to ILD

812

6066

1.15

3.54

1.5

1.4

0.37

0.41

nmol/l

0.95

627

4796

Anisometropia and aniseikonia

151

2.08

3.53

1.5

1.6

0.33

nmol/l

0.02

120

Voice disturbances

215

1654

1.31

3.52

1.4

0.40

nmol/l

0.03

159

1249

Stroke, including SAH

155

1525

0.74

3.51

1.5

1.4

0.21

0.28

nmol/l

1.41

118

1103

Complications of other internal prosthetic devices, implants and grafts

145

2.09

3.48

1.3

1.5

0.42

0.31

nmol/l

0.28

112

Disturbance of activity and attention

215

1626

1.31

3.48

1.6

0.29

0.45

nmol/l

4.73

183

1388

Neuralgia and neuritis, unspecified

280

1.77

3.48

1.5

0.49

0.37

nmol/l

0.26

231

Other coagulation defects

535

1.55

3.48

1.6

1.5

0.58

0.44

nmol/l

0.23

433

Disorders of vestibular function (Vertigo)

295

2323

1.25

3.47

1.4

0.29

0.39

nmol/l

2.47

217

1726

Other medical care

277

1978

1.26

3.46

1.6

1.4

0.35

0.36

nmol/l

0.02

183

1512

Hypermobility syndrome

626

1.51

3.45

1.4

1.5

0.37

0.46

nmol/l

0.70

513

Congenital malformations of breast

224

1.88

3.45

1.7

1.5

0.88

0.39

nmol/l

0.43

189

Other disorders of skin and subcutaneous tissue

498

3731

1.19

3.44

1.5

1.4

0.27

0.39

nmol/l

4.68

377

2838

Astigmatism

402

1.63

3.44

1.6

1.5

0.25

0.41

nmol/l

2.07

324

Other and unspecified epidermal thickening

126

2.17

3.44

1.6

1.5

0.22

0.38

nmol/l

1.45

100

Other external causes of accidental injury

942

4150

1.14

3.44

1.5

1.4

0.38

0.45

nmol/l

1.66

727

3327

Thyroiditis

513

1.55

3.43

1.4

0.37

0.41

nmol/l

0.22

408

Persistent mood disorders

173

1296

1.34

3.43

1.4

0.32

0.41

nmol/l

0.87

140

1018

Cardiovascular diseases (excluding rheumatic etc)

961

4879

1.14

3.40

1.4

1.5

0.44

nmol/l

0.00

747

3976

Coagulation defects, purpura and other haemorrhagic conditions

167

1247

1.35

3.39

1.7

1.5

0.48

0.40

nmol/l

0.21

129

989

L04AD Calcineurin inhibitors

578

1.51

3.39

1.6

1.5

0.26

0.35

nmol/l

1.13

445

Aplastic and other anaemias

218

1572

1.29

3.38

1.6

1.4

0.27

0.34

nmol/l

1.63

176

1168

Asthma-related pneumonia or sepsis

230

1791

1.28

3.38

1.4

1.5

0.34

0.38

nmol/l

0.39

167

1388

Asthma, hospital admissions 3, pneumonia

230

1791

1.28

3.38

1.4

1.5

0.34

0.38

nmol/l

0.39

167

1388

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.88

3.38

1.9

1.3

0.16

0.31

nmol/l

—

Viral infections characterized by skin and mucous membrane lesions

349

2855

1.22

3.37

1.5

0.34

0.40

nmol/l

0.75

283

2243

Asthma-related pneumonia

229

1783

1.29

3.37

1.4

1.5

0.34

0.38

nmol/l

0.39

166

1381

Other disorders of bladder

358

1.66

3.37

1.5

1.4

0.37

0.34

nmol/l

0.08

283

Benign neoplasm of brain and other parts of central nervous system

298

1.73

3.36

1.8

1.5

0.25

0.33

nmol/l

0.86

231

Cholangitis (primary sclerosing, PSC)

210

1.87

3.35

1.3

1.4

0.40

0.29

nmol/l

0.52

163

Disorders of breast

593

4621

1.17

3.35

1.5

1.4

0.39

0.45

nmol/l

0.74

437

3561

Cervicobrachial syndrome

197

1510

1.31

3.34

1.3

1.5

0.34

0.41

nmol/l

0.63

151

1158

Drug-induced polyneuropathy

4.45

3.34

4.3

1.3

0.21

0.14

nmol/l

—

Care involving use of rehabilitation procedures

523

4087

1.18

3.33

1.5

1.4

0.29

0.37

nmol/l

3.64

411

3130

Spondylosis

317

2092

1.24

3.31

1.3

1.4

0.29

0.32

nmol/l

0.46

220

1531

Autism

263

1.78

3.31

1.7

1.6

0.30

0.38

nmol/l

0.59

222

Hyperkinetic disorders

224

1714

1.29

3.31

1.6

0.29

0.45

nmol/l

4.79

191

1460

Chronic lower respiratory diseases

1246

5954

1.12

3.29

1.5

0.40

0.41

nmol/l

0.07

955

4749

Other and unspecified mental retardation

2.44

3.28

1.4

1.5

0.29

0.35

nmol/l

0.23

Varicella [chickenpox]

219

1.84

3.28

1.7

1.5

0.48

0.30

nmol/l

0.43

181

Abnormal findings on examination of blood, without diagnosis

249

1806

1.27

3.28

1.4

0.28

0.36

nmol/l

1.86

198

1401

Other or unspecified ileus, impaction or obstruction

518

1.53

3.26

1.4

0.29

0.28

nmol/l

0.07

379

Diabetic nephropathy, excluding more controls

526

0.54

3.26

1.5

1.6

0.25

0.38

nmol/l

0.97

412

Other salmonella infections

227

1.82

3.25

1.4

0.51

0.35

nmol/l

0.36

177

Any death

143

1388

0.74

3.25

1.3

1.4

0.16

0.24

nmol/l

3.28

997

Social phobias

133

967

1.39

3.25

1.5

0.34

0.46

nmol/l

0.77

109

805

Diseases of salivary glands

282

2268

1.25

3.25

1.4

1.5

0.36

0.42

nmol/l

0.74

210

1759

Pregnancy with abortive outcome

892

4100

1.14

3.25

1.5

1.4

0.46

0.42

nmol/l

0.44

695

3247

Other malignant neoplasms of skin (=non-melanoma skin cancer)

138

684

1.39

3.24

1.3

0.27

0.25

nmol/l

0.21

104

503

Retinal breaks without detachment

592

1.49

3.24

1.5

1.4

0.29

0.25

nmol/l

0.28

415

Other nonscarring hair loss

2.39

3.24

1.4

0.44

0.36

nmol/l

0.21

Malignant neoplasm of cervix uteri, including Hilmo

157

2.01

3.22

1.3

1.4

0.33

0.42

nmol/l

0.36

137

Anogenital herpesviral [herpes simplex] infection

191

1470

1.31

3.21

1.4

1.5

0.44

0.49

nmol/l

0.33

157

1216

Ulcer of vagina/vulva

207

1.87

3.21

1.2

1.5

0.47

0.38

nmol/l

0.35

171

Anomalies of dental arch relationship, including avohilmo

253

1814

1.26

3.20

1.5

0.44

0.40

nmol/l

0.19

188

1446

Vestibular neuronitis

356

1.64

3.19

1.6

1.5

0.27

0.30

nmol/l

0.29

269

Phobic anxiety disorders

201

1555

1.30

3.19

1.6

1.5

0.39

0.43

nmol/l

0.21

165

1284

Pneumonia, organism unspecified

640

5172

0.87

3.19

1.4

1.5

0.35

0.40

nmol/l

0.75

478

4055

Other noninfective gastroenteritis and colitis

206

1598

1.29

3.19

1.5

0.29

0.40

nmol/l

2.80

150

1251

Urticaria and erythema

403

3368

1.20

3.18

1.5

0.51

0.41

nmol/l

0.64

308

2651

Ehlers-Danlos syndrome

152

2.04

3.17

1.7

1.5

0.27

0.39

nmol/l

1.58

130

Hernia

591

4590

0.86

3.14

1.5

1.4

0.28

0.39

nmol/l

5.32

459

3524

Benign neoplasm: Sigmoid colon

483

1.54

3.14

1.5

1.4

0.29

0.23

nmol/l

0.54

348

Atrophic disorders of skin

120

862

1.40

3.14

1.4

0.29

0.40

nmol/l

0.83

639

Zoster [herpes zoster]

309

2479

1.23

3.13

1.4

0.35

0.38

nmol/l

0.21

228

1868

Wide developmental disorders

320

1.68

3.13

1.7

1.6

0.29

0.35

nmol/l

0.55

267

Chronic sinusitis

395

3298

1.20

3.12

1.6

1.4

0.34

0.40

nmol/l

1.06

302

2549

Continuous positive airway pressure

100

583

1.45

3.12

1.4

1.3

0.16

0.29

nmol/l

3.04

412

Complications following infusion, transfusion and therapeutic injection

2.85

3.10

1.2

1.5

0.35

0.27

nmol/l

—

Obstructed labour due to maternal pelvic abnormality

1129

0.67

3.08

1.2

1.4

0.41

0.34

nmol/l

0.15

788

Myocardial infarction

824

0.67

3.06

1.1

1.4

0.19

0.20

nmol/l

0.17

579

Kela-code for severe mental illness

339

2803

1.21

3.02

1.5

0.35

0.41

nmol/l

0.75

256

2221

Small fibre neuropathy

2.32

3.02

1.4

1.5

0.16

0.34

nmol/l

1.48

Exposure to unspecified factor

977

6278

1.12

2.99

1.5

1.4

0.35

0.41

nmol/l

1.27

751

4993

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

2.77

2.99

1.4

1.5

0.12

0.29

nmol/l

—

Asthma, unspecified (mode), excluding more controls

500

3194

1.17

2.99

1.5

1.4

0.33

0.40

nmol/l

2.03

365

2530

Localized swelling, mass and lump of skin and subcutaneous tissue

242

1934

1.26

2.98

1.4

1.5

0.50

0.41

nmol/l

0.25

188

1493

Noninfective enteritis and colitis

412

3468

1.19

2.98

1.4

1.5

0.35

0.39

nmol/l

0.73

320

2724

Congenital malformations of breast

243

1.77

2.97

1.7

1.5

0.86

0.39

nmol/l

0.42

206

Malignant neoplasm of bladder, including Hilmo

126

2.05

2.96

1.3

0.21

0.17

nmol/l

0.19

100

Benign leiomyoma with endometriosis

114

821

1.40

2.96

1.3

1.4

0.58

0.35

nmol/l

1.35

581

Pain in thoracic spine

146

1094

1.34

2.96

1.4

0.35

0.41

nmol/l

0.46

107

851

Infections of the skin and subcutaneous tissue

529

4509

1.16

2.96

1.4

1.5

0.34

0.40

nmol/l

0.82

423

3568

Viral warts

228

1813

1.26

2.95

1.7

1.5

0.41

0.43

nmol/l

0.13

184

1453

Postpartum hemorraghe, parous women as controls

492

3586

1.17

2.95

1.4

0.56

0.50

nmol/l

0.37

415

2858

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

198

1.83

2.94

1.4

1.5

0.19

0.29

nmol/l

1.29

143

Invasive ventilation

242

1.75

2.94

1.6

1.5

0.17

0.30

nmol/l

3.44

192

Speech and linguistic disorders, excluding more controls

647

1.44

2.94

1.8

1.4

0.33

0.45

nmol/l

0.97

544

Other inflammation of eyelid

101

714

1.42

2.92

1.3

1.4

0.31

0.38

nmol/l

0.57

554

Nonhereditary hypogammaglobulinemia

2.75

2.92

1.5

1.4

0.29

0.30

nmol/l

—

Attention to artificial openings

2.23

2.90

1.2

1.5

0.19

0.34

nmol/l

1.25

Seborrhoeic keratosis

681

1.43

2.90

1.5

1.4

0.25

nmol/l

0.02

478

Cramp and spasm

266

1.71

2.90

1.3

1.5

0.23

0.34

nmol/l

1.23

210

Asthma, unspecified (mode)

500

3224

1.17

2.90

1.5

1.4

0.33

0.40

nmol/l

1.93

365

2555

Balanced rearrangements and structural markers, not elsewhere classified

3.52

2.88

1.8

1.6

0.43

0.49

nmol/l

0.11

Cluster headache, wide,, including avohilmo

415

1.56

2.87

1.4

0.26

0.41

nmol/l

1.96

341

Coronary atherosclerosis

151

1260

0.76

2.86

1.5

1.4

0.19

0.23

nmol/l

0.70

100

885

Diseases of middle ear and mastoid

704

5064

1.14

2.86

1.5

0.37

0.45

nmol/l

1.47

572

4138

Pulmonary heart disease

129

953

1.36

2.85

1.4

0.33

0.32

nmol/l

0.05

709

Pulmonary embolism

129

955

1.35

2.82

1.4

0.33

0.32

nmol/l

0.05

709

Pneumothorax

179

1.85

2.82

1.3

1.6

0.38

0.29

nmol/l

0.41

145

Viral and other specified intestinal infections

368

2980

1.20

2.82

1.6

1.5

0.40

0.43

nmol/l

0.27

294

2467

Other hearing loss

104

727

1.40

2.82

1.5

1.4

0.24

0.31

nmol/l

1.05

533

Other viral diseases

474

4034

1.17

2.82

1.4

1.5

0.36

0.42

nmol/l

0.71

383

3258

Hepatic failure, not elsewhere classified

110

2.11

2.79

1.6

1.5

0.15

0.34

nmol/l

2.49

Seborrhoeic dermatitis

417

1.54

2.79

1.3

1.5

0.26

0.35

nmol/l

0.63

327

Symptoms and signs involving speech and voice

242

1951

1.24

2.79

1.5

1.4

0.38

0.39

nmol/l

0.07

180

1473

Dizziness and giddiness

615

4254

1.15

2.79

1.4

0.30

0.40

nmol/l

4.83

462

3287

Unspecified haematuria

177

1136

1.29

2.77

1.3

1.4

0.40

0.32

nmol/l

0.24

138

870

Palmar fascial fibromatosis [Dupuytren]

254

1.70

2.76

1.1

1.5

0.19

0.20

nmol/l

0.11

197

Phlebitis and thrombophlebitis (not including DVT)

156

1193

1.31

2.76

1.3

1.4

0.30

0.38

nmol/l

0.94

101

911

Gingivitis and periodontal diseases

942

4344

1.12

2.75

1.4

0.40

0.41

nmol/l

0.15

728

3435

Cluster headache, strict, including avohilmo

404

1.55

2.74

1.4

0.27

0.40

nmol/l

1.67

335

Angina pectoris

111

1012

0.73

2.73

1.2

1.4

0.18

0.20

nmol/l

0.43

696

Gastro-oesophageal reflux disease

525

3919

1.16

2.72

1.5

1.4

0.34

0.37

nmol/l

0.35

412

2973

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

206

1636

1.26

2.72

1.3

1.5

0.29

0.38

nmol/l

1.53

164

1280

Atypical facial pain

310

1.63

2.71

1.6

1.4

0.29

0.35

nmol/l

0.34

235

Haemolytic anaemias

132

1.99

2.71

1.6

1.5

0.28

0.34

nmol/l

0.40

108

Diaphragmatic hernia

175

1362

1.29

2.71

1.5

1.4

0.29

0.32

nmol/l

0.26

140

979

Renal tubulo-interstitial diseases

626

5308

0.88

2.69

1.4

0.35

0.41

nmol/l

1.19

472

4179

Symptoms and signs involving the urinary system

497

3262

1.16

2.69

1.5

1.4

0.33

0.38

nmol/l

0.36

396

2486

Persons encountering health services for specific procedures, not carried out

593

1.44

2.68

1.4

1.5

0.65

0.41

nmol/l

0.44

475

Amblyopia ex anopsia

265

1.68

2.68

1.4

1.6

0.31

0.33

nmol/l

0.09

216

Erosion of teeth , including avohilmo

294

2432

1.21

2.68

1.4

1.5

0.35

0.45

nmol/l

1.34

224

1968

Pruritus

101

727

1.40

2.67

1.4

1.5

0.31

0.45

nmol/l

1.47

580

Diseases of inner ear

331

2674

1.20

2.67

1.4

0.29

0.37

nmol/l

2.39

243

1990

Supervision of normal pregnancy

377

1811

1.19

2.67

1.3

1.4

0.38

0.32

nmol/l

0.38

292

1353

Hydrocephalus

168

1.85

2.67

1.7

1.5

0.23

0.28

nmol/l

0.44

131

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

406

1.54

2.67

1.5

0.26

0.38

nmol/l

1.39

319

Disorders of lipoprotein metabolism and other lipidaemias

350

2582

0.84

2.67

1.4

0.23

0.30

nmol/l

1.98

247

1886

Other and unspecified disorders of autonomic nervous system

3.50

2.66

1.5

0.48

0.23

nmol/l

—

Cervicalgia

159

1227

1.30

2.65

1.3

1.5

0.31

0.39

nmol/l

0.92

121

942

Infections with a predominantly sexual mode of transmission

602

4917

1.14

2.65

1.4

1.5

0.40

0.46

nmol/l

1.06

504

4005

Nontoxic multinodular goitre

109

796

1.37

2.64

1.2

1.4

0.29

0.38

nmol/l

1.16

576

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

151

779

1.32

2.63

1.3

0.26

0.28

nmol/l

0.24

110

580

Other salmonella infections

162

1.87

2.63

1.5

0.53

0.31

nmol/l

0.37

128

Other and unspecified disorders of white blood cells

162

1.87

2.63

1.4

1.5

0.19

0.33

nmol/l

1.93

131

Other bacterial intestinal infections

161

1246

1.30

2.63

1.6

1.4

0.28

0.42

nmol/l

2.74

133

969

Other systemic involvement of connective tissue (FG)

202

1587

1.26

2.62

1.4

0.34

0.42

nmol/l

0.81

156

1211

Ehlers-Danlos syndrome

114

2.08

2.62

1.6

1.5

0.25

0.40

nmol/l

1.51

Vasomotor and allergic rhinitis

451

3808

1.17

2.60

1.5

1.4

0.36

0.41

nmol/l

0.43

363

3033

Inguinal hernia

227

1878

0.81

2.60

1.3

1.5

0.21

0.35

nmol/l

5.19

182

1489

Intestinal adhesions without obstruction

244

1.69

2.59

1.2

1.5

0.29

0.30

nmol/l

0.03

173

Other specified and unspecified personality disorders

105

766

1.38

2.59

1.3

1.5

0.31

0.44

nmol/l

1.30

621

Iron deficiency anaemia secondary to blood loss (chronic)

622

1.42

2.58

1.3

1.5

0.39

0.37

nmol/l

0.09

488

Diseases of the myoneural junction and muscle

425

1.51

2.58

1.6

1.4

0.23

0.32

nmol/l

1.80

326

Other and unspecified coagulation defects

402

1.53

2.58

1.5

1.4

0.66

0.39

nmol/l

0.36

326

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

3.09

2.57

1.2

1.3

0.62

0.35

nmol/l

—

Bacterial Sepsis

207

1412

1.25

2.57

1.5

1.4

0.25

0.33

nmol/l

1.80

153

1066

Sarcoidosis

598

1.43

2.57

1.4

0.22

0.35

nmol/l

1.98

448

Other disorders of eyelid

195

1475

1.26

2.56

1.3

1.4

0.26

0.29

nmol/l

0.51

138

1057

Oral lichen planus and hypothyroidism or thyroxine medication

2.45

2.55

1.3

1.5

0.16

0.27

nmol/l

—

Other and unspecified myopathies

230

1.70

2.55

1.7

1.5

0.22

0.25

nmol/l

0.37

181

Xerosis cutis

2.64

2.54

1.1

1.5

0.22

0.26

nmol/l

—

Diabetes medication

839

5553

0.89

2.54

1.5

1.4

0.42

0.41

nmol/l

0.04

642

4356

GI-bleeding

137

1042

1.32

2.54

1.3

1.5

0.27

0.31

nmol/l

0.46

105

809

Myocardial infarction, strict

734

0.69

2.53

1.1

1.4

0.14

0.19

nmol/l

1.59

516

Subjective visual disturbances

212

1706

1.25

2.53

1.6

1.5

0.34

0.42

nmol/l

0.72

162

1344

Tongue abnormality

231

1.70

2.53

1.2

1.4

0.25

0.29

nmol/l

0.33

174

Other acute lower respiratory infections

420

3431

1.17

2.52

1.5

0.32

0.38

nmol/l

1.49

317

2725

Convulsions, not elsewhere classified

197

1552

1.26

2.52

1.6

1.5

0.28

0.45

nmol/l

4.34

155

1265

Heterophoria

660

1.40

2.52

1.4

1.5

0.32

0.45

nmol/l

0.67

521

Haemorrhage in early pregnancy

420

3511

1.17

2.51

1.4

0.61

0.44

nmol/l

1.35

340

2741

Epilepsy

223

1800

1.24

2.51

1.5

0.33

0.41

nmol/l

1.05

173

1430

Disorders of psychological development

161

1164

1.29

2.50

1.7

1.6

0.31

0.41

nmol/l

1.29

138

963

Osteonecrosis

187

1.78

2.49

1.5

0.26

0.27

nmol/l

0.11

142

Abnormal findings on diagnostic imaging of lung

191

1457

1.26

2.48

1.4

0.22

0.29

nmol/l

1.62

138

1058

Diabetes mellitus in pregnancy

697

3960

1.13

2.47

1.5

1.4

0.57

0.43

nmol/l

1.63

568

3152

Vocal cord dysfunction

129

876

1.33

2.47

1.3

1.4

0.31

0.42

nmol/l

1.28

683

Other and unspecified nonscarring hair loss

2.37

2.46

1.3

1.5

0.26

0.39

nmol/l

0.61

Complications of labour and delivery

802

3984

1.12

2.46

1.4

0.52

0.38

nmol/l

2.28

648

3060

Congenital malformations of the musculoskeletal system, not elsewhere classified

189

1.78

2.45

1.6

1.5

0.25

0.37

nmol/l

1.85

162

Papillary adenocarcinoma of thyroid gland

218

1.71

2.45

1.7

1.4

0.24

0.36

nmol/l

1.33

182

Other and unspecified local infections of skin and subcutaneous tissue

496

1.46

2.45

1.3

1.5

0.32

0.39

nmol/l

0.50

393

Presbyopia

359

1.54

2.43

1.2

1.4

0.34

0.26

nmol/l

0.56

252

Other systemic involvement of connective tissue

204

1643

1.25

2.43

1.4

1.5

0.34

0.42

nmol/l

0.77

157

1255

Inflammatory bowel disease treatment related agents

1154

5880

1.10

2.42

1.5

1.4

0.34

0.42

nmol/l

3.69

883

4684

Pervasive developmental disorders excl. Autism + Asperger

2.15

2.41

1.4

1.6

0.22

0.32

nmol/l

0.60

Emotionally unstable personality disorder

203

1639

1.25

2.40

1.5

0.42

0.47

nmol/l

0.17

164

1345

Osteoporosis with pathological fracture (FG)

131

1.92

2.40

2.0

1.4

0.19

nmol/l

0.00

Urticaria

339

2873

1.18

2.40

1.5

0.48

0.42

nmol/l

0.30

260

2264

Implicit bacterial Sepsis

157

1086

1.28

2.38

1.6

1.4

0.26

0.31

nmol/l

0.70

120

816

Biguanides

650

4467

0.89

2.38

1.6

1.4

0.42

0.39

nmol/l

0.14

499

3431

All kidney diseases

802

6100

0.90

2.38

1.4

0.36

0.41

nmol/l

1.32

605

4841

Mixed and other personality disorders

676

1.39

2.38

1.3

1.5

0.38

0.42

nmol/l

0.24

550

Collagenous colitis

442

1.48

2.37

1.6

1.5

0.31

0.38

nmol/l

0.57

346

Vasomotor rhinitis (mode)

394

1.51

2.36

1.3

1.5

0.21

0.34

nmol/l

2.53

306

Brachial plexus disorders

113

848

1.34

2.36

1.4

0.40

0.44

nmol/l

0.18

660

Excessive earwax

320

2636

1.19

2.35

1.4

0.27

0.37

nmol/l

1.88

248

2019

Explicit bacterial Sepsis

394

1.50

2.35

1.4

1.5

0.20

0.31

nmol/l

1.81

319

Skin changes due to chronic exposure to nonionizing radiation

591

1.39

2.35

1.2

1.4

0.21

0.19

nmol/l

0.32

404

Thyrotoxicosis

223

1823

1.23

2.33

1.4

0.42

0.41

nmol/l

0.01

165

1384

Benign neoplasm of bone and articular cartilage

544

1.42

2.32

1.4

0.32

0.37

nmol/l

0.26

427

Other bacterial intestinal infections

104

772

1.35

2.32

1.6

1.4

0.23

0.38

nmol/l

3.01

593

Obesity due to excess calories

508

4453

1.14

2.31

1.4

0.33

0.44

nmol/l

2.93

399

3502

Stroke, excluding SAH

142

1331

0.78

2.31

1.5

1.4

0.19

0.27

nmol/l

1.62

108

962

Recurrent aphthous stomatitis , including avohilmo

116

877

1.33

2.30

1.5

0.45

0.41

nmol/l

0.15

697

Presbycusis

104

2.00

2.30

1.2

1.3

0.13

nmol/l

0.00

Unspecified kidney failure

177

1.76

2.29

1.5

0.23

0.25

nmol/l

0.12

138

106

723

1.35

2.29

1.2

1.4

0.22

0.20

nmol/l

0.24

501

Noninfectious colitis NAS

109

817

1.34

2.29

1.5

0.31

0.39

nmol/l

0.97

646

Schizophrenia or delusion, excluding more controls

254

2087

1.21

2.28

1.5

1.4

0.32

0.43

nmol/l

2.08

188

1658

Tinnitus

149

1168

1.28

2.26

1.4

0.32

0.37

nmol/l

0.54

118

855

Other diseases of intestine

431

1.47

2.24

1.7

1.4

0.24

0.27

nmol/l

0.25

312

Benign neoplasm: Transverse colon

247

1.63

2.24

1.1

1.5

0.25

nmol/l

0.02

186

Other disorders of breast

149

1171

1.28

2.24

1.4

0.34

0.45

nmol/l

1.46

117

907

Deforming dorsopathies

225

1850

1.22

2.23

1.5

0.38

0.39

nmol/l

0.03

180

1439

Other embolism and thrombosis

531

1.42

2.23

1.4

0.44

0.35

nmol/l

0.35

419

Pulmonary heart disease, diseases of pulmonary circulation

135

1047

1.29

2.21

1.4

0.32

0.31

nmol/l

0.05

769

Actinic keratosis

522

1.40

2.21

1.1

1.4

0.16

0.15

nmol/l

0.16

355

Pure hypercholesterolaemia

267

2084

0.83

2.21

1.4

0.21

0.28

nmol/l

2.54

195

1505

Disorders of optic nerve and visual pathways

685

1.37

2.21

1.7

1.5

0.43

0.42

nmol/l

0.03

551

Oesophageal varices

2.20

2.21

1.1

1.7

0.29

0.23

nmol/l

0.26

Hypercalcemia

121

1.91

2.21

1.2

1.5

0.61

0.29

nmol/l

0.73

Retention of urine

128

807

1.30

2.20

1.7

1.4

0.28

0.32

nmol/l

0.40

636

Benign neoplasm: Brain, unspecified

3.42

2.20

1.6

1.5

0.17

0.43

nmol/l

—

Pregnancy hypertension

624

4980

1.13

2.20

1.4

0.48

0.47

nmol/l

0.05

504

3900

Benign neoplasm of breast

106

798

1.34

2.19

1.4

0.32

0.41

nmol/l

1.35

613

Melanocytic naevi, other sites/unspecified

543

1.41

2.17

1.3

1.5

0.46

0.40

nmol/l

0.20

431

Other disorders of white blood cells

234

1.64

2.17

1.4

1.5

0.19

0.31

nmol/l

2.19

188

Leiomyoma of uterus

645

3253

1.13

2.16

1.4

0.42

nmol/l

0.00

471

2420

Retinal detachments and breaks

148

1166

1.27

2.16

1.5

1.4

0.28

0.29

nmol/l

0.08

112

824

Insulin medication

293

2909

0.85

2.16

1.3

1.5

0.38

nmol/l

0.01

219

2279

Abnormal involuntary movements

679

1.36

2.16

1.3

1.5

0.35

0.37

nmol/l

0.05

541

Systemic connective tissue disorders

252

2103

1.20

2.16

1.5

1.4

0.35

0.41

nmol/l

0.58

196

1596

Nontoxic diffuse goitre

137

1.84

2.14

1.2

1.5

0.38

0.35

nmol/l

0.17

105

Benign neoplasm: Rectum, anus and anal canal

527

1.41

2.14

1.4

0.27

0.24

nmol/l

0.20

376

Other inflammation of vagina/vulva

421

1.47

2.14

1.5

0.57

0.49

nmol/l

0.32

348

Other and unspecified hydrocephalus

2.39

2.13

1.8

1.5

0.16

0.37

nmol/l

—

Acute otitis externa, noninfective

2.23

2.12

1.2

1.4

0.22

0.41

nmol/l

—

Viral hepatitis, IBD co-morbidity

396

1.47

2.12

1.4

1.5

0.24

0.49

nmol/l

2.96

323

Single delivery by caesarean section

363

1788

1.17

2.12

1.4

1.5

0.57

0.39

nmol/l

1.41

305

1452

Immunodeficiency with predominantly antibody defects

160

1.77

2.11

1.9

1.5

0.22

0.37

nmol/l

1.76

127

Diagnoses used for exclusion with ILD

126

976

1.29

2.11

1.4

0.28

0.32

nmol/l

0.37

724

Other problems related to primary support group, including family circumstances

169

1323

1.25

2.10

1.4

1.5

0.32

0.42

nmol/l

0.85

135

1077

Other neurological diseases

430

2944

1.15

2.10

1.3

1.4

0.32

0.38

nmol/l

1.04

328

2233

Poisoning by drugs, medicaments and biological substances

278

2349

1.19

2.10

1.5

0.36

0.42

nmol/l

0.35

216

1888

Sudden idiopathic hearing loss

364

1.49

2.09

1.6

1.5

0.23

0.31

nmol/l

0.82

276

Benign neoplasm: Rectum

463

1.43

2.08

1.4

0.28

0.23

nmol/l

0.28

335

Dislocation, sprain and strain of joints and ligaments of head

341

1.51

2.08

1.4

0.26

0.42

nmol/l

1.71

269

Other viral diseases, not elsewhere classified

307

2603

1.18

2.08

1.4

1.5

0.38

0.42

nmol/l

0.25

251

2077

Seminoma of testis, including Hilmo

3.55

2.06

1.3

1.5

0.16

0.17

nmol/l

—

Diabetic retinopathy, excluding more controls

711

0.75

2.06

1.3

1.6

0.27

0.40

nmol/l

1.12

547

Abnormalities of gait and mobility

349

1.50

2.06

1.9

1.5

0.34

0.27

nmol/l

0.39

268

Varicella [chickenpox]

293

1.55

2.05

1.7

1.5

0.45

0.32

nmol/l

0.34

243

Benign neoplasm: Ascending colon

325

1.51

2.05

1.6

1.5

0.28

0.23

nmol/l

0.31

232

6-mercaptopurine

262

1.58

2.05

1.8

1.5

0.42

0.41

nmol/l

0.02

214

Melanocytic naevi of scalp and neck

162

1.75

2.04

1.8

1.5

0.32

0.35

nmol/l

0.10

138

Postpartum haemorrhage due to retained placenta

240

2011

1.20

2.03

1.4

1.5

0.47

0.50

nmol/l

0.21

204

1599

Other female pelvic inflammatory diseases

159

1276

1.25

2.03

1.4

0.47

0.43

nmol/l

0.18

121

979

Soft tissue disorders related to use, overuse and pressure

158

1266

1.25

2.03

1.3

1.5

0.33

0.35

nmol/l

0.16

122

958

Keratoconus

118

1.88

2.03

1.1

1.4

0.89

0.34

nmol/l

0.46

100

Zoster [herpes zoster]

678

1.35

2.02

1.6

1.4

0.28

0.33

nmol/l

0.70

521

Follow-up care involving plastic surgery

247

1.59

2.02

1.4

0.32

0.35

nmol/l

0.12

186

Accidents

911

4150

1.10

2.02

1.5

1.4

0.38

0.45

nmol/l

1.57

706

3327

Other facial nerve disorders

140

1.80

2.02

1.4

1.5

0.40

0.35

nmol/l

0.11

111

Diabetic nephropathy

546

0.63

2.02

1.5

0.25

0.41

nmol/l

1.20

433

Other specified/unspecified spondylopathies

2.52

2.01

1.3

1.7

0.16

0.24

nmol/l

0.80

Erysipelas

271

2025

1.19

2.01

1.4

0.28

0.32

nmol/l

0.34

186

1534

Other local infections of skin and subcutaneous tissue

526

1.39

2.01

1.3

1.4

0.32

0.40

nmol/l

0.51

414

Acute bronchitis

292

2437

1.18

2.01

1.4

1.5

0.34

0.41

nmol/l

1.23

212

1922

Other disorders of ear

568

4172

0.89

1.99

1.4

0.28

0.38

nmol/l

4.12

436

3165

Rheumatism, unspecified

741

1.33

1.99

1.3

1.4

0.30

0.37

nmol/l

0.72

556

Insulin, fast-acting (human)

1124

0.74

1.97

1.3

1.5

0.34

0.45

nmol/l

1.09

930

Undetermined asthma

106

811

1.31

1.97

1.5

1.4

0.30

0.36

nmol/l

0.51

636

Osteogenesis imperfecta

4.75

1.97

1.8

1.3

0.21

0.88

nmol/l

—

Benign neoplasm: Caecum

233

1.59

1.95

1.3

1.5

0.22

0.27

nmol/l

0.42

172

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

650

5086

1.11

1.95

1.4

0.47

nmol/l

0.02

528

3972

Viral warts

709

1.33

1.95

1.5

0.44

0.41

nmol/l

0.10

570

Acne

167

1354

1.24

1.95

1.6

0.38

0.46

nmol/l

0.77

142

1136

Benign neoplasm of other and ill-defined parts of digestive system

700

1.33

1.95

1.5

1.4

0.29

0.31

nmol/l

0.11

519

Undetermined asthma, excluding more controls

106

813

1.31

1.94

1.5

1.4

0.30

0.37

nmol/l

0.53

636

Unequal limb length (acquired)

2.10

1.94

1.3

1.6

0.26

0.41

nmol/l

—

Hypertrophic scar

463

1.42

1.94

1.4

1.5

0.39

0.43

nmol/l

0.20

375

Cervicocranial syndrome

658

1.34

1.94

1.5

1.4

0.65

0.37

nmol/l

0.50

504

Crohn's disease NAS

463

1.41

1.93

1.4

1.5

0.43

0.41

nmol/l

0.08

367

Injury of muscle and tendon at hip and thigh level

488

1.40

1.93

1.5

1.4

0.24

0.32

nmol/l

0.78

362

Disorders of eyelid, lacrimal system and orbit

715

4907

1.11

1.92

1.4

0.33

0.40

nmol/l

1.42

536

3792

Mixed disorders of conduct and emotions, excluding more controls

235

1.60

1.92

1.2

1.6

0.27

0.49

nmol/l

1.83

205

Enthesopathies of lower limb, excluding foot

176

1438

1.23

1.92

1.5

1.4

0.37

0.40

nmol/l

0.23

125

1100

Autoimmune thyroiditis

143

1.77

1.91

1.5

1.4

0.42

0.39

nmol/l

0.07

123

Congenital malformations of the musculoskeletal system, not elsewhere classified

151

1.76

1.90

1.5

0.24

0.39

nmol/l

2.03

128

Postmenopausal osteoporosis with pathological fracture

1.96

1.90

2.2

1.5

0.13

0.16

nmol/l

—

Sequelae of cerebrovascular disease

777

0.72

1.89

1.7

1.4

0.23

nmol/l

0.02

554

Hallux rigidus

439

1.42

1.89

1.1

1.4

0.25

0.30

nmol/l

0.50

295

Schizophrenia

956

0.73

1.89

1.4

1.5

0.21

0.35

nmol/l

3.02

763

Ganglion

214

1786

1.20

1.89

1.3

1.5

0.33

0.44

nmol/l

1.91

168

1428

Mental and behavioural disorders due to opioids

300

1.51

1.89

1.4

1.5

0.23

0.39

nmol/l

1.97

258

Bacterial intestinal infections, IBD co-morbidities

103

791

1.31

1.88

1.6

1.5

0.24

0.37

nmol/l

2.33

615

Poisoning by medicine

253

2145

1.18

1.88

1.4

1.5

0.37

0.43

nmol/l

0.25

195

1729

Manic episode

182

1.66

1.86

1.3

1.4

0.29

0.36

nmol/l

0.53

144

Other diseases of the digestive system

133

1057

1.26

1.86

1.4

1.5

0.27

0.31

nmol/l

0.47

101

817

Seminoma of testis

3.58

1.84

1.0

1.3

0.17

0.19

nmol/l

—

Other viral diseases

329

2843

1.16

1.84

1.4

1.5

0.30

0.41

nmol/l

4.07

261

2282

Diabetic retinopathy

103

831

0.77

1.84

1.2

1.5

0.26

0.39

nmol/l

1.36

639

Congenital deformities of hip

160

1.71

1.84

1.4

1.5

0.30

0.33

nmol/l

0.14

133

Other disorders of central nervous system

2.16

1.83

1.2

1.5

0.17

0.33

nmol/l

—

Hypotension

342

1.46

1.83

1.3

1.5

0.26

nmol/l

0.03

271

Erythema multiforme

108

1.87

1.83

1.5

1.4

0.82

0.31

nmol/l

0.41

DVT of lower extremities and pulmonary embolism

191

1577

1.21

1.80

1.4

0.39

0.32

nmol/l

0.37

136

1166

Status epilepticus

123

1.80

1.3

1.5

0.22

0.36

nmol/l

1.56

101

Stomatitis and related lesions

172

1413

1.22

1.80

1.5

0.43

0.41

nmol/l

0.13

129

1123

conjunctival haemorrhage

199

1.61

1.80

1.9

1.4

0.30

0.29

nmol/l

0.04

148

Diabetes mellitus

869

5545

0.91

1.80

1.5

1.4

0.40

0.41

nmol/l

0.11

669

4350

Statin medication

612

3821

0.90

1.80

1.4

0.31

0.42

nmol/l

4.20

438

2990

Fracture of rib(s), sternum and thoracic spine

134

1072

1.25

1.78

1.5

1.4

0.23

0.32

nmol/l

1.72

813

Other bacterial diseases

708

4316

1.10

1.78

1.5

1.4

0.27

0.38

nmol/l

3.94

509

3336

Other and unspecified disorders of vitreous body

175

1421

1.22

1.78

1.3

1.4

0.22

0.26

nmol/l

0.79

123

949

Focal epilepsy, strict definition

127

1011

1.26

1.77

1.5

0.34

0.37

nmol/l

0.21

102

802

Benign neoplasm: Brain, supratentorial

1.92

1.77

1.9

1.4

0.24

0.34

nmol/l

0.57

Injury, poisoning and certain other consequences of external causes

645

2914

1.11

1.76

1.5

0.44

0.48

nmol/l

0.32

504

2352

Hydrocephalus in other diseases

3.40

1.76

1.0

1.4

—

0.31

nmol/l

—

Vasculitis limited to skin, not elsewhere classified

1.95

1.75

1.4

1.5

0.16

0.35

nmol/l

1.91

Dyspnoea

748

5034

1.10

1.75

1.4

0.31

0.41

nmol/l

3.27

540

3954

Congenital deformities of hip

178

1.65

1.74

1.4

1.5

0.41

0.34

nmol/l

0.23

148

Oral corticosteroids

1014

5548

1.09

1.74

1.5

1.4

0.34

0.42

nmol/l

3.63

775

4401

Benign neoplasm of other and unspecified female genital organs

241

1.55

1.74

1.8

1.4

0.45

0.34

nmol/l

0.44

182

Pre-eclampsia or eclampsia

296

2562

1.16

1.73

1.4

1.5

0.54

0.48

nmol/l

0.24

240

1998

Diffuse brain injury

155

1.69

1.73

1.3

1.4

0.16

0.41

nmol/l

4.16

133

Diabetes, varying definitions

862

5506

0.92

1.72

1.5

1.4

0.40

0.41

nmol/l

0.10

664

4315

Glaucoma, exfoliation

110

1.82

1.72

1.8

1.5

0.23

0.20

nmol/l

0.13

Injury of nerves at wrist and hand level

194

1.61

1.72

1.9

1.4

0.23

0.34

nmol/l

1.29

158

Dermatophytosis

499

1.37

1.72

1.6

1.4

0.23

0.31

nmol/l

1.27

385

Falls/tendency to fall

1189

5524

1.08

1.71

1.5

1.4

0.35

0.43

nmol/l

3.01

911

4439

Unspecified lump in breast

135

1088

1.25

1.71

1.5

1.4

0.25

0.42

nmol/l

4.26

821

Urolithiasis

157

1285

1.22

1.71

1.3

1.4

0.28

0.34

nmol/l

0.71

121

997

Carbimazole or st.post thyroidectomy, condition for graves disease

198

1659

1.20

1.71

1.5

1.4

0.41

nmol/l

0.05

149

1267

Spontaneous rupture of synovium and tendon

274

1.50

1.71

1.2

1.5

0.19

0.26

nmol/l

0.93

214

Helminthiases

349

1.45

1.70

1.4

0.41

0.45

nmol/l

0.13

297

Acute sinusitis

574

4793

1.11

1.70

1.5

1.4

0.35

0.45

nmol/l

2.90

452

3823

Sequelae of other external causes

275

1.50

1.69

1.5

1.4

0.34

0.31

nmol/l

0.14

210

Preterm labour and delivery

309

2688

1.15

1.68

1.6

1.4

0.53

0.39

nmol/l

0.92

239

1996

Secondary hypertension

312

1.46

1.68

1.7

1.5

0.24

0.32

nmol/l

0.46

256

Congenital malformations of genital organs

144

1166

1.24

1.68

1.6

1.5

0.53

0.47

nmol/l

0.37

119

947

Pre-eclampsia

286

2476

1.16

1.68

1.4

1.5

0.54

0.49

nmol/l

0.21

233

1931

Calculus of kidney and ureter

149

1216

1.23

1.68

1.2

1.4

0.29

0.34

nmol/l

0.63

116

943

Other (not insulin) diabetes medications

713

4638

0.91

1.66

1.6

1.4

0.41

0.40

nmol/l

0.11

544

3587

Gout

418

1.37

1.66

1.3

1.4

0.23

0.22

nmol/l

0.08

310

Asthma and allergy

190

1571

1.20

1.66

1.5

0.58

0.43

nmol/l

0.59

158

1301

Implicit Sepsis

480

3234

1.12

1.65

1.5

0.32

0.38

nmol/l

1.02

364

2499

Nerve, nerve root and plexus disorders

941

5314

1.09

1.65

1.4

0.33

0.43

nmol/l

4.11

702

4186

Elevated blood glucose level

376

1.42

1.65

1.5

0.29

0.32

nmol/l

0.18

292

Other diseases of pancreas

220

1.55

1.65

1.5

0.23

0.26

nmol/l

0.16

165

Hernia of abdominal wall

270

2329

1.16

1.64

1.6

1.4

0.30

0.37

nmol/l

1.22

204

1792

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1.85

1.64

1.1

1.2

0.14

0.18

nmol/l

0.50

Single delivery by forceps and vacuum extractor

321

1685

1.15

1.64

1.4

1.5

0.46

0.40

nmol/l

0.74

268

1382

Postpartum hemorraghe, all women as controls

492

4349

1.12

1.64

1.4

1.5

0.56

0.48

nmol/l

0.59

415

3496

Congenital ovarian cysts

557

1.34

1.63

1.4

1.5

0.55

0.46

nmol/l

0.44

461

Asthma and allergy, excluding more controls

190

1574

1.20

1.63

1.5

0.58

0.42

nmol/l

0.61

158

1300

Other specified disorders of kidney and ureter

120

1.76

1.63

1.2

1.5

0.34

0.32

nmol/l

0.08

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

598

1.32

1.62

1.6

0.29

0.41

nmol/l

1.01

502

Conductive and sensorineural hearing loss

353

2708

0.88

1.62

1.4

0.24

0.34

nmol/l

3.74

269

2000

Sicca syndrome [Sjögren]

445

1.38

1.62

1.2

1.4

0.34

0.38

nmol/l

0.11

331

Cellulitis

151

1240

1.22

1.62

1.3

1.5

0.27

0.40

nmol/l

2.69

124

967

Abnormal serum enzyme levels

102

780

1.28

1.62

1.5

1.4

0.23

0.27

nmol/l

0.64

617

Other chronic obstructive pulmonary disease, including avohilmo

122

1252

0.80

1.62

1.4

0.20

0.23

nmol/l

0.78

889

STROKE

254

2007

0.86

1.61

1.4

0.26

0.32

nmol/l

1.20

183

1453

Any dementia

365

0.67

1.60

1.6

1.5

0.14

0.19

nmol/l

1.11

262

Other symptoms and signs involving the urinary system

353

1.42

1.60

1.8

1.5

0.34

0.31

nmol/l

0.15

281

Combined immunodeficiencies

2.36

1.60

1.8

1.4

0.16

0.37

nmol/l

—

Excessive vomiting in pregnancy

132

1073

1.24

1.59

1.3

1.5

0.39

0.47

nmol/l

0.79

107

863

Diseases of the digestive system

263

2259

1.16

1.59

1.4

1.5

0.32

0.38

nmol/l

0.70

199

1749

Urethral stricture

1.91

1.59

1.3

1.6

0.37

0.25

nmol/l

—

Ischaemic Stroke, excluding all haemorrhages

131

1200

0.81

1.59

1.5

1.4

0.20

0.26

nmol/l

1.08

863

Other specified/unspecified systemic involvement of connective tissue

354

1.42

1.59

1.5

1.4

0.33

0.35

nmol/l

0.09

268

Iron deficiency anaemia

288

2467

1.15

1.58

1.4

0.40

0.41

nmol/l

0.02

234

1891

Respiratory and cardiovascular disorders specific to the perinatal period

156

1.62

1.58

1.6

0.16

0.24

nmol/l

1.13

129

Injuries involving multiple body regions

223

1.54

1.57

1.2

1.5

0.44

0.37

nmol/l

0.32

183

Other keratitis

770

1.28

1.57

1.4

1.5

0.34

0.44

nmol/l

0.69

617

Implicit bacterial Sepsis

171

1229

1.20

1.57

1.6

1.4

0.27

0.31

nmol/l

0.55

129

927

Type1 diabetes, definitions combined, early onset

714

0.72

1.57

1.2

1.5

0.36

0.44

nmol/l

0.45

600

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

739

0.73

1.55

1.1

1.5

0.30

0.47

nmol/l

2.13

576

Aneurysms, operations, SAH

624

0.70

1.55

1.3

1.4

0.56

0.28

nmol/l

0.68

454

Colectomy operation

500

1.34

1.55

1.4

1.5

0.35

0.27

nmol/l

0.54

378

Abnormal spermatozoa

137

1.68

1.55

1.4

0.10

0.14

nmol/l

1.20

109

Disorder of external ear, unspecified

145

1.67

1.55

1.5

0.33

nmol/l

0.01

114

Type 2 diabetes, strict (exclude DM1)

706

4528

0.91

1.54

1.6

1.4

0.40

nmol/l

0.01

539

3491

Blepharochalasis

114

914

1.25

1.54

1.4

0.21

0.24

nmol/l

0.46

608

Nontoxic goitre/thyroid nodule

175

1467

1.20

1.53

1.3

1.4

0.28

0.36

nmol/l

1.65

118

1076

Specific development disorders of scholastic skills

436

1.37

1.53

1.9

1.6

0.37

0.35

nmol/l

0.06

361

Sequelae of tuberculosis

3.35

1.52

1.6

1.5

0.32

0.11

nmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

122

987

1.24

1.52

1.4

1.5

0.32

0.38

nmol/l

0.52

782

Crohn disease

121

979

1.24

1.52

1.4

1.5

0.39

0.44

nmol/l

0.47

101

787

Mental retardation, excluding more controls

195

1.56

1.52

1.7

1.4

0.28

0.32

nmol/l

0.19

159

Exposure to other specified electric current

183

0.49

1.52

2.0

1.5

0.13

0.35

nmol/l

—

148

Trigeminal neuralgia

324

1.43

1.51

1.3

1.4

0.43

0.38

nmol/l

0.16

248

Enteropathic arthropathies

154

1.64

1.51

1.2

1.4

0.50

0.40

nmol/l

0.24

129

Degenerative macular diseases

225

1.51

1.6

1.5

0.19

0.24

nmol/l

0.49

169

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

2.16

1.50

1.0

1.4

0.27

0.24

nmol/l

—

Trochanteric bursitis

704

1.28

1.50

1.3

1.4

0.29

0.35

nmol/l

0.43

538

Toxic effect of corrosive substances

2.50

1.50

1.6

1.5

0.50

0.41

nmol/l

—

Hypertrophic disorders of skin

504

1.34

1.50

1.4

1.5

0.39

0.43

nmol/l

0.23

406

Hypertensive diseases (excluding secondary)

574

3023

1.10

1.50

1.5

1.4

0.32

0.42

nmol/l

2.17

406

2369

Nontraumatic intracranial haemmorrhage

490

0.67

1.49

1.3

1.4

0.27

0.24

nmol/l

0.22

358

Bell's palsy

608

1.30

1.49

1.3

1.4

0.26

0.40

nmol/l

1.71

476

Other abnormal findings of blood chemistry

218

1.52

1.49

1.4

1.5

0.24

0.37

nmol/l

1.55

177

Disorders of vitreous body

220

1820

1.17

1.49

1.3

1.4

0.24

0.28

nmol/l

0.83

156

1260

Type 2 diabetes

784

4971

0.92

1.48

1.6

1.4

0.41

nmol/l

0.04

601

3863

Type 2 diabetes, definitions combined

706

4518

0.92

1.48

1.6

1.4

0.40

nmol/l

0.00

539

3483

Benign neoplasm: Skin of eyelid, including canthus

591

1.31

1.48

1.3

1.4

0.54

0.32

nmol/l

0.94

436

Other congenital malformations of circulatory system

124

1.71

1.48

1.3

1.5

0.24

0.36

nmol/l

0.71

104

Fentanyl

234

1.50

1.48

1.4

0.18

0.30

nmol/l

1.70

171

Other diseases of gallbladder

147

1.64

1.47

1.3

1.4

0.17

0.33

nmol/l

1.80

113

Volume depletion

235

1.49

1.46

1.4

1.5

0.23

0.29

nmol/l

0.53

191

MS-disease / Multiple Sclerosis

696

0.73

1.46

1.5

1.4

0.43

0.44

nmol/l

0.04

567

Other disorders of nervous system

219

1.51

1.46

1.3

1.4

0.25

0.30

nmol/l

0.25

165

Muscular dystrophy

2.54

1.46

1.3

1.4

0.15

0.28

nmol/l

—

Any dementia, excluding more controls

329

0.67

1.46

1.6

1.4

0.14

0.19

nmol/l

1.01

231

Other diseases of stomach and duodenum

195

1.54

1.45

1.4

1.5

0.45

0.30

nmol/l

0.48

140

Insulin, combination of fast acting with intermediate-acting or long-acting

293

3047

0.88

1.45

1.3

1.5

0.38

0.37

nmol/l

0.04

219

2375

Osteosarcoma, including Hilmo

3.20

1.45

1.2

1.4

0.12

0.76

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

567

1.31

1.44

1.2

1.5

0.23

0.24

nmol/l

0.01

397

Hemiplegia

236

1.49

1.44

1.4

0.22

0.37

nmol/l

1.98

186

Exclusion endpoint for clefts

156

1.62

1.44

1.3

1.5

0.45

0.37

nmol/l

0.16

128

Effects of foreign body entering through natural orifice

162

1358

1.20

1.44

1.3

1.5

0.26

0.36

nmol/l

2.06

130

1090

Pneumonia due to other infectious organisms, not elsewhere classified

125

1.69

1.44

1.5

0.40

0.31

nmol/l

0.28

100

Raynaud syndrome

683

1.28

1.43

1.6

1.4

0.29

0.45

nmol/l

2.25

548

ILD medications: azathioprine

132

1086

1.22

1.43

1.6

1.5

0.41

0.43

nmol/l

0.10

102

861

Unknown and unspecified causes of morbidity

353

1.39

1.43

1.7

1.4

0.23

0.47

nmol/l

3.27

293

Other and unspecified mononeuropathies, also in other diseases

110

1.74

1.43

1.9

1.4

0.32

0.33

nmol/l

0.05

Embedded and impacted teeth

441

3274

1.11

1.43

1.6

1.5

0.40

0.46

nmol/l

0.83

371

2762

Ascites

212

1.51

1.43

1.3

1.5

0.15

0.29

nmol/l

2.01

160

Demyelinating diseases of the central nervous system

818

0.75

1.42

1.4

0.43

0.45

nmol/l

0.06

664

Disorders of synovium and tendon

476

3767

1.11

1.42

1.3

1.5

0.32

0.42

nmol/l

3.27

342

3001

Anxious personality disorder

173

1.58

1.41

1.4

1.5

0.29

0.38

nmol/l

0.67

146

Cerebrovascular diseases (FINNGEN)

161

1356

0.84

1.41

1.5

1.4

0.31

0.34

nmol/l

0.19

124

1015

Other bullous disorders

103

1.76

1.41

1.2

1.5

0.24

0.33

nmol/l

0.56

Alcohol abuse, main dg, excluding more controls

782

1.26

1.41

1.4

0.31

0.39

nmol/l

0.90

635

Cutaneous abscess, furuncle and carbuncle

215

1851

1.16

1.40

1.4

1.5

0.38

0.41

nmol/l

0.14

167

1475

Transient global amnesia

181

1.55

1.39

1.5

0.18

0.19

nmol/l

0.06

130

Type 2 diabetes, definitions combined, including avohilmo

726

4588

0.92

1.39

1.6

1.4

0.39

0.40

nmol/l

0.05

558

3539

Fracture of skull and facial bones

146

1217

1.20

1.39

1.5

0.26

0.40

nmol/l

2.88

115

950

Viral and other specified intestinal infections

256

2181

1.15

1.39

1.7

1.6

0.37

0.41

nmol/l

0.29

208

1827

Entropion and trichiasis of eyelid

111

1.72

1.39

1.8

1.6

0.41

0.26

nmol/l

0.55

Etanercept

504

0.69

1.38

1.3

1.5

0.43

0.39

nmol/l

0.16

399

Non-invasive ventilation

135

1451

0.83

1.38

1.4

0.49

0.44

nmol/l

0.14

114

1132

Other meningitis

1.82

1.38

1.6

1.5

0.27

0.35

nmol/l

0.36

Acute laryngitis and tracheitis

152

1253

1.20

1.38

1.5

1.6

0.34

0.45

nmol/l

1.22

124

1056

Umbilical hernia

169

1429

1.19

1.38

1.5

1.4

0.31

0.39

nmol/l

0.74

136

1128

Thyrotoxicosis with diffuse goitre

134

1110

1.21

1.37

1.5

1.4

0.45

0.44

nmol/l

0.07

101

860

Scleritis and episcleritis

399

1.36

1.37

1.2

1.5

0.30

0.38

nmol/l

0.63

318

Allergic urticaria

670

1.28

1.37

1.7

1.4

0.58

0.41

nmol/l

0.26

540

Other specified congenital malformation syndromes affecting multiple systems

135

1.65

1.37

1.2

1.4

0.52

0.35

nmol/l

0.31

109

Peripheral artery disease

695

0.77

1.37

1.2

1.4

0.19

0.20

nmol/l

0.07

505

Herpesviral [herpes simplex] infections

750

1.26

1.37

1.4

0.27

0.41

nmol/l

2.62

593

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

196

1681

1.17

1.36

1.4

1.5

0.32

0.44

nmol/l

2.53

147

1347

Rotator cuff syndrome

362

2314

1.12

1.36

1.3

1.4

0.27

0.34

nmol/l

1.83

270

1755

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

688

1.27

1.36

1.3

1.4

0.52

0.34

nmol/l

0.35

521

Myopia

158

1332

1.19

1.35

1.3

1.5

0.44

0.45

nmol/l

0.08

125

1073

Acne vulgaris

130

1077

1.21

1.35

1.6

0.37

0.46

nmol/l

0.64

111

897

Congenital deformities of feet

307

1.41

1.35

1.7

1.5

0.34

0.35

nmol/l

0.04

258

Symptoms and signs involving cognition, perception, emotional state and behaviour

854

5404

1.08

1.35

1.5

1.4

0.30

0.42

nmol/l

6.34

658

4225

Disorders of choroid and retina

363

2886

0.89

1.35

1.6

1.4

0.30

0.36

nmol/l

0.85

265

2168

Other shoulder lesions

619

1.28

1.34

1.4

1.5

0.56

0.40

nmol/l

0.21

498

Implicit Sepsis

581

3884

1.09

1.33

1.5

0.32

0.38

nmol/l

1.31

446

3003

Other diseases of oesophagus

299

1.41

1.33

1.4

1.5

0.22

0.28

nmol/l

0.61

231

Degenerative diseases of the nervous system

308

0.67

1.32

1.3

1.5

0.15

0.14

nmol/l

0.13

222

Azathioprine

132

1097

1.21

1.32

1.6

1.5

0.41

0.43

nmol/l

0.10

102

866

Congenital malformations of uterus and cervix

284

1.43

1.32

1.5

0.54

0.42

nmol/l

0.47

248

Benign neoplasm: Adrenal gland

258

1.44

1.31

1.6

1.5

0.32

0.27

nmol/l

0.36

185

Implicit parasitic Sepsis

2.54

1.31

2.3

1.3

0.29

0.32

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

561

0.75

1.31

1.2

1.4

0.15

0.18

nmol/l

0.69

411

Impacted cerumen

300

1.40

1.31

1.4

1.5

0.24

0.31

nmol/l

0.68

233

Diplopia

621

1.28

1.31

1.4

1.5

0.42

0.38

nmol/l

0.20

497

Morphin

2.51

1.30

1.7

1.2

0.10

0.22

nmol/l

—

Mixed connective tissue disease

403

1.35

1.30

1.5

1.4

0.32

0.37

nmol/l

0.45

309

Other and unspecified iron deficiency

234

2039

1.15

1.30

1.4

0.39

0.43

nmol/l

0.28

189

1577

Disorders of vitreous body and globe

224

1869

1.15

1.30

1.3

1.4

0.26

0.28

nmol/l

0.25

159

1300

Other disorders of carbohydrate metabolism

2.83

1.29

2.2

1.8

0.35

0.33

nmol/l

—

Nutritional anaemias

313

2682

1.13

1.29

1.4

0.39

0.40

nmol/l

0.09

254

2046

Shoulder lesions

545

3014

1.10

1.28

1.3

1.4

0.31

0.40

nmol/l

0.99

399

2344

Rash and other nonspecific skin eruption

535

1.29

1.28

1.5

1.4

0.45

0.37

nmol/l

0.18

416

Other enthesopathies

224

1951

1.15

1.28

1.3

1.4

0.27

0.38

nmol/l

3.11

170

1484

Type 1 diabetes, strict definition

835

0.77

1.27

1.2

1.5

0.35

0.45

nmol/l

0.69

695

Other disorders of eye and adnexa

126

1047

1.21

1.27

1.4

1.5

0.37

0.42

nmol/l

0.34

828

Malignant neoplasm of stomach

2.00

1.27

1.3

0.38

0.24

nmol/l

—

Episcleritis

362

1.36

1.27

1.2

1.5

0.30

0.37

nmol/l

0.43

288

Haemangioma and lymphangioma, any site

536

1.29

1.26

1.4

0.29

0.38

nmol/l

0.61

413

Other follicular disorders

563

1.29

1.26

1.4

1.5

0.30

0.44

nmol/l

1.82

453

Other heart diseases, wide

815

5355

0.93

1.26

1.4

0.37

0.41

nmol/l

0.47

615

4206

Poisoning by narcotics and psychodysleptics [hallucinogens]

115

1.67

1.26

2.0

1.6

0.21

0.40

nmol/l

1.31

Algoneurodystrophy

261

1.43

1.26

1.4

0.24

0.35

nmol/l

1.17

206

Other disorders starting during childhood or adolescence

576

1.28

1.25

1.6

0.23

0.42

nmol/l

3.12

485

Long labour

420

3257

1.11

1.24

1.5

1.4

0.61

0.42

nmol/l

1.68

351

2543

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

248

2182

1.14

1.24

1.4

1.5

0.48

nmol/l

0.03

203

1762

Benign neoplasm of male genital organs

2.41

1.24

2.7

1.2

0.15

0.17

nmol/l

—

Pre-eclampsia or poor fetal growth

489

4451

1.10

1.24

1.5

1.4

0.49

0.48

nmol/l

0.05

398

3555

Artificial joint re-operation

123

1.63

1.24

1.4

1.5

0.22

0.19

nmol/l

0.11

Pediculosis and phthiriasis

2.09

1.24

2.6

1.6

0.99

0.43

nmol/l

—

Thrombocytopenia, unspecified

270

1.41

1.23

1.7

1.5

1.03

0.32

nmol/l

0.56

217

Purpura and other haemorrhagic conditions

689

1.25

1.23

1.8

1.5

0.64

0.37

nmol/l

0.44

547

Lymphangioma, anys site

2.08

1.23

2.6

1.5

0.35

0.46

nmol/l

—

Haemangioma, any site

495

1.30

1.22

1.3

1.4

0.28

0.35

nmol/l

0.54

381

Atopic dermatitis, strict definition with reimbursement

426

3735

1.10

1.22

1.6

1.5

0.37

0.45

nmol/l

1.30

333

3045

Other retinal disorders

239

2119

0.88

1.22

1.6

1.4

0.31

0.38

nmol/l

0.67

175

1605

Focal epilepsy

142

1198

1.19

1.22

1.4

0.33

0.40

nmol/l

0.65

112

943

Other disorders of bone

173

1485

1.17

1.22

1.6

1.5

0.29

0.41

nmol/l

2.83

142

1162

Hyperosmolality and hypernatraemia

2.65

1.22

1.6

1.4

0.13

0.18

nmol/l

—

Foreign body on external eye

628

1.26

1.21

1.2

1.5

0.28

0.32

nmol/l

0.26

523

Benign mammary dysplasia

736

1.24

1.21

1.6

1.4

0.43

0.40

nmol/l

0.12

543

Type 1 diabetes, strict definition, subgroup 1

794

0.78

1.20

1.2

1.5

0.36

0.46

nmol/l

0.65

659

Diabetic maculopathy

569

0.74

1.20

1.3

1.5

0.29

0.48

nmol/l

1.51

455

Other chromosome abnormalities, not elsewhere classified

2.36

1.20

1.2

1.6

0.32

0.25

nmol/l

—

Other and unspecified mood [affective] disorders

765

1.24

1.19

1.6

1.5

0.26

0.46

nmol/l

3.91

627

Other secondary coxarthrosis

109

1.66

1.19

1.6

1.5

0.27

0.24

nmol/l

0.19

Cholelithiasis, broad definition with cholecystitis

612

4459

0.92

1.18

1.4

0.37

0.41

nmol/l

0.55

479

3401

Gingival hyperplasia

173

1.51

1.18

1.5

0.22

0.32

nmol/l

1.25

138

Other neurotic disorders

173

1.51

1.18

1.7

1.4

0.20

0.31

nmol/l

1.27

133

Other and unspecified visual disturbances

542

1.28

1.18

1.5

0.48

0.39

nmol/l

0.28

433

Hallux valgus (acquired)

181

1506

0.86

1.17

1.5

1.4

0.28

0.35

nmol/l

1.34

140

1099

Diseases of spleen

1.79

1.17

1.3

1.4

0.26

0.40

nmol/l

—

Juvenile osteochondrosis

265

1.41

1.17

1.4

1.5

0.32

0.33

nmol/l

0.08

222

Tooth agenesis EXCLUDE clefts and syndromes

420

1.32

1.17

1.4

1.6

0.39

0.37

nmol/l

0.11

354

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

379

3432

1.11

1.17

1.4

1.5

0.42

0.45

nmol/l

0.23

293

2793

Other specified and unspecified disorders of eyelid

2.02

1.17

1.2

1.5

0.17

0.28

nmol/l

—

Other disorders affecting eyelid function

0.00

1.17

0.0

1.5

—

0.29

—

Other disorders of conjunctiva

481

1.29

1.16

1.7

1.4

0.37

0.26

nmol/l

0.79

360

Adverse effects, not elsewhere classified

210

1837

1.15

1.16

1.6

1.5

0.49

0.44

nmol/l

0.15

153

1467

Other retinal artery occlusion

0.00

1.16

0.0

1.4

—

0.18

—

Implicit parasitic Sepsis

2.54

1.16

2.6

1.2

0.32

0.35

nmol/l

—

Calcific tendinitis of shoulder

308

1.37

1.15

1.2

1.4

0.22

0.29

nmol/l

0.67

231

154

1792

0.85

1.15

1.5

0.59

0.52

nmol/l

0.20

130

1483

Benign neoplasm of other and unspecified sites

126

1.60

1.15

1.8

1.5

0.19

0.32

nmol/l

1.29

Senile cataract

171

1216

0.86

1.14

1.3

1.4

0.18

0.21

nmol/l

0.84

118

826

Fibroblastic disorders

104

859

1.21

1.14

1.2

1.4

0.31

0.34

nmol/l

0.24

661

Medical abortion

695

4057

0.93

1.14

1.4

0.44

0.42

nmol/l

0.13

528

3207

Complications of the puerperium, not elsewhere classified

600

1.26

1.13

1.4

0.55

0.50

nmol/l

0.24

487

Allergic asthma (mode)

291

2547

1.12

1.13

1.5

1.4

0.54

0.44

nmol/l

0.54

235

2088

Scabies

119

1414

0.84

1.13

1.4

1.5

0.34

0.41

nmol/l

0.48

1142

Ptosis of eyelid

335

1.35

1.13

1.4

0.28

0.29

nmol/l

0.04

250

Disorder of lipoprotein metabolism, unspecified

275

1.38

1.13

1.3

1.4

0.20

0.24

nmol/l

0.35

202

Impacted teeth

324

2594

1.11

1.12

1.7

1.5

0.38

0.45

nmol/l

0.83

279

2210

Mental and behavioural disorders due to sedatives or hypnotics

440

1.30

1.12

1.5

0.21

0.36

nmol/l

2.98

355

Injuries to the ankle and foot

752

6237

1.07

1.12

1.5

0.33

0.42

nmol/l

4.21

592

4954

Speech and linguistic disorders

100

792

1.22

1.12

1.8

1.6

0.32

0.38

nmol/l

0.40

654

Gout, FINNGEN

509

1.27

1.12

1.3

1.4

0.23

0.19

nmol/l

0.23

394

Allergic asthma (mode), excluding more controls

291

2550

1.12

1.11

1.5

1.4

0.54

0.44

nmol/l

0.53

235

2090

Other enthesopathy of foot (+metatarsalgia)

663

1.24

1.11

1.3

1.4

0.26

0.40

nmol/l

2.28

529

Metabolic disorders

745

4235

1.07

1.11

1.5

1.4

0.29

0.38

nmol/l

3.63

546

3258

Sub-endpoint used in defining T1D endpoints

169

1918

0.87

1.10

1.4

1.5

0.39

0.42

nmol/l

0.21

132

1555

Substance use, excluding alcohol

170

1471

1.16

1.10

1.5

0.25

0.41

nmol/l

4.60

126

1188

Pacemaker

558

1.25

1.10

1.3

1.4

0.18

0.21

nmol/l

0.71

410

Anorexia

120

1.60

1.10

1.6

1.4

0.35

0.36

nmol/l

0.02

Cardiomyopathy, other and unspecified

201

1.45

1.09

1.3

1.5

0.21

0.26

nmol/l

0.42

165

Intracranial injury

447

3871

1.09

1.5

0.27

0.40

nmol/l

6.64

334

3062

Lumbar disc prolapse

514

3628

1.09

1.5

1.4

0.29

0.42

nmol/l

6.10

386

2837

Congenital malformations of ovaries, fallopian tubes and broad ligaments

693

1.24

1.09

1.4

1.5

0.57

0.48

nmol/l

0.43

566

Arthropod-borne viral fevers and viral haemorrhagic fevers

116

973

1.19

1.09

1.3

1.5

0.45

0.39

nmol/l

0.25

770

Impingement syndrome of shoulder

114

955

1.20

1.09

1.4

0.25

0.28

nmol/l

0.45

698

Heart failure and hypertrophic cardiomyopathy

2.39

1.09

2.8

1.4

0.13

0.31

nmol/l

—

Type 1 diabetes, wide definition

147

1709

0.86

1.09

1.3

1.5

0.41

0.43

nmol/l

0.10

116

1383

Mucosal proctocolitis

112

938

1.20

1.08

1.5

0.45

0.41

nmol/l

0.18

766

Traumatic subdural haemorrhage

201

1.43

1.08

1.3

1.4

0.13

0.25

nmol/l

2.44

167

Other disorders of patella

176

1531

1.15

1.07

1.5

1.4

0.37

0.46

nmol/l

0.52

146

1200

Strabismus

244

2163

1.13

1.07

1.4

1.5

0.37

0.43

nmol/l

0.37

181

1721

Allergic rhinitis

384

3458

1.10

1.07

1.5

0.39

0.42

nmol/l

0.22

312

2769

Sacroiliitis, not elsewhere classified

462

1.28

1.06

1.5

0.38

0.42

nmol/l

0.20

382

Insulin, intermediate and long-acting

247

2693

0.89

1.06

1.3

1.5

0.31

0.37

nmol/l

0.56

182

2097

Ventral hernia

124

1050

1.18

1.06

1.6

1.4

0.28

0.37

nmol/l

1.07

778

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

365

1.32

1.06

1.5

0.25

0.21

nmol/l

0.29

270

COPD, hospital admission 2, with asthma infections

575

0.77

1.05

1.2

1.4

0.20

nmol/l

0.06

422

Other viral diseases, not elsewhere classified

175

1520

1.15

1.05

1.4

1.5

0.29

0.41

nmol/l

2.97

137

1206

Use of disulfiram, acamprosate or naltrexone

401

1.30

1.05

1.3

1.5

0.31

0.32

nmol/l

0.04

312

Other infectious diseases

401

1.30

1.05

1.4

1.5

0.28

0.39

nmol/l

0.78

321

Other specified/unspecified inflammatory spondylopathies

384

1.31

1.04

1.2

1.5

0.36

0.40

nmol/l

0.23

302

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1.79

1.04

1.2

1.4

0.10

0.20

nmol/l

—

Paroxysmal tachycardia

183

1337

1.15

1.04

1.3

1.5

0.36

0.39

nmol/l

0.19

147

1042

Enterobiasis

255

1.39

1.04

1.4

1.5

0.35

0.47

nmol/l

0.69

220

Artificial joint operation, meniscal resection

447

3162

0.92

1.04

1.4

0.22

0.33

nmol/l

5.07

329

2327

Maternal care for other conditions predominantly related to pregnancy

374

3345

1.10

1.04

1.3

1.4

0.45

nmol/l

0.02

310

2669

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.29

1.03

2.2

1.6

0.26

0.21

nmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

562

1.25

1.03

1.6

1.5

0.25

0.37

nmol/l

2.56

471

Spinal stenosis

177

1170

1.15

1.03

1.4

0.27

0.24

nmol/l

0.26

119

820

Pain in throat and chest

813

4578

1.07

1.03

1.3

1.5

0.34

0.43

nmol/l

1.94

604

3659

Heartburn

652

1.23

1.03

1.4

0.38

nmol/l

0.00

516

Spirochaetal infections, other/unspecified

376

1.31

1.03

1.4

0.30

0.31

nmol/l

0.03

281

Polyarthritis, unspecified

171

1.47

1.02

2.3

1.4

0.52

0.33

nmol/l

0.48

134

Mixed disorders of conduct and emotions

273

1.37

1.02

1.2

1.6

0.27

0.39

nmol/l

0.92

238

Other strabismus

217

1916

1.13

1.02

1.4

1.5

0.39

0.44

nmol/l

0.28

159

1531

Disorders of lens

244

1709

0.89

1.01

1.4

0.24

0.27

nmol/l

0.38

169

1204

Internal derangement of knee

287

2572

1.11

1.01

1.6

1.4

0.35

0.42

nmol/l

0.52

217

2002

Other diseases of anus and rectum

158

1367

1.15

1.01

1.4

0.36

0.38

nmol/l

0.09

127

1027

Other deformities of toe(s)

155

1.49

1.01

1.6

1.4

0.40

0.33

nmol/l

0.20

123

Infections, IBD-co-morbidities

125

758

1.18

1.01

1.6

1.4

0.25

0.43

nmol/l

3.69

105

592

Herpesviral [herpes simplex] infections

271

2436

1.12

1.00

1.5

0.35

0.45

nmol/l

2.47

215

1924

Labour and delivery complicated by fetal stress [distress]

520

3150

1.08

1.00

1.5

1.4

0.54

0.42

nmol/l

1.54

445

2529

Substance abuse, excluding more controls

396

3088

1.09

1.00

1.4

0.31

0.42

nmol/l

3.38

298

2452

Aortic valve malfunction, age under 60 years

404

1.29

1.00

1.3

1.5

0.68

0.27

nmol/l

0.89

305

Non-allergic asthma (mode), excluding more controls

134

1138

1.17

1.00

1.5

1.4

0.31

0.38

nmol/l

0.93

897

Lichen simplex chronicus

131

1.53

1.00

2.3

1.5

0.15

0.33

nmol/l

2.04

Postprocedural disorders of digestive system, not elsewhere classified

123

1.55

0.99

1.2

1.6

0.26

0.34

nmol/l

0.62

Familial hypercholesterolemia, with ischemic heart disease

107

1.59

0.99

1.1

1.6

0.13

0.16

nmol/l

0.40

5-aminosalicylic acid

192

1692

1.14

0.99

1.5

0.43

nmol/l

0.05

156

1359

Disorders of continuity of bone

620

1.23

0.98

1.6

1.5

0.25

0.38

nmol/l

2.17

481

Exposure to other and unspecified animate mechanical forces

249

1.38

0.98

1.4

1.5

0.53

0.37

nmol/l

0.22

205

Maternal care for other known or suspected fetal problems

511

2994

1.08

0.98

1.4

0.46

0.44

nmol/l

0.20

417

2413

Disorders of muscles

557

1.24

0.98

1.5

0.30

0.40

nmol/l

0.73

463

Varicose veins of other sites

181

1.44

0.98

1.5

1.6

0.19

0.25

nmol/l

0.55

145

Progressive vascular leukoencephalopathy

2.18

0.98

1.8

1.5

0.16

0.09

nmol/l

—

Superficial injury of wrist and hand

160

1832

0.87

0.98

1.6

1.5

0.30

0.43

nmol/l

1.22

128

1477

Unstable angina pectoris

567

0.79

0.97

1.2

1.5

0.18

0.17

nmol/l

0.16

406

Benign neoplasm of mouth and pharynx

459

1.27

0.97

1.3

1.5

0.45

0.29

nmol/l

0.75

352

Paralytic strabismus

249

1.37

0.97

1.7

1.5

0.21

0.31

nmol/l

1.17

190

Type 1 diabetes, strict (exclude DM2)

923

0.82

0.97

1.3

1.5

0.35

0.44

nmol/l

0.71

760

Gonarthrosis,primary

397

2669

0.92

0.97

1.4

1.3

0.26

0.29

nmol/l

0.37

283

1896

Type 1 diabetes, wide definition, subgroup 1

142

1637

0.86

0.97

1.3

1.5

0.41

0.44

nmol/l

0.11

111

1330

Post-traumatic wound infection, not elsewhere classified

116

1.56

0.97

1.5

0.32

nmol/l

0.01

Non-allergic asthma (mode)

134

1142

1.16

0.97

1.5

1.4

0.31

0.38

nmol/l

0.91

901

Scoliosis

749

1.21

0.96

1.7

1.6

0.35

0.39

nmol/l

0.29

619

Delirium, not induced by alcohol and other psychoactive substances

198

1.41

0.96

1.4

0.34

0.25

nmol/l

0.30

155

Malignant neoplasm of stomach, including Hilmo

1.74

0.96

1.7

1.3

0.36

0.22

nmol/l

—

Atopic dermatitis, strict definition

408

3674

1.09

0.96

1.6

1.5

0.36

0.44

nmol/l

1.24

317

3004

Cyst of kidney

157

1.47

0.96

1.3

1.5

0.16

0.28

nmol/l

1.21

121

Injuries to the hip and thigh

242

1962

1.12

0.95

1.5

1.4

0.28

0.36

nmol/l

1.13

190

1492

Mandibular retrognathia

645

0.78

0.95

1.4

1.5

0.36

0.38

nmol/l

0.11

517

Viral haemorrhagic fevers, not elsewhere classified/unspecified

103

868

1.19

0.95

1.3

1.5

0.48

0.38

nmol/l

0.37

690

Keratitis

271

2445

1.11

0.95

1.3

1.5

0.40

0.41

nmol/l

0.08

211

1925

Mixed conductive and sensorineural hearing loss

381

1.29

0.95

1.2

1.5

0.29

0.30

nmol/l

0.07

288

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

128

1102

1.17

0.94

1.4

0.31

0.47

nmol/l

3.34

103

869

Insulin, fast-acting or short human

195

2197

0.89

0.94

1.3

1.5

0.36

0.40

nmol/l

0.36

149

1749

Fall on same level

1063

6115

0.95

0.94

1.5

0.32

0.42

nmol/l

5.41

808

4889

Certolizumab pegol

175

1.44

0.94

2.1

1.5

0.35

0.41

nmol/l

0.26

151

Cholelithiasis

596

4401

0.93

0.94

1.4

0.37

0.41

nmol/l

0.39

466

3347

Problems related to lifestyle

779

1.20

0.93

1.4

1.5

0.31

0.46

nmol/l

1.69

634

COPD, hospital admissions 3, with asthma pneumonia sepsis

399

0.75

0.93

1.2

1.4

0.23

0.21

nmol/l

0.13

295

Injury of nerves at lower leg level

1.84

0.93

1.3

1.5

0.17

0.31

nmol/l

—

Other superficial mycoses

107

909

1.18

0.92

1.3

1.5

0.46

nmol/l

0.00

745

Other vitreous opacities

142

1.49

0.92

1.9

1.4

0.31

0.33

nmol/l

0.04

109

Streptococcal septicaemia

269

1.34

0.92

1.4

0.15

0.26

nmol/l

2.15

223

Infective dermatitis

555

0.77

0.92

1.5

0.16

0.40

nmol/l

4.90

441

Dipeptidyl peptidase 4 (DPP-4) inhibitors

153

1402

0.87

0.92

1.4

0.20

0.26

nmol/l

1.71

105

998

Acute nasopharyngitis (common cold)

558

1.23

0.92

1.2

1.5

0.49

0.35

nmol/l

0.53

465

Melanocytic naevi of other and unspecified parts of face

410

1.27

0.92

1.5

0.34

0.41

nmol/l

0.39

323

Ulcerative colitis, NAS

114

974

1.17

0.92

1.4

1.5

0.41

0.42

nmol/l

0.05

784

Other diseases of arteries and capillaries

339

1.30

0.92

1.5

1.4

0.21

0.30

nmol/l

1.31

260

Familial hypercholesterolemia

304

1.32

0.91

1.2

1.5

0.20

0.23

nmol/l

0.21

233

Bullous disorders

184

1.42

0.91

1.2

1.5

0.27

0.30

nmol/l

0.23

148

Retinal detachment with retinal break

348

1.30

0.91

1.2

1.4

0.23

0.25

nmol/l

0.14

259

Melanocytic naevi of lower limb, including hip

296

1.32

0.91

1.7

1.4

0.35

0.39

nmol/l

0.20

241

Acute pancreatitis

726

1.20

0.91

1.6

1.4

0.26

0.32

nmol/l

0.63

562

Condition for Implicit Sepsis (Organ dysfunction codes)

737

4777

1.06

0.91

1.4

1.5

0.34

0.39

nmol/l

0.48

571

3727

Disorders of orbit

227

1.37

0.90

1.5

0.39

0.33

nmol/l

0.33

180

Ulcerative ileocolitis

279

1.33

0.90

1.8

1.4

0.47

0.36

nmol/l

0.47

222

Other aneurysm

102

1.57

0.90

1.2

1.6

0.20

nmol/l

—

Other peripheral vascular diseases

465

1.25

0.90

1.6

1.4

0.24

0.41

nmol/l

2.31

377

Other disorders of the genitourinary system

465

1.25

0.89

1.4

0.23

0.31

nmol/l

1.01

332

Other juvenile arthritis

430

1.26

0.89

1.7

1.5

0.33

0.42

nmol/l

0.68

358

Heart failure and coronary heart disease

542

0.81

0.89

1.2

1.5

0.18

0.16

nmol/l

0.31

393

Pathological resorption of teeth

194

1.40

0.88

1.3

1.5

0.23

0.34

nmol/l

1.44

157

Dermatitis due to substances taken internally

315

1.31

0.88

1.5

0.25

0.38

nmol/l

1.65

253

Conjunctivitis (acute, non atopic)

254

2287

1.11

0.88

1.5

0.35

0.41

nmol/l

1.00

203

1813

Cholecystectomy

531

4269

1.07

0.88

1.4

0.36

0.40

nmol/l

0.67

411

3216

Wet age-related macular degeneration

139

1.47

0.88

1.6

1.4

0.11

0.13

nmol/l

0.50

Diseases of pulp and periapical tissues, including avohilmo

1046

5146

1.05

0.88

1.4

1.5

0.43

0.41

nmol/l

0.24

813

4127

Neuromuscular dysfunction of bladder

377

1.28

0.88

1.9

1.4

0.23

0.34

nmol/l

1.31

294

Meniscus derangement

300

2219

0.91

0.88

1.3

1.4

0.28

0.36

nmol/l

1.36

218

1667

Benign lipomatous neoplasm

164

1445

1.14

0.88

1.3

1.4

0.43

0.35

nmol/l

0.25

114

1070

Mental disorders, not otherwise specified

813

1.19

0.87

1.3

1.5

0.42

0.46

nmol/l

0.24

661

Visual impairment including blindness (binocular or monocular)

237

1.35

0.87

1.6

1.5

0.25

0.31

nmol/l

0.42

190

Disorders of sclera, cornea, iris and ciliary body

425

3934

1.08

0.87

1.4

1.5

0.35

0.40

nmol/l

0.58

329

3053

Other disorders of cornea

413

1.26

0.87

1.4

1.5

0.63

0.33

nmol/l

0.52

318

Crohn's disease of large intestine

360

1.28

0.87

1.3

1.4

0.40

0.42

nmol/l

0.09

291

Functional dyspepsia

204

1823

1.12

0.87

1.4

0.39

0.40

nmol/l

0.06

160

1394

Fracture of foot, except ankle

179

2015

0.89

0.87

1.5

0.31

0.42

nmol/l

1.34

135

1599

Convergence insufficiency and excess

128

1.50

0.87

1.5

0.16

0.39

nmol/l

3.58

106

Left ventricular outflow tract obstruction (LVOTO), broad definition

458

1.25

0.87

1.3

1.5

0.63

0.27

nmol/l

0.85

342

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

279

2537

1.10

0.86

1.4

1.5

0.38

0.42

nmol/l

0.21

220

2016

Adjustment and management of implanted device

396

1.26

0.86

1.4

1.5

0.22

0.24

nmol/l

0.14

299

Nontoxic single thyroid nodule

352

1.28

0.85

1.4

0.31

0.40

nmol/l

0.60

265

Car occupant injured in noncollision transport accident

263

0.68

0.85

1.3

1.5

0.34

0.36

nmol/l

0.09

220

Other benign neoplasms of skin

217

1949

1.11

0.85

1.5

1.4

0.35

0.37

nmol/l

0.17

165

1457

Superficial injury of hip and thigh

631

1.21

0.85

1.3

1.5

0.24

0.37

nmol/l

2.24

505

Alzheimer disease, including avohilmo

268

0.74

0.85

1.3

1.4

0.13

0.12

nmol/l

0.05

190

Other obstructed labour

822

0.82

0.85

1.3

1.5

0.46

0.39

nmol/l

0.23

621

ILD, hospital admissions 1, main diag only

282

1.31

0.84

1.8

1.5

0.17

0.26

nmol/l

1.80

212

Faecal incontinence

335

1.29

0.84

1.3

1.4

0.31

0.32

nmol/l

0.07

252

Persons encountering health services for specific procedures and health care

1041

5939

1.05

0.84

1.5

1.4

0.34

0.42

nmol/l

1.89

793

4709

Hypertensive heart and/or renal disease

355

1.24

0.84

1.2

1.5

0.20

nmol/l

0.04

264

Use of fingolimod

114

0.52

0.84

2.0

1.4

0.48

0.38

nmol/l

—

Subarachnoid haemorrhage

286

0.70

0.84

1.4

1.5

0.38

0.25

nmol/l

0.63

214

Missing teeth due to accident, extraction or parodontitis

287

2464

1.10

0.84

1.4

0.37

0.35

nmol/l

0.16

195

1822

COPD, hospital admissions

889

0.85

0.84

1.4

0.18

0.21

nmol/l

0.47

638

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

764

4895

0.94

0.84

1.5

1.4

0.36

0.43

nmol/l

1.70

572

3911

764

4895

0.94

0.84

1.5

1.4

0.36

0.43

nmol/l

1.70

572

3911

Chronic laryngitis and laryngotracheitis

660

1.20

0.84

1.5

1.4

0.32

0.37

nmol/l

0.31

490

Injuries to the head

970

6269

0.95

0.84

1.5

1.4

0.29

0.42

nmol/l

9.96

753

4976

Cyst of Bartholin Gland

354

1.28

0.83

1.4

0.49

0.43

nmol/l

0.26

283

Metatarsalgia

606

1.21

0.83

1.3

1.4

0.26

0.39

nmol/l

1.89

482

Placenta praevia

708

1.19

0.83

1.5

0.56

0.49

nmol/l

0.29

572

Insulin, fast-acting

195

2175

0.89

0.83

1.3

1.5

0.36

0.40

nmol/l

0.33

149

1735

All chronic kidney diseases

247

2228

0.91

0.83

1.4

1.5

0.30

0.39

nmol/l

1.10

189

1729

Superficial injury of lower leg

176

1974

0.89

0.82

1.5

0.28

0.42

nmol/l

3.98

138

1575

Presence of other devices

732

1.19

0.82

1.3

1.4

0.24

0.37

nmol/l

2.48

565

Ocular pain

626

1.20

0.81

1.2

1.5

0.42

0.43

nmol/l

0.02

500

Fissure and fistula of anal and rectal regions

158

1398

1.13

0.81

1.2

1.4

0.32

0.39

nmol/l

1.16

121

1075

Acute pancreatitis (for exclusion)

736

1.18

0.81

1.6

1.4

0.26

0.32

nmol/l

0.63

573

Type of accident

179

2004

0.89

0.81

1.4

1.5

0.29

0.40

nmol/l

2.59

137

1580

Alzheimer disease

217

0.71

0.81

1.4

0.12

0.13

nmol/l

0.39

156

Primary coxarthrosis, bilateral

626

1.20

0.81

1.2

1.4

0.26

0.21

nmol/l

0.44

412

Bacterial, viral and other infectious agents

581

1.21

0.81

1.4

1.5

0.69

0.39

nmol/l

0.61

463

Other infectious diseases

311

1.29

0.81

1.3

1.5

0.21

0.34

nmol/l

1.93

254

Other and unspecified psoriasis

276

1.31

0.80

1.6

1.5

0.22

0.31

nmol/l

0.92

210

Motorcycle rider injured in other and unspecified transport accidents

365

1.27

0.80

1.4

1.6

0.24

0.30

nmol/l

0.57

297

Malignant neoplasm of colon, including Hilmo

311

1.29

0.80

1.5

1.3

0.21

0.24

nmol/l

0.25

236

Deep bite

111

841

1.16

0.80

1.5

0.44

0.34

nmol/l

0.42

674

Congenital hypothyroidism without goiter

1.84

0.79

2.2

1.6

0.54

0.49

nmol/l

—

Congenital malformations of spine and bony thorax

1.69

0.79

2.3

1.6

0.22

0.31

nmol/l

—

Other autoimmune haemolytic anaemias

1.83

0.79

1.2

1.3

0.28

0.36

nmol/l

—

Agoraphobia

357

1.27

0.79

1.8

1.5

0.26

0.47

nmol/l

2.44

301

Other disorders of kidney and ureter

437

1.24

0.79

1.3

1.4

0.26

nmol/l

0.03

331

Adenocarcinoma and ductal carcinoma of pancreas

1.82

0.79

1.3

1.2

0.14

0.24

nmol/l

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.79

0.0

1.6

—

0.24

—

COPD, hospital admissions 1, only main diagnosis

606

0.82

0.79

1.4

0.15

0.21

nmol/l

1.71

438

Unspecified acute lower respiratory infection

776

1.17

0.78

1.5

0.33

0.40

nmol/l

0.48

645

Cardiac murmurs and other cardiac sounds

740

1.18

0.78

1.6

1.5

0.35

0.37

nmol/l

0.08

603

Dislocation, sprain and strain of joints and ligaments at neck level

169

1507

1.12

0.78

1.4

1.5

0.40

0.45

nmol/l

0.32

132

1217

COPD, early/later onset

897

0.85

0.78

1.4

0.18

0.20

nmol/l

0.44

644

Chronic periodontitis, complicated

226

2469

0.91

0.77

1.5

1.4

0.41

0.32

nmol/l

0.35

154

1819

Other CVD (FINNGEN)

269

1.27

0.77

1.3

1.5

0.28

0.31

nmol/l

0.17

218

Memory loss

182

1.38

0.77

1.5

1.6

0.23

0.25

nmol/l

0.14

146

Foreign body or object entering through skin

340

1.27

0.77

1.3

1.5

0.44

0.34

nmol/l

0.16

280

Inflammatory bowel disease

267

2441

1.10

0.77

1.4

1.5

0.39

0.42

nmol/l

0.24

218

1925

Injuries to the neck

216

1955

1.11

0.76

1.4

1.5

0.36

0.45

nmol/l

0.87

168

1582

Other and unspecified effects of external causes

286

2624

1.09

0.76

1.5

0.45

0.42

nmol/l

0.12

202

2114

Diseases of arteries, arterioles and capillaries

221

1802

0.90

0.76

1.4

0.21

0.32

nmol/l

4.63

175

1340

Other inflammatory liver diseases

305

1.28

0.76

1.3

1.5

0.23

0.35

nmol/l

1.41

232

Multiple delivery

952

0.85

0.76

2.3

1.4

0.38

0.41

nmol/l

0.22

727

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

422

2861

0.93

0.76

1.4

0.44

0.42

nmol/l

0.11

311

2236

Diseases of arteries, arterioles and capillaries (FINNGEN)

631

0.84

0.75

1.3

1.4

0.19

0.26

nmol/l

1.57

461

AV-block

314

1.26

0.75

1.2

1.5

0.17

0.24

nmol/l

1.18

255

Laparoscopic right hemicolectomy

1.54

0.75

1.8

1.5

0.22

nmol/l

—

Other demyelinating diseases of the central nervous system

369

0.75

1.4

0.40

0.45

nmol/l

0.23

302

Sensorineural hearing loss

314

2313

0.92

0.74

1.4

0.23

0.32

nmol/l

3.41

239

1687

Medial epicondylitis

201

1.35

0.74

1.3

1.5

0.21

0.29

nmol/l

0.75

155

Inflammatory disorders of breast

809

0.84

0.74

1.4

1.5

0.33

0.54

nmol/l

2.41

658

Benign neoplasm of eye and adnexa

405

1.24

0.74

1.6

1.5

0.59

0.31

nmol/l

0.80

314

Exposure to other specified factors

697

6062

1.06

0.74

1.4

1.5

0.33

0.40

nmol/l

2.01

559

4788

Type 1 diabetes, definitions combined

925

0.85

0.74

1.3

1.5

0.34

0.44

nmol/l

0.78

761

Seropositive rheumatoid arthritis, strict definition

755

0.83

0.74

1.6

1.4

0.25

0.36

nmol/l

1.41

566

Tumor necrosis factor alpha inhibitors

122

1387

0.88

0.73

1.4

1.5

0.33

0.44

nmol/l

1.69

1098

Puerperal sepsis

906

0.85

0.73

1.4

0.37

0.40

nmol/l

0.24

665

Diseases of oesophagus, stomach and duodenum

873

5479

0.95

0.73

1.5

1.4

0.39

0.41

nmol/l

0.23

682

4287

malignant neoplasm of male genital organs

256

1.24

0.73

1.5

1.4

0.12

nmol/l

0.07

211

Mental retardation

235

1.32

0.73

1.7

1.5

0.28

0.32

nmol/l

0.22

185

Carcinoma in situ of skin

150

1.40

0.73

1.3

1.5

0.25

nmol/l

0.02

118

Hydrocele

150

1.40

0.73

1.8

1.4

0.12

nmol/l

0.01

126

Mental retardation, wide definition

244

1.31

0.73

1.7

1.5

0.28

0.33

nmol/l

0.31

191

Injuries to the thorax

240

2189

1.10

0.72

1.3

1.4

0.34

0.37

nmol/l

0.22

172

1698

Ankylosing spondylitis, strict definition

288

0.73

0.72

1.5

0.19

0.32

nmol/l

2.26

231

Benign neoplasm: Conjunctiva

142

1.42

0.72

1.7

1.5

0.92

0.34

nmol/l

0.66

108

Anogenital herpesviral [herpes simplex] infection

765

1.17

0.72

1.4

1.5

0.46

0.49

nmol/l

0.18

632

Hypertensive Heart Disease

317

1.24

0.72

1.2

1.4

0.22

0.19

nmol/l

0.18

234

Acute renal failure

497

1.21

0.72

1.6

1.4

0.23

0.24

nmol/l

0.14

372

Allergic colitis

211

1.34

0.72

1.8

1.6

0.18

0.33

nmol/l

1.83

168

Maxillary prognathism

1.78

0.72

1.1

1.6

1.40

0.23

nmol/l

—

Other disorders of binocular movement

194

1.35

0.72

1.3

1.4

0.19

0.39

nmol/l

4.09

165

Benign neoplasm: Skin of other and unspecified parts of face

434

1.22

0.72

1.5

0.21

0.36

nmol/l

2.09

334

Abscess of anal and rectal regions

425

1.23

0.72

1.2

1.5

0.26

0.39

nmol/l

0.87

331

Hypoglycaemia, other or unspecified

371

1.24

0.71

1.4

1.5

0.19

0.36

nmol/l

4.08

300

Somnolence, stupor and coma

177

1.36

0.70

1.5

1.6

0.26

0.35

nmol/l

0.83

150

Lactose intolerance

212

1.33

0.70

1.6

1.5

0.55

0.38

nmol/l

0.36

174

Spinal instabilities

143

1.41

0.70

1.0

1.5

0.32

0.34

nmol/l

0.07

101

Other respiratory diseases principally affecting the interstitium

408

1.23

0.70

1.7

1.4

0.16

0.24

nmol/l

2.63

304

Other and unspecified nerve root and plexus disorders, also in other diseases

136

1207

1.13

0.70

1.5

1.4

0.33

0.39

nmol/l

0.59

107

924

Childhood asthma (age<16)

235

1692

1.10

0.70

1.5

0.47

nmol/l

0.01

203

1448

Congenital malformations of the urinary system

365

0.76

0.70

1.5

0.25

0.37

nmol/l

0.92

294

False labour

557

3276

1.06

0.69

1.5

1.4

0.54

0.42

nmol/l

1.04

452

2588

Nummular dermatitis

301

1.27

0.69

1.7

1.5

0.20

0.30

nmol/l

0.88

237

Other infective otitis externa

328

1.25

0.69

1.5

0.44

0.35

nmol/l

0.54

260

Adalimumab

781

0.84

0.69

1.4

1.5

0.30

0.40

nmol/l

1.02

621

Overexertion and strenuous or repetitive movements

583

1.19

0.69

1.2

1.5

0.26

0.37

nmol/l

1.79

464

Dislocation, sprain and strain of joints and ligaments of thorax

178

1.35

0.69

1.3

1.5

0.53

0.32

nmol/l

0.28

146

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

231

1.26

0.68

1.8

1.4

0.16

0.31

nmol/l

3.20

169

Childhood asthma (age<16), excluding more controls

235

1694

1.10

0.68

1.5

0.47

nmol/l

0.01

203

1450

Peroneal tendinitis

102

1.48

0.68

1.5

1.4

0.17

0.37

nmol/l

—

Chronic apical periodontitis

1001

5949

0.96

0.68

1.4

1.5

0.40

0.41

nmol/l

0.11

745

4751

Fall on and from ladder

180

0.67

1.6

1.5

0.13

0.26

nmol/l

—

150

Other respiratory disorders and diseases

520

1.19

0.67

1.5

0.17

0.25

nmol/l

2.61

391

Other diseases of the respiratory system

520

1.19

0.67

1.5

0.17

0.25

nmol/l

2.61

391

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

153

1.38

0.67

1.4

1.5

0.45

0.34

nmol/l

0.31

118

Other diseases of pleura

146

1143

1.12

0.67

1.4

0.23

0.29

nmol/l

1.01

106

852

Delivery, wide proxy

365

1803

1.08

0.67

1.5

0.49

0.34

nmol/l

1.20

313

1442

161

1.36

0.67

2.2

1.4

0.40

0.38

nmol/l

0.07

130

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.63

0.67

1.1

1.4

0.33

0.40

nmol/l

—

Accessory breast

1.57

0.67

1.5

1.4

0.45

nmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

251

1.26

0.66

1.4

1.3

0.41

0.20

nmol/l

0.60

194

Presence of cardiac and vascular implants and grafts

660

0.86

0.66

1.1

1.5

0.29

0.20

nmol/l

0.30

485

Other condition

896

0.86

0.66

1.4

1.5

0.27

0.37

nmol/l

0.98

708

Carcinoma in situ of skin of trunk

1.79

0.66

1.8

1.6

0.24

0.18

nmol/l

—

Pedal cyclist injured in noncollision transport accidents

745

0.84

0.66

2.2

1.5

0.29

0.37

nmol/l

0.97

593

Benign neoplasm: Liver

171

1.35

0.66

1.3

1.4

0.26

0.34

nmol/l

0.67

138

Other blood glucose lowering drugs, excl. Insulins

373

0.78

0.66

1.1

1.5

0.15

0.24

nmol/l

1.69

264

Single spontaneous delivery

369

2095

0.93

0.65

1.4

1.5

0.44

0.36

nmol/l

0.59

295

1672

Atopic conjunctivitis

340

1.24

0.65

1.7

1.4

0.32

0.36

nmol/l

0.22

270

Hyperkinetic disorders (excl. ADHD)

144

1.38

0.65

1.6

0.24

0.37

nmol/l

0.98

118

Other obstructive and reflux uropathy

313

1.25

0.65

1.5

1.4

0.31

0.39

nmol/l

0.86

263

ILD, hospital admission 2, with pulmonary infections

206

1.31

0.65

1.7

1.6

0.16

0.24

nmol/l

1.66

161

Disturbances of smell and taste

180

1.34

0.65

2.0

1.4

0.19

0.34

nmol/l

2.33

139

Chronic Coagulation defects

189

1.33

0.65

1.8

1.5

0.30

0.37

nmol/l

0.46

157

Other contact dermatitis

559

0.82

0.65

1.2

1.5

0.35

0.43

nmol/l

0.37

448

Family history of certain disabilities and chronic diseases leading to disablement

477

1.20

0.65

1.8

1.5

0.36

0.50

nmol/l

0.80

394

Autoimmune hyperthyroidism

477

1.20

0.64

1.8

1.4

0.42

0.43

nmol/l

0.09

388

Condition for Implicit Sepsis (Organ dysfunction codes)

617

4130

1.05

0.64

1.5

0.32

0.38

nmol/l

1.54

471

3199

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.73

0.64

1.2

1.4

0.15

0.30

nmol/l

—

Juvenile arthritis (FINNGEN)

478

1.20

0.64

1.7

1.5

0.32

0.44

nmol/l

0.95

397

Cysts of oral region, not elsewhere classified

287

1.26

0.63

1.3

1.5

0.28

0.33

nmol/l

0.29

227

Oral lichen planus, including avohilmo , including avohilmo

287

1.26

0.63

1.3

1.4

0.28

0.36

nmol/l

0.25

211

Lesion of ulnar nerve

681

1.16

0.63

1.5

1.4

0.39

0.36

nmol/l

0.10

523

Certain conditions originating in the perinatal period

112

878

1.14

0.63

1.6

0.26

0.34

nmol/l

1.25

726

Other arrhythmias

465

3722

0.94

0.63

1.4

0.34

0.39

nmol/l

0.48

343

2876

Exclusion endpoint for supernumerary teeth

102

0.58

0.62

1.7

1.5

0.48

0.38

nmol/l

—

Chronic suppurative otitis media

347

0.78

0.62

1.6

1.5

0.24

0.37

nmol/l

1.83

287

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.56

0.62

2.0

1.5

0.42

0.35

nmol/l

0.15

Cerebral aneurysm, nonruptured

369

0.78

0.62

1.3

1.4

0.59

0.29

nmol/l

0.47

270

Unspecific neurodegenerative disorder

344

0.81

0.62

1.5

1.4

0.14

0.17

nmol/l

0.40

244

Pedal cyclist injured in other and unspecified transport accidents

674

1.16

0.61

1.8

1.5

0.42

0.37

nmol/l

0.15

536

Other puerperal infections

149

1345

1.11

0.61

1.3

1.5

0.55

0.53

nmol/l

0.04

126

1144

Conduction disorders

110

788

1.13

0.61

1.4

0.32

0.30

nmol/l

0.08

603

Birth trauma

1.59

0.61

1.3

1.6

0.19

0.37

nmol/l

—

Panniculitis affecting regions of neck and back

191

1.31

0.61

1.6

0.36

0.35

nmol/l

0.04

147

Carcinoma in situ of skin of lower limb, including hip

0.00

0.60

0.0

1.5

—

0.16

—

Other congenital malformations of urinary system

0.00

0.60

0.0

1.7

—

0.55

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

172

1564

1.10

0.60

1.3

1.4

0.23

0.33

nmol/l

2.11

125

1156

Glucagon-like peptide-1 (GLP-1) analogues

172

1564

1.10

0.60

1.3

1.4

0.23

0.33

nmol/l

2.11

125

1156

Bicornuate uterus

1.47

0.60

1.0

1.4

0.51

0.41

nmol/l

—

Other diseases of spinal cord

122

1.40

0.60

1.5

1.3

0.28

0.33

nmol/l

0.22

Other/unspecified enthesopathies of lower limb, excluding foot

463

1.19

0.60

1.4

0.29

0.39

nmol/l

1.10

357

Injury of nerves and spinal cord at thorax level

0.00

0.59

0.0

1.6

—

0.20

—

Complications of anaesthesia during labour and delivery

1.54

0.59

1.1

1.5

0.31

0.39

nmol/l

—

Operations for atrial fibrillation

0.00

0.59

0.0

1.4

—

0.13

—

Folate deficiency anaemia

0.00

0.58

0.0

1.3

—

0.19

—

Fitting and adjustment of other devices

100

1020

0.88

0.58

1.5

1.4

0.18

0.30

nmol/l

3.21

736

Mandibular retrognathia AND surgery (BSSO)

242

0.74

0.58

1.3

1.4

0.34

0.37

nmol/l

0.09

195

Biological medication for rheuma

137

1518

0.90

0.58

1.4

1.5

0.34

0.43

nmol/l

1.05

1205

Hidradenitis suppurativa

346

1.22

0.58

1.4

0.29

0.46

nmol/l

1.57

288

Pediculosis, acariasis and other infestations

139

1538

0.90

0.57

1.5

0.39

0.41

nmol/l

0.07

110

1243

Contusion of toe(s) without damage to nail

202

1.29

0.57

1.2

1.5

0.37

0.36

nmol/l

0.06

170

Viral hepatitis

502

1.18

0.57

1.4

1.5

0.24

0.40

nmol/l

2.78

405

Maternal care for cervical incompetence

337

1.22

0.57

2.3

1.5

0.56

0.42

nmol/l

0.26

282

Benign neoplasm: Pharynx, unspecified

1.68

0.57

1.0

1.6

0.47

0.48

nmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

407

3797

1.06

0.56

1.4

1.5

0.44

0.47

nmol/l

0.19

322

3100

Graves disease, strict definition

103

916

1.13

0.56

1.6

1.4

0.49

0.43

nmol/l

0.35

728

Psoriasis (vulgaris), strict definition

150

1.34

0.56

1.1

1.5

0.24

0.32

nmol/l

0.38

123

Pollen allergy

253

2321

1.08

0.56

1.5

0.44

0.42

nmol/l

0.06

210

1890

Other specified disorders of muscle

124

1.38

0.56

2.3

1.5

0.21

0.33

nmol/l

—

103

Postzoster neuralgia

1.63

0.55

1.5

1.3

0.29

0.34

nmol/l

—

ILD, hospital admissions

329

1.22

0.55

1.8

1.4

0.16

0.25

nmol/l

2.04

250

Fracture of shoulder and upper arm

189

1733

1.09

0.55

1.5

0.32

0.36

nmol/l

0.32

136

1311

Acute pharyngitis

137

1500

0.90

0.55

1.5

1.6

0.31

0.44

nmol/l

1.84

105

1260

Lung cancer and mesothelioma

292

0.79

0.55

1.2

1.4

0.20

0.16

nmol/l

0.50

210

Bruxism

186

1.30

0.55

1.6

1.4

0.33

0.35

nmol/l

0.11

148

Paranoid personality disorder

116

1.39

0.54

1.1

1.4

0.47

0.38

nmol/l

0.12

Allergic purpura

195

1.29

0.54

2.2

1.4

0.33

0.35

nmol/l

0.07

159

Dementia

437

0.85

0.54

1.6

1.5

0.15

0.19

nmol/l

1.02

314

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

312

1.22

0.54

1.3

1.5

0.35

0.27

nmol/l

0.34

228

Inflammatory diseases of the central nervous system

459

1.18

0.54

1.6

1.4

0.30

0.35

nmol/l

0.27

361

Acute suppurative otitis media

352

3091

1.06

0.54

1.5

0.32

0.44

nmol/l

4.20

289

2592

Open wound of ankle and foot

608

1.15

0.54

1.4

1.5

0.24

0.41

nmol/l

3.27

488

Other chronic obstructive pulmonary disease

847

0.88

0.54

1.4

0.18

0.21

nmol/l

0.49

614

Supplementary factors related to causes of morbidity and mortality classified elsewhere

205

2218

0.92

0.53

1.5

0.29

0.40

nmol/l

2.63

160

1756

Viral pneumonia (unknown virus, not influenza)

340

1.21

0.53

1.7

1.5

0.33

0.34

nmol/l

0.05

279

Birth asphyxia

1.55

0.53

2.0

1.7

0.17

0.22

nmol/l

—

Habit and impulse disorders

108

1.40

0.53

1.3

0.20

0.35

nmol/l

—

Pilonidal cyst

665

1.15

0.53

1.4

1.5

0.40

0.44

nmol/l

0.11

548

Other and/or unspecified nontoxic goitre

331

1.21

0.53

1.2

1.4

0.24

0.35

nmol/l

0.87

240

Maternal care for known or suspected abnormality of pelvic organs

457

2950

1.06

0.53

1.5

1.4

0.57

0.44

nmol/l

1.17

380

2335

Injuries to the knee and lower leg

1069

6142

0.97

0.53

1.4

1.5

0.30

0.42

nmol/l

8.17

830

4877

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

675

4514

0.96

0.53

1.4

0.37

0.40

nmol/l

0.23

502

3473

Arthropod-borne viral fevers and viral haemorrhagic fevers

423

1.18

0.53

1.3

1.5

0.48

0.37

nmol/l

0.20

327

Benign neoplasm: salivary glands, exclude unknown (D119)

327

0.79

0.53

1.2

1.5

0.12

0.28

nmol/l

5.54

241

Special screening examination for other diseases and disorders

656

1.14

0.52

1.5

0.47

0.41

nmol/l

0.14

526

LeFortI or BSSO operation

403

0.82

0.52

1.3

1.5

0.48

0.39

nmol/l

0.24

325

Rheumatoid arthritis

168

1642

0.92

0.52

1.4

0.29

0.40

nmol/l

1.78

123

1241

Fall on same level involving ice and snow

413

3912

1.06

0.52

1.4

1.5

0.36

0.38

nmol/l

0.23

311

3001

Other bursitis of hip

1.45

0.52

1.4

0.44

0.32

nmol/l

—

Interstitial lung disease endpoints

332

1.21

0.52

1.8

1.4

0.16

0.25

nmol/l

2.01

252

Interstitial lung disease

332

1.21

0.52

1.8

1.4

0.16

0.25

nmol/l

2.01

252

Other disorders of glucose regulation and pancreatic internal secretion

452

1.17

0.52

1.4

1.5

0.27

0.37

nmol/l

0.72

361

Open bite

611

1.15

0.52

1.7

1.5

0.57

0.46

nmol/l

0.21

506

Coeliac disease

818

1.13

0.51

1.6

1.5

0.39

0.40

nmol/l

0.03

651

Other superficial mycoses

135

1.34

0.51

1.1

1.5

0.48

0.37

nmol/l

0.34

112

Other viral hepatitis

462

1.17

0.51

1.4

1.5

0.23

0.41

nmol/l

2.82

379

Chronic gastritis

865

1.12

0.51

1.4

0.34

0.28

nmol/l

0.40

621

Primary open-angle glaucoma

527

1.16

0.51

1.7

1.4

0.17

0.20

nmol/l

0.32

358

Suicide or other Intentional self-harm

238

2217

1.07

0.51

1.4

1.5

0.36

0.42

nmol/l

0.62

174

1772

Type 1 diabetes

171

1856

0.92

0.51

1.4

1.5

0.39

0.43

nmol/l

0.25

134

1491

Lateral epicondylitis

847

1.12

0.51

1.3

1.4

0.26

0.34

nmol/l

0.77

645

Other interstitial pulmonary diseases

333

1.20

0.50

1.8

1.4

0.16

0.25

nmol/l

2.00

253

LSIL lesion of the cervix uteri

152

1659

0.91

0.50

1.5

0.37

0.52

nmol/l

2.47

125

1347

Myocardial infarction, without ST-elevation

641

0.87

0.50

1.2

1.4

0.17

nmol/l

0.02

471

Other obstetric trauma

839

0.88

0.50

1.4

1.5

0.81

0.42

nmol/l

1.52

661

Benign neoplasm: Parotid gland

302

0.79

0.49

1.2

1.4

0.10

0.29

nmol/l

7.19

222

Failed induction of labour

115

1040

1.11

0.49

1.4

1.6

0.55

0.46

nmol/l

0.39

102

854

Disorders of gallbladder, biliary tract and pancreas

731

4795

0.96

0.49

1.4

0.37

0.41

nmol/l

0.55

565

3690

Other predominantly sexually transmitted diseases, not elsewhere classified

264

2816

0.94

0.49

1.4

1.5

0.39

0.47

nmol/l

1.31

227

2308

Injuries to the elbow and forearm

545

5010

0.96

0.49

1.4

1.5

0.35

0.39

nmol/l

0.54

418

3909

Eustachian salpingitis and obstruction

746

1.13

0.49

1.6

1.4

0.59

0.46

nmol/l

0.20

631

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

530

1.15

0.48

1.5

0.22

0.38

nmol/l

3.38

432

Other and unspecified corneal deformities and disorders

154

1.30

0.48

1.5

0.27

0.34

nmol/l

0.59

128

Dementia, including avohilmo

490

0.87

0.48

1.5

1.4

0.15

0.19

nmol/l

1.25

353

Glomerular disorders in diseases classified elsewhere

464

0.84

0.48

1.7

1.5

0.52

0.32

nmol/l

0.47

369

Other, unspecified and serous retinal detachments

1.45

0.48

2.5

1.4

0.22

0.32

nmol/l

0.48

Ulcerative enterocolitis

199

1.26

0.48

1.3

1.4

0.32

0.34

nmol/l

0.10

161

Schizotypal disorder

166

0.72

0.48

1.1

1.5

0.59

0.36

nmol/l

—

140

Concussion

475

3694

1.05

0.48

1.5

0.27

0.45

nmol/l

10.60

347

2983

Other necrotizing vasculopathies

199

1.26

0.48

1.8

1.6

0.22

0.33

nmol/l

1.44

157

Cardiac arrhythmias

608

4121

0.96

0.48

1.4

0.35

0.42

nmol/l

1.00

469

3242

Other pleural conditions

190

1.26

0.47

1.2

1.5

0.10

0.24

nmol/l

3.48

149

Malignant neoplasm of rectum, including Hilmo

190

1.26

0.47

1.5

1.3

0.53

0.23

nmol/l

0.58

147

Other intracranial haemorrhages

1.49

0.47

1.1

1.4

0.16

0.21

nmol/l

—

Pneumococcal septicemia

137

1.32

0.47

1.2

1.5

0.22

0.31

nmol/l

0.69

111

Pneumonia derived septicemia

137

1.32

0.47

1.2

1.5

0.22

0.32

nmol/l

0.71

111

Need for other prophylactic measures

272

1.22

0.47

1.4

1.5

0.20

0.31

nmol/l

1.43

209

Congenital dislocation of hip, unilateral

1.47

0.47

1.4

1.6

0.21

0.24

nmol/l

—

Dental operations

419

2042

1.05

0.47

1.4

1.5

0.34

0.39

nmol/l

0.75

323

1610

Specific development disorders of speech and language

404

1.17

0.47

1.6

0.24

0.40

nmol/l

1.63

330

Anomalies of pupillary function

155

1.30

0.47

1.6

0.33

nmol/l

0.03

127

Glaucoma suspect

137

1253

1.09

0.47

1.3

1.4

0.21

0.31

nmol/l

3.37

893

Injuries to the wrist and hand

938

6281

1.03

0.46

1.5

1.4

0.34

0.41

nmol/l

2.08

739

4979

Glomerulonephritis

448

1.16

0.46

1.5

1.4

0.41

0.33

nmol/l

0.22

346

Benign neoplasm: Stomach

300

1.20

0.46

1.8

1.5

0.21

0.29

nmol/l

0.92

212

Early complications of trauma

191

1.26

0.46

1.5

1.6

0.33

0.31

nmol/l

0.08

156

!Aliquae complicationes praecoces traumatis

191

1.26

0.46

1.5

1.6

0.33

0.31

nmol/l

0.08

156

Necrosis of pulp, including avohilmo

498

5194

0.96

0.46

1.4

1.5

0.42

0.40

nmol/l

0.08

385

4065

Chronic ulcer of skin, not elsewhere classified

182

1.27

0.46

1.3

1.5

0.27

nmol/l

0.01

137

Allergic contact dermatitis

113

1244

0.91

0.46

1.4

0.41

0.44

nmol/l

0.19

977

Infections of genitourinary tract in pregnancy

1097

0.90

0.46

1.4

1.6

0.71

0.47

nmol/l

0.80

896

Impacted maxillary molar

864

1.12

0.46

1.8

1.6

0.41

0.46

nmol/l

0.26

725

Dyshidrosis [pompholyx]

120

0.66

0.46

1.1

1.4

0.16

0.38

nmol/l

—

102

Lichen ruber planus, wide definition including periferal and oral lichen planus

105

949

1.11

0.46

1.4

0.25

0.34

nmol/l

0.98

687

Other specified/unspecified hearing loss

273

1.21

0.46

1.4

1.5

0.28

nmol/l

0.04

207

Diseases of external ear

216

2016

1.07

0.45

1.4

0.42

0.39

nmol/l

0.15

160

1577

Dislocation, sprain and strain of joint and ligaments of hip

103

1.36

0.45

1.6

1.5

0.53

0.33

nmol/l

0.30

Other appendicitis

514

0.85

0.45

1.5

1.4

0.37

0.34

nmol/l

0.11

404

Chalazion

694

1.13

0.45

1.5

0.39

0.40

nmol/l

0.01

547

Inflammatory disease of uterus

191

1777

1.08

0.45

1.4

1.5

0.43

0.50

nmol/l

0.43

155

1423

Status post-ami

294

0.83

0.45

1.0

1.5

0.14

0.15

nmol/l

0.05

221

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

320

1.19

0.45

1.2

1.5

0.27

0.43

nmol/l

1.26

263

Caught, crushed, jammed or pinched in or between objects

308

0.81

0.44

1.4

1.5

0.23

0.32

nmol/l

0.58

251

Maltreatment syndromes

507

1.15

0.44

1.3

1.5

0.43

0.38

nmol/l

0.11

424

Dermatitis due to ingested food

352

1.18

0.44

1.6

0.24

0.37

nmol/l

1.01

277

Benign neoplasm: Liver/bile ducts

184

1.26

0.43

1.3

1.4

0.26

0.33

nmol/l

0.57

147

Persistent delusional disorders

321

1.19

0.43

1.5

0.52

0.30

nmol/l

0.82

242

Meningitis

275

1.20

0.43

1.5

1.4

0.33

nmol/l

0.03

221

Meralgia paraesthetica

157

1.28

0.43

1.2

1.4

0.46

0.35

nmol/l

0.35

127

Oral leukoplakia, including avohilmo

1.41

0.43

1.5

0.16

0.34

nmol/l

—

Cardiodefibrillation

638

1.13

0.43

1.2

1.5

0.16

0.19

nmol/l

0.50

466

Carpal tunnel syndrome

437

3678

1.05

0.43

1.3

1.4

0.31

0.39

nmol/l

2.05

311

2773

Lichen simplex chronicus and prurigo

248

1.21

0.43

1.9

1.5

0.16

0.29

nmol/l

1.94

187

190

1.24

0.43

1.4

0.20

0.13

nmol/l

0.54

129

Congenital malformations of eye, ear, face and neck

565

1.14

0.42

1.3

1.5

0.34

0.40

nmol/l

0.28

467

Protein-energy malnutrition of moderate and mild degree

1.57

0.42

2.2

1.7

0.19

0.26

nmol/l

—

Other congenital malformations of tongue, mouth and pharynx

104

1.35

0.42

1.4

1.6

0.36

0.37

nmol/l

0.04

Eclampsia

1.54

0.42

1.4

1.6

0.45

0.35

nmol/l

—

Malignant neoplasm of bronchus and lung, including Hilmo

247

0.81

0.42

1.3

0.21

0.19

nmol/l

0.16

188

Procedures for purposes other than remedying health state

167

1.26

0.42

1.5

1.4

0.33

nmol/l

0.00

128

Combinations of oral blood glucose lowering drugs

807

0.89

0.42

1.4

0.14

0.24

nmol/l

3.93

587

Lesion of radial nerve

149

1.28

0.42

1.7

1.4

0.19

0.36

nmol/l

—

115

Female pelvic inflammatory disorders in diseases classified elsewhere

1.38

0.41

1.4

1.6

0.40

0.47

nmol/l

—

Other and unspecified disorders of skin and subcutaneous tissue

294

0.81

0.41

2.5

1.5

0.18

0.32

nmol/l

2.69

224

Spondylolisthesis/Spondylolysis

870

1.10

0.41

1.3

1.4

0.44

0.32

nmol/l

0.33

642

Benign lipomatous neoplasm of other sites/unspecified

283

0.81

0.41

1.3

1.5

0.16

0.28

nmol/l

1.72

216

Other chondrocalcinosis

0.00

0.41

0.0

1.1

—

0.18

—

Benign neoplasm of major salivary glands

359

0.83

0.41

1.3

1.5

0.14

0.28

nmol/l

4.48

264

Crystalline deposits in vitreous body

0.00

0.41

0.0

1.5

—

0.15

—

Toxic effects of substances chiefly nonmedicinal as to source

785

1.11

0.41

1.5

0.43

nmol/l

0.02

635

Fibrosis and cirrhosis of liver

222

1.22

0.41

1.4

1.5

0.25

0.28

nmol/l

0.16

160

Epileptic seizures related to alcohol

0.00

0.41

0.0

1.3

—

0.19

—

Perioral dermatitis

195

1.24

0.41

1.2

1.5

0.43

0.41

nmol/l

0.07

162

Complications peculiar to reattachment and amputation

0.00

0.41

0.0

1.5

—

0.17

—

Fracture of femur

531

1.13

0.40

1.5

0.33

0.25

nmol/l

0.46

384

Bicipital tendinitis

177

1.25

0.40

1.0

1.5

0.43

0.30

nmol/l

0.66

137

Smoking dependency

465

0.86

0.40

1.3

1.4

0.24

0.34

nmol/l

0.85

357

Atlantoaxial subluxation

0.00

0.40

0.0

1.4

—

0.27

—

Diabetic maculopathy, excluding more controls

518

0.87

0.40

1.3

1.5

0.29

0.40

nmol/l

1.06

420

Dialysis, with operation codes

427

1.15

0.40

1.5

0.21

0.26

nmol/l

0.96

327

All dysplastic lesions of the vulva

346

0.84

0.39

1.2

1.4

0.24

0.33

nmol/l

0.96

259

Other specified and unspecified disorders of conjunctiva

1.43

0.39

1.0

1.4

0.19

0.42

nmol/l

—

Mental and behavioural disorders due to tobacco

464

0.86

0.39

1.3

1.4

0.24

0.34

nmol/l

0.88

356

Colonic or urogenital fistula

165

1537

1.07

0.39

1.3

1.4

0.31

0.38

nmol/l

1.13

128

1185

Aortic aneurysm

401

1.15

0.39

1.3

1.4

0.15

0.19

nmol/l

0.46

316

Arthrosis

522

2751

1.04

0.39

1.4

0.31

0.39

nmol/l

1.95

386

2095

Macular pucker

251

1.20

0.39

1.6

1.5

0.19

0.17

nmol/l

0.12

171

Other disorders of skin and subcutaneous tissue, not elsewhere classified

608

1.12

0.38

1.8

1.5

0.20

0.36

nmol/l

3.33

475

Other and unspecified iridocyclitis

247

0.81

0.38

1.6

1.4

0.33

0.32

nmol/l

0.02

205

Bleeding

419

3110

0.96

0.38

1.4

1.5

0.25

0.36

nmol/l

5.38

320

2363

Other intervertebral disc disorders

690

4016

1.03

0.37

1.4

0.29

0.43

nmol/l

7.64

526

3161

LSIL lesion of the cervix uteri, vagina or vulva

182

1940

0.94

0.37

1.6

1.5

0.34

0.49

nmol/l

3.26

149

1542

Organic, including symptomatic, mental disorders

106

823

0.92

0.37

1.6

1.4

0.25

0.23

nmol/l

0.19

599

Nasal polyp

768

0.90

0.37

1.3

1.4

0.41

0.34

nmol/l

0.28

584

Ménière disease

336

1.16

0.37

1.7

1.5

0.27

0.30

nmol/l

0.17

247

Colorectal neuroendocrine tumor and carcinoma

1.35

0.37

2.0

1.6

0.36

0.47

nmol/l

—

Complications predominantly related to the puerperium

361

3452

1.05

0.37

1.3

1.5

0.51

0.49

nmol/l

0.09

295

2754

Follicular cysts of skin and subcutaneous tissue

107

983

1.09

0.36

1.5

1.4

0.45

0.38

nmol/l

0.33

755

Contact with hypodermic needle

1.28

0.36

2.0

1.7

0.26

0.41

nmol/l

—

Autoimmune diseases excluding thyroid diseases

928

4921

1.03

0.36

1.5

1.4

0.36

0.40

nmol/l

0.60

710

3930

Arthropathic psoriasis

598

0.89

0.36

1.4

0.36

nmol/l

0.02

456

Congenital vesicoureteral reflux

0.65

0.36

1.0

1.6

0.31

0.42

nmol/l

—

Impacted maxillary canine

0.64

0.36

2.2

1.7

0.19

0.30

nmol/l

—

Additional codes for the location of defect, injury or illness

310

0.84

0.36

1.2

1.5

0.28

0.34

nmol/l

0.39

245

Thoracic aortic aneurysm

272

1.18

0.36

1.4

1.5

0.17

0.21

nmol/l

0.36

215

Overjet

234

1.19

0.36

1.4

1.6

0.23

0.31

nmol/l

1.16

193

Sequelae of injuries of upper limb

507

1.13

0.36

1.5

0.43

0.34

nmol/l

0.20

397

Other benign neoplasms of connective and other soft tissue

526

1.12

0.36

1.3

1.4

0.43

0.37

nmol/l

0.34

410

Other and unspecified tonsillitis

428

3456

1.04

0.35

1.5

0.33

0.48

nmol/l

5.52

337

2907

Gout, idiopatic and unspecified

432

1.13

0.35

1.2

1.4

0.15

0.19

nmol/l

0.84

332

Viral haemorrhagic fevers, not elsewhere classified/unspecified

357

1.15

0.35

1.3

1.5

0.54

0.33

nmol/l

0.33

272

Foreign body in respiratory tract

301

1.17

0.35

1.4

1.5

0.24

0.37

nmol/l

0.99

237

Mental and behavioural disorders due to use of other stimulants, including caffeine

233

0.81

0.35

1.4

1.5

0.17

0.36

nmol/l

2.96

193

Ankylosing spondylitis, ICD10

543

0.88

0.35

1.4

0.24

0.36

nmol/l

1.95

428

Impetigo

348

1.15

0.35

1.5

0.37

0.36

nmol/l

0.03

281

Retained placenta and membranes, without haemorrhage

109

1180

0.92

0.35

1.7

1.4

0.62

0.42

nmol/l

0.84

888

Sequelae of infectious and parasitic diseases

386

1.14

0.34

1.3

1.4

0.25

0.42

nmol/l

2.02

302

Other mental disorders due to brain damage and dysfunction and to physical disease

255

1.18

0.34

2.0

1.6

0.30

0.26

nmol/l

0.23

200

Event of undetermined intent

424

1.13

0.34

1.5

0.34

0.36

nmol/l

0.06

341

Exposure to other and unspecified inanimate mechanical forces

443

1.13

0.34

1.4

1.5

0.34

0.39

nmol/l

0.31

358

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

264

1.17

0.34

1.3

1.6

0.52

0.37

nmol/l

0.38

220

Other and unspecified rosacea

538

1.12

0.34

1.5

1.4

0.31

0.38

nmol/l

0.55

415

Benign neoplasm: Skin of lip

1.34

0.34

1.3

1.4

0.16

0.30

nmol/l

—

All-cause Heart Failure

119

906

0.93

0.33

1.3

1.4

0.22

0.19

nmol/l

0.48

642

279

1.16

0.33

1.5

1.4

0.17

0.13

nmol/l

0.48

181

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

127

1.26

0.33

1.3

1.4

0.25

0.33

nmol/l

—

Coxarthrosis [arthrosis of hip](FG)

194

1447

0.94

0.33

1.3

1.4

0.21

0.26

nmol/l

0.92

140

1009

Abnormal findings on antenatal screening of mother

150

1600

0.94

0.33

1.4

1.5

0.71

0.48

nmol/l

1.24

129

1353

Infectious mononucleosis

115

1067

1.08

0.33

1.4

1.5

0.29

0.46

nmol/l

3.87

876

Convergent concomitant strabismus

477

0.88

0.33

1.6

1.5

0.30

0.42

nmol/l

0.88

382

Pedestrian injured in transport accident

371

0.86

0.33

1.9

1.5

0.26

0.37

nmol/l

0.92

299

Intracranial trauma

525

3819

0.97

0.33

1.5

0.29

0.45

nmol/l

6.09

386

3085

Alcohol abuse, main dg

903

1.09

0.33

1.4

1.5

0.31

0.36

nmol/l

0.51

728

Injury of muscle and tendon at lower leg level

656

0.90

0.33

1.3

1.4

0.29

0.34

nmol/l

0.42

521

Other/unspecified rheumatoid arthritis

424

0.87

0.32

1.3

1.4

0.27

0.30

nmol/l

0.12

314

Heart failure, strict

123

933

0.93

0.32

1.4

0.22

0.19

nmol/l

0.44

661

Bacterial, viral and other infectious agents

530

1.12

0.32

1.4

1.5

0.79

0.40

nmol/l

0.65

422

Diabetic retinopathy, strict definition

699

0.91

0.32

1.3

1.6

0.27

0.43

nmol/l

1.74

547

Galactorrhea

119

1.27

0.32

1.3

1.6

0.24

0.38

nmol/l

—

102

Polyarthrosis

554

1.11

0.32

1.3

1.4

0.24

nmol/l

0.01

358

Fracture of forearm

379

3610

0.96

0.32

1.4

1.5

0.35

0.38

nmol/l

0.33

283

2761

Optic neuritis

391

0.87

0.32

1.6

1.4

0.70

0.45

nmol/l

0.50

320

Heart failure, not strict

295

2096

0.96

0.32

1.5

1.4

0.22

0.30

nmol/l

2.89

220

1521

Other/unspecified seropositive rheumatoid arthritis

115

1237

0.93

0.32

1.4

0.29

0.37

nmol/l

1.09

912

Injury of other and unspecified intrathoracic organs

192

1.20

0.32

1.2

1.6

0.20

0.30

nmol/l

1.00

147

Antepartum haemorrhage, not elsewhere classified

150

1409

1.07

0.31

1.4

1.5

0.54

0.50

nmol/l

0.13

120

1131

Foreign body in alimentary tract

248

1.17

0.31

1.7

1.5

0.33

0.30

nmol/l

0.09

197

COPD

102

901

0.92

0.31

1.4

0.18

0.21

nmol/l

0.85

648

Achilles tendinitis

503

1.11

0.31

1.6

1.4

0.42

0.32

nmol/l

0.52

365

Other spirochaetal diseases

186

1759

1.06

0.31

1.7

1.4

0.29

0.37

nmol/l

1.62

141

1309

Malignant neoplasm of digestive organs

608

1.09

0.31

1.4

1.3

0.31

0.23

nmol/l

0.45

456

Seropositive rheumatoid arthritis, wide

117

1255

0.93

0.31

1.4

0.29

0.37

nmol/l

1.09

925

Non-ischemic cardiomyopathy

574

1.09

0.30

1.4

1.5

0.25

0.21

nmol/l

0.41

419

Other arthritis (FG)

215

2043

1.05

0.30

1.4

0.34

0.41

nmol/l

0.74

154

1573

Unspecified fall

324

3063

1.04

0.30

1.7

1.4

0.27

0.37

nmol/l

3.36

243

2380

Suggestive for eosinophilic asthma

347

0.86

0.30

1.5

0.28

0.30

nmol/l

0.05

273

Other disorders of pigmentation

184

1.20

0.30

1.2

1.5

0.37

0.30

nmol/l

0.17

141

Bacterial pneumoniae

200

1858

0.95

0.30

1.6

1.5

0.31

0.37

nmol/l

0.78

156

1436

Chronic pancreatitis

343

1.14

0.30

1.5

0.30

0.24

nmol/l

0.26

260

Mental and behavioural disorders due to cannabinoids

240

1.17

0.30

1.4

1.5

0.33

0.35

nmol/l

0.08

204

Ulcerative colitis

193

1830

1.06

0.30

1.4

1.5

0.41

0.43

nmol/l

0.14

155

1458

Rubella [German measles]

1.27

0.30

2.1

1.4

0.14

0.15

nmol/l

—

Maxillary retrognathism

157

1.22

0.29

1.6

0.22

0.33

nmol/l

1.37

127

Ulcerative colitis (strict definition, require KELA)

120

1283

0.93

0.29

1.4

1.5

0.45

0.42

nmol/l

0.12

1028

342

3212

0.96

0.29

1.3

1.5

0.32

0.37

nmol/l

0.92

261

2543

Failed attempted abortion

195

0.81

0.29

1.3

1.4

0.32

0.44

nmol/l

0.67

165

Other and unspecified injuries of shoulder and upper arm

148

1.22

0.29

1.6

1.5

0.42

0.31

nmol/l

0.19

122

Viral conjunctivitis

307

1.14

0.29

1.3

1.5

0.37

nmol/l

0.00

250

Sequelae of injuries of lower limb

545

0.90

0.29

1.9

1.5

0.28

0.39

nmol/l

1.07

427

Presence of other functional implants

196

1290

1.05

0.28

1.4

0.22

0.27

nmol/l

0.64

125

915

Spasmodic torticollis

173

0.81

0.28

1.2

1.5

0.30

0.33

nmol/l

0.15

138

Intestinal malabsorption

251

1.16

0.28

1.6

1.5

0.45

0.33

nmol/l

0.44

203

All dysplastic lesions of the cervix uteri

402

4124

0.97

0.28

1.5

0.48

0.50

nmol/l

0.12

327

3311

Diabetic neuropathy

321

0.87

0.28

1.2

1.5

0.36

0.33

nmol/l

0.05

245

Unspecified privation

584

1.10

0.28

2.0

1.5

0.32

0.40

nmol/l

0.89

468

Nonischemic cardiomyopathy

251

1.16

0.28

1.2

1.6

0.17

0.26

nmol/l

0.99

191

L04AX Other immunosuppressants

408

4218

0.97

0.28

1.5

1.4

0.34

0.39

nmol/l

0.55

304

3266

Acute appendicitis

629

5720

1.03

0.28

1.5

1.4

0.44

0.42

nmol/l

0.24

496

4488

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

115

1228

0.94

0.28

1.4

0.29

0.37

nmol/l

1.11

907

Unspecified abortion

441

1.11

0.28

1.6

1.3

0.42

0.33

nmol/l

0.44

308

Striking against or struck by other objects

262

2509

1.04

0.27

1.5

0.26

0.39

nmol/l

5.92

196

2014

All influenza (not pneumonia)

777

1.08

0.27

1.5

0.30

0.35

nmol/l

0.52

644

DVT of lower extremities

729

1.08

0.27

1.4

0.45

0.34

nmol/l

0.28

553

Gonarthrosis

392

2155

1.04

0.27

1.4

0.29

0.35

nmol/l

0.90

282

1595

Conductive hearing loss, unspecified

451

1.11

0.27

1.3

1.5

0.28

0.35

nmol/l

0.71

350

Injury of muscle and tendon at ankle and foot level

131

1.23

0.27

1.5

0.22

0.32

nmol/l

0.71

107

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

311

0.87

0.27

1.2

1.4

0.34

0.30

nmol/l

0.26

228

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

106

1098

0.93

0.27

1.7

1.5

0.38

0.39

nmol/l

0.02

882

Congenital malformations of aortic and mitral valves

168

1.19

0.27

1.3

1.6

0.29

nmol/l

0.01

133

Use of ropinirole

1.23

0.27

1.0

1.5

0.25

0.24

nmol/l

—

Heart failure and bmi 25plus

498

1.08

0.27

1.4

0.18

0.19

nmol/l

0.15

355

Flat foot [pes planus] (acquired)

511

0.90

0.27

1.5

1.4

0.21

0.38

nmol/l

2.76

373

Other Crohn's disease

528

1.10

0.27

1.4

1.5

0.49

0.43

nmol/l

0.28

426

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

332

0.87

0.27

1.4

0.53

0.42

nmol/l

0.13

241

Other congenital malformations of skin

634

1.09

0.27

1.4

1.5

0.44

0.42

nmol/l

0.13

503

Nephropathy related operations

423

1.11

0.26

1.6

1.5

0.21

0.26

nmol/l

1.08

324

Crohn's disease of small intestine

519

1.10

0.26

1.4

1.5

0.43

0.39

nmol/l

0.16

414

Diseases of pulp and periapical tissues and dental caries

478

2526

0.97

0.26

1.5

0.30

0.38

nmol/l

2.59

374

2011

Psoriatic arthropathies

552

0.90

0.26

1.3

1.4

0.34

0.39

nmol/l

0.19

429

Polymyalgia rheumatica

193

0.83

0.26

1.2

1.5

0.19

0.18

nmol/l

—

142

Other/unspecified synovitis and tenosynovitis

673

1.09

0.26

1.3

1.4

0.33

0.40

nmol/l

0.42

542

Superficial injury of neck

171

0.82

0.26

1.1

1.5

0.24

0.37

nmol/l

—

143

Asthma/COPD (KELA code 203)

886

5940

1.02

0.26

1.4

1.5

0.41

nmol/l

0.05

688

4736

Other diseases of biliary tract

234

1.15

0.26

1.1

1.5

0.25

0.28

nmol/l

0.20

179

Psoriatic arthropathies, ICD10

551

0.91

0.26

1.3

1.4

0.34

0.36

nmol/l

0.08

417

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

367

1.12

0.26

1.4

0.32

0.30

nmol/l

0.19

270

Budesonide

110

1032

1.07

0.26

1.5

0.49

0.44

nmol/l

0.25

814

Bitten or struck by other mammals

102

1089

0.94

0.25

1.4

1.5

0.27

0.44

nmol/l

3.39

871

Corns and callosities

267

0.86

0.25

1.3

1.5

0.14

0.31

nmol/l

4.42

200

Malignant neoplasm of corpus uteri, including Hilmo

169

1.18

0.25

1.4

1.3

0.23

0.29

nmol/l

0.47

119

Acute and transient psychotic disorders

761

1.08

0.25

1.5

0.39

0.38

nmol/l

0.07

602

Methotrexate

819

1.08

0.25

1.3

1.4

0.29

0.37

nmol/l

0.95

619

Gluteal tendinitis

216

1.16

0.25

1.3

1.4

0.45

0.33

nmol/l

0.22

155

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

117

1243

0.94

0.25

1.4

1.5

0.45

0.42

nmol/l

0.13

1003

Major anomalies of jaw size

188

1.17

0.25

1.6

1.5

0.61

0.30

nmol/l

0.69

150

Spirochaetal infections, other/unspecified

180

1715

1.05

0.25

1.5

1.4

0.29

0.37

nmol/l

1.77

137

1274

Other spirochaetal diseases

181

1725

1.05

0.25

1.5

1.4

0.29

0.37

nmol/l

1.69

136

1282

Paraplegia, diplegia of upper limbs

1.22

0.25

1.1

1.4

0.24

0.37

nmol/l

—

Vitreous haemorrhage

351

0.88

0.25

1.2

1.5

0.27

0.29

nmol/l

0.17

271

D07AA Corticosteroids, weak (group I)

141

1486

0.95

0.25

1.5

0.34

0.45

nmol/l

1.52

112

1195

Infections with a predominantly sexual mode of transmission

400

3871

1.03

0.25

1.4

1.5

0.40

0.47

nmol/l

1.28

343

3129

Other and unspecified nonorganic psychotic disorders

180

1716

1.05

0.25

1.4

1.5

0.28

0.41

nmol/l

3.79

140

1390

Cellulitis of external ear

1.20

0.25

1.8

1.5

0.43

0.38

nmol/l

—

Glucosamine medication

113

847

1.06

0.25

1.5

1.4

0.23

0.20

nmol/l

0.23

558

Coxarthrosis

190

1315

0.95

0.25

1.3

1.4

0.22

0.28

nmol/l

1.52

137

934

Use of rivastigmine

123

1.22

0.24

1.3

1.4

0.18

0.13

nmol/l

—

Gastroduodenal ulcer

635

1.08

0.24

1.5

1.4

0.60

0.24

nmol/l

0.53

459

Hypertension

667

3672

1.03

0.24

1.5

1.4

0.30

0.38

nmol/l

2.11

465

2829

Other disorders of veins

263

2516

1.04

0.24

1.3

1.4

0.40

0.39

nmol/l

0.06

201

1850

Lyme disease

178

1698

1.05

0.24

1.5

1.4

0.29

0.38

nmol/l

1.69

135

1259

Colorectal adenocarcinoma

286

0.87

0.24

1.4

1.3

0.37

0.20

nmol/l

0.28

214

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

217

1.15

0.24

1.2

1.4

0.26

0.29

nmol/l

0.25

168

Diseases of peritoneum

407

1.11

0.24

1.4

1.5

0.41

0.31

nmol/l

0.44

306

Viral infections of central nervous system, not elsewhere classified/unspecified

0.73

0.24

1.7

1.5

0.31

0.37

nmol/l

—

Peritonsillar abscess

205

1963

1.05

0.24

1.4

1.5

0.37

0.43

nmol/l

0.59

159

1602

Acute alcohol intoxication ICD-9

1.28

0.24

1.0

1.5

0.20

0.21

nmol/l

—

Tooth eruption problems

216

2020

1.04

0.24

1.6

0.42

0.43

nmol/l

0.05

169

1715

Coronary artery bypass grafting

253

0.88

0.24

1.1

1.4

0.20

0.14

nmol/l

0.59

192

Congenital nasolacrimal duct obstruction or stenosis

1.36

0.23

1.0

1.7

0.17

0.19

nmol/l

—

Bacterial pneumonia, not elsewhere classified

187

1722

0.96

0.23

1.6

1.5

0.32

0.37

nmol/l

0.60

147

1342

Malignant neoplasm of corpus uteri

115

1.22

0.23

1.5

1.2

0.19

0.26

nmol/l

—

Complex cardiac defects

1.32

0.23

2.4

1.5

0.18

0.29

nmol/l

—

Other injuries of spine and trunk, level unspecified

1.32

0.23

1.0

1.6

0.33

0.44

nmol/l

—

Amputation of ankle bones

1.32

0.23

1.0

1.3

0.14

0.18

nmol/l

—

Leisure time condition

107

1135

0.94

0.23

1.4

1.5

0.29

0.39

nmol/l

1.28

907

Mental and behavioural disorders due to hallucinogens

1.29

0.23

1.0

1.6

0.37

0.35

nmol/l

—

Benign neoplasm: Choroid

190

1.16

0.23

1.5

0.25

0.27

nmol/l

0.07

142

Amyloidosis, other/unspecified

1.28

0.23

1.2

1.5

0.27

0.23

nmol/l

—

Other bacterial diseases

828

5145

1.02

0.23

1.5

1.4

0.28

0.40

nmol/l

5.58

597

4024

Spondyloarthritis

124

1174

1.06

0.23

1.4

0.33

0.41

nmol/l

0.83

931

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

534

1.09

0.23

1.4

1.5

0.48

0.43

nmol/l

0.22

432

Sequelae of injuries, of poisoning and of other consequences of external causes

135

1421

0.95

0.22

1.5

0.35

0.38

nmol/l

0.12

108

1110

Lactose intolerance, other/unspecified

181

1.16

0.22

1.6

0.70

0.35

nmol/l

0.60

149

Hypertensive diseases

667

3679

1.02

0.22

1.5

1.4

0.30

0.38

nmol/l

2.19

465

2836

Hordeolum and other deep inflammation of eyelid

379

0.90

0.22

1.8

1.4

0.61

0.40

nmol/l

0.22

303

Calcific aortic valvular stenosis

398

0.90

0.22

1.2

1.4

0.65

0.17

nmol/l

0.69

298

Calcific aortic valvular stenosis, operated

398

0.90

0.22

1.2

1.4

0.65

0.17

nmol/l

0.69

298

Other and unspecified injuries of ankle and foot

352

1.11

0.22

1.3

1.5

0.27

0.40

nmol/l

1.37

286

Diverticular disease of intestine

339

2095

1.03

0.22

1.4

0.26

0.29

nmol/l

0.44

245

1484

Heart failure,strict

117

873

0.95

0.22

1.4

0.22

0.19

nmol/l

0.42

618

Chronic suppurative otitis media, including avohilmo

431

0.90

0.22

1.9

1.5

0.22

0.39

nmol/l

2.61

355

Toxic effect of ethanol

276

1.13

0.22

1.5

0.38

0.37

nmol/l

0.02

231

Rheumatoid arthritis, including avohilmo

204

2124

0.96

0.22

1.4

0.35

0.40

nmol/l

0.32

150

1580

Other injuries of lower limb, level unspecified

1.22

0.22

1.6

1.4

0.84

0.34

nmol/l

—

Open wound of forearm

535

1.09

0.22

1.4

1.5

0.29

0.38

nmol/l

1.06

443

Benign neoplasm: Oesophagus

1.22

0.22

1.4

0.55

0.40

nmol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

397

0.90

0.22

1.2

1.4

0.65

0.17

nmol/l

0.70

298

Congenital malformations of cardiac septa

447

0.91

0.22

1.7

1.5

0.53

0.32

nmol/l

0.42

354

Superficial injury of ankle and foot

106

1122

0.94

0.22

1.4

1.5

0.32

0.43

nmol/l

1.14

907

Chondropathies

117

1108

1.06

0.22

1.6

1.5

0.32

0.41

nmol/l

1.11

876

Obstructed labour due to malposition and malpresentation of fetus

362

3277

1.03

0.22

1.4

0.60

0.41

nmol/l

1.45

296

2522

Lung diseases due to external agents

343

1.11

0.22

1.5

0.48

0.25

nmol/l

0.74

265

Spondylopathies (FG)

115

1089

1.06

0.21

1.5

1.4

0.34

0.43

nmol/l

0.78

868

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.3

—

0.30

—

Injury of eye and orbit

875

1.06

0.21

1.4

1.5

0.24

0.39

nmol/l

3.94

695

Frostbite

1.19

0.21

1.4

1.5

1.63

0.34

nmol/l

—

Other diseases of appendix

1.19

0.21

1.2

1.4

0.18

0.24

nmol/l

—

Late syphilis

1.19

0.21

1.0

1.6

0.18

0.39

nmol/l

—

Oesophagitis

163

1.17

0.21

1.2

1.5

0.22

0.31

nmol/l

0.60

135

Nonspecific lymphadenitis

409

0.90

0.21

1.4

1.5

0.24

0.34

nmol/l

1.40

313

Schizophrenia, schizotypal and delusional disorders

254

2452

1.04

0.21

1.5

0.32

0.40

nmol/l

1.52

188

1944

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

115

1177

0.95

0.21

1.7

1.5

0.38

0.40

nmol/l

0.09

943

Any prescribed medicine buy

0.00

0.21

0.0

1.3

—

0.14

—

Other specified/unspecified arthritis

182

1745

1.04

0.21

1.4

0.32

0.43

nmol/l

1.56

129

1349

Changes in corneal membranes

0.00

0.21

0.0

1.6

—

0.24

—

Donors of organs and tissues

101

0.79

0.21

2.3

1.4

2.96

0.37

nmol/l

—

Other and unspecified injuries of head

315

1.11

0.21

1.7

1.4

0.28

0.31

nmol/l

0.27

245

Acute appendicitis, no complications

525

5102

1.02

0.21

1.5

1.4

0.46

0.41

nmol/l

0.44

413

4005

Open wound of shoulder and upper arm

101

0.79

0.21

1.6

1.5

0.27

0.34

nmol/l

—

Cerebral atherosclerosis

0.00

0.21

0.0

1.2

—

0.12

—

Trigger finger

802

0.93

0.21

1.2

1.4

0.22

0.35

nmol/l

2.55

620

Schizophrenia or delusion

254

2453

1.04

0.21

1.5

0.32

0.40

nmol/l

1.53

188

1944

Other congenital malformations of heart

1.17

0.21

1.6

0.32

nmol/l

—

Polyhydramnios

729

0.93

0.21

1.3

1.5

0.57

0.47

nmol/l

0.26

594

Use of other anti-dementia drugs

182

1.14

0.21

1.3

1.4

0.12

nmol/l

0.00

131

Use of memantine

182

1.14

0.21

1.3

1.4

0.12

nmol/l

0.00

131

Pediculosis and phthiriasis

0.00

0.21

0.0

1.8

—

0.32

—

Fracture of lower leg, including ankle

369

3550

1.03

0.21

1.5

0.25

0.38

nmol/l

5.63

267

2718

377

3413

0.97

0.20

1.3

1.5

0.32

0.37

nmol/l

1.15

283

2703

Radial styloid tenosynovitis [de Quervain]

460

1.09

0.20

1.6

1.4

0.35

0.40

nmol/l

0.24

378

Diseases of appendix

662

5843

1.02

0.20

1.5

1.4

0.44

0.42

nmol/l

0.18

520

4592

Renal failure

129

1085

1.05

0.20

1.5

1.4

0.21

0.28

nmol/l

1.30

102

805

Alcohol-induced chronic pancreatitis

145

1.17

0.20

1.5

0.17

0.21

nmol/l

—

111

Alcoholic liver disease

230

1.13

0.20

1.5

0.24

0.22

nmol/l

0.06

178

Pleural effusion

335

1.11

0.20

1.2

1.5

0.25

nmol/l

0.01

259

Other heart diseases

481

3063

1.03

0.20

1.4

0.38

0.40

nmol/l

0.22

365

2401

Congenital malformations of spine and bony thorax

1.26

0.20

2.2

1.6

0.26

0.30

nmol/l

—

Synovial cyst of popliteal space [Baker]

261

0.88

0.20

1.1

1.5

0.58

0.27

nmol/l

0.76

200

Transport accidents

455

3817

1.03

0.20

1.6

1.5

0.38

0.46

nmol/l

1.15

376

3068

Corneal ulcer

130

1239

1.05

0.20

1.3

1.5

0.35

0.41

nmol/l

0.66

981

Alcohol dependence

102

1077

0.95

0.20

1.3

1.4

0.33

nmol/l

0.00

830

Other congenital malformations of face and neck

229

0.87

0.20

1.3

1.5

0.30

0.38

nmol/l

0.51

191

Bursitis of shoulder

113

0.79

0.20

1.2

1.4

0.25

0.34

nmol/l

—

Appendicitis, broad definition

659

5840

1.02

0.20

1.5

1.4

0.44

0.42

nmol/l

0.20

517

4589

Inflammatory disease of cervix uteri

336

1.10

0.19

1.6

1.4

0.29

0.40

nmol/l

0.50

250

Pedal cyclist injured in collision with motor vehicle

197

0.86

0.19

1.4

1.6

0.26

0.37

nmol/l

0.76

161

Injury of unspecified body region

396

0.91

0.19

1.4

1.5

0.33

0.34

nmol/l

0.01

318

Transient ischemic attack

153

1293

0.96

0.19

1.3

1.4

0.25

0.28

nmol/l

0.27

103

922

Bicuspidal aortic valve syndrome

127

1.18

0.19

1.2

1.5

0.34

0.31

nmol/l

—

100

Calcific aortic valvular stenosis, diagnosis (helper)

394

0.91

0.19

1.2

1.4

0.65

0.17

nmol/l

0.70

295

Operations 2 for CAVS

394

0.91

0.19

1.2

1.4

0.65

0.17

nmol/l

0.70

295

Ulcerative colitis (strict definition, all Crohn cases excluded)

100

1055

0.95

0.19

1.4

1.5

0.44

0.42

nmol/l

0.10

857

Second line medication for Crohn's disease

433

4435

0.98

0.19

1.5

0.35

0.39

nmol/l

0.46

324

3433

Scabies

279

1.11

0.19

1.6

0.30

0.33

nmol/l

0.21

234

Reimbursement for rheumatic diseases

392

4002

0.97

0.19

1.5

1.4

0.35

0.39

nmol/l

0.57

286

3073

Chorioretinal inflammation

137

1.17

0.19

1.8

1.5

0.35

0.31

nmol/l

—

115

Superficial injury of forearm

783

1.06

0.19

1.4

1.5

0.40

0.43

nmol/l

0.10

636

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

114

1086

1.05

0.18

1.3

1.5

0.36

0.48

nmol/l

1.40

881

Finngen Rheumatological endpoints

949

5485

0.98

0.18

1.5

0.34

0.43

nmol/l

3.40

734

4386

Contracture of joint

1.13

0.18

1.5

1.3

0.09

0.45

nmol/l

—

Speech therapy

121

1268

0.95

0.18

1.4

0.24

0.35

nmol/l

2.66

943

Thiazolidinediones

251

1.12

0.18

1.4

1.5

0.14

0.22

nmol/l

1.50

185

Assault

111

1057

1.05

0.18

1.3

1.5

0.24

0.43

nmol/l

4.41

866

Non-allergic asthma

395

1.09

0.18

1.7

1.5

0.35

0.36

nmol/l

0.04

310

Other psoriatic arthropathies

539

0.93

0.18

1.3

1.4

0.34

0.36

nmol/l

0.08

410

Dislocation, sprain and strain of joints and ligaments of elbow

487

0.92

0.18

1.7

1.5

0.26

0.38

nmol/l

1.09

392

Substance abuse

396

3631

1.02

0.18

1.4

1.5

0.31

0.38

nmol/l

1.67

298

2884

Wegener granulomatosis

1.19

0.18

2.0

1.4

0.35

0.38

nmol/l

—

Superficial injury of abdomen, lower back and pelvis

106

1113

0.95

0.18

1.4

1.5

0.26

0.44

nmol/l

3.02

914

Colorectal cancer

387

1.09

0.18

1.4

1.3

0.33

0.23

nmol/l

0.30

291

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

753

1.06

0.18

1.5

0.43

0.46

nmol/l

0.16

625

Biomechanical lesions, not elsewhere classified

204

1.13

0.18

1.3

1.4

0.29

0.32

nmol/l

0.11

157

Psoriatic and enteropathic arthropathies

697

1.06

0.18

1.3

1.4

0.40

0.38

nmol/l

0.07

531

Alcohol use disorder, Swedish definition

320

2855

1.03

0.18

1.3

1.5

0.33

0.36

nmol/l

0.52

242

2249

Hyperlipidaemia, other/unspecified

103

902

1.05

0.17

1.4

0.23

0.21

nmol/l

0.15

633

Use of donepezil

159

1.14

0.17

1.6

1.4

0.09

0.12

nmol/l

0.81

114

Other and unspecified injuries of lower leg

579

0.93

0.17

1.4

1.5

0.34

0.39

nmol/l

0.27

467

Tobacco use

341

0.91

0.17

1.3

1.5

0.44

0.39

nmol/l

0.13

285

Burns and corrosions

866

0.95

0.17

1.4

1.5

0.37

nmol/l

0.01

696

Sequelae of injuries of head

247

0.89

0.17

1.0

1.5

0.29

0.31

nmol/l

0.10

199

Complications following abortion and ectopic and molar pregnancy

184

0.87

0.17

1.2

1.5

0.32

0.29

nmol/l

0.17

133

Other and specified injuries of hip and thigh

1.22

0.17

1.4

1.6

0.15

0.38

nmol/l

—

Perineal laceration during delivery

303

2601

0.97

0.17

1.5

0.57

0.44

nmol/l

1.56

270

2140

Early onset COPD, excluding more controls

620

1.06

0.17

1.3

0.20

0.24

nmol/l

0.46

454

Adhesive capsulitis of shoulder

718

1.06

0.17

1.3

1.4

0.29

0.31

nmol/l

0.08

546

Otalgia

543

1.07

0.17

1.3

1.5

0.29

0.40

nmol/l

1.20

432

Perforation of tympanic membrane

543

1.07

0.17

1.4

1.5

0.26

0.40

nmol/l

1.83

431

Tubulo-interstitial nephritis, not specified as acute or chronic

340

0.91

0.16

1.3

1.4

0.33

0.37

nmol/l

0.25

266

Anterior Iridocyclitis

114

1191

0.96

0.16

1.4

0.25

0.37

nmol/l

2.64

921

Lichen sclerosus et atrophicus

466

1.07

0.16

1.5

1.4

0.21

0.36

nmol/l

2.06

335

Nonsuppurative otitis media

268

2383

0.97

0.16

1.6

0.40

0.45

nmol/l

0.21

228

2007

Papulosquamous disorders

213

2196

0.97

0.16

1.4

0.26

0.37

nmol/l

2.61

154

1647

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

132

1373

0.96

0.16

1.4

1.5

0.43

0.42

nmol/l

0.09

107

1095

Rosacea

808

1.05

0.16

1.4

0.34

0.40

nmol/l

0.56

624

Fracture at wrist and hand level

243

2357

1.03

0.16

1.6

1.5

0.26

0.39

nmol/l

3.46

192

1862

Open wound of wrist and hand

345

3293

1.02

0.16

1.4

1.5

0.31

0.40

nmol/l

2.63

266

2639

ILD medications: immunosuppressive drugs

532

4849

1.02

0.16

1.5

1.4

0.33

0.42

nmol/l

2.07

409

3804

Pre-eclampsia superimposed on chronic hypertension

0.77

0.16

2.0

1.3

0.54

0.37

nmol/l

—

L04AA Selective immunosuppressants

148

1535

0.96

0.15

1.4

0.30

0.39

nmol/l

1.39

117

1186

Hereditary deficiency of other clotting factors

0.76

0.15

3.3

1.4

0.14

0.39

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

235

1.11

0.15

1.2

1.5

0.24

0.29

nmol/l

0.44

180

Chronic viral hepatitis

409

1.08

0.15

1.4

1.5

0.21

0.41

nmol/l

3.98

339

Pedal cyclist injured in transport accident

156

1616

0.96

0.15

1.9

1.5

0.35

0.40

nmol/l

0.35

127

1275

All influenza

140

1348

1.04

0.15

1.4

1.5

0.28

0.38

nmol/l

1.80

109

1075

Crohn disease (strict definition, all UC cases excluded)

361

1.08

0.15

1.4

1.5

0.39

0.35

nmol/l

0.15

296

All dysplastic lesions of the cervix uteri, vagina or vulva

437

4390

0.98

0.15

1.5

1.4

0.46

0.49

nmol/l

0.25

355

3501

Coxarthrosis, primary

167

1462

0.97

0.15

1.3

1.4

0.21

0.22

nmol/l

0.19

126

997

Multiple gestation

144

1389

1.04

0.15

2.0

1.4

0.45

0.47

nmol/l

0.12

117

1083

Schizoaffective disorder

585

1.06

0.15

1.4

1.5

0.20

0.42

nmol/l

4.38

463

Acute bronchiolitis

492

1.06

0.14

1.6

0.23

0.32

nmol/l

0.81

400

Benign neoplasm of middle ear and respiratory system

265

1.10

0.14

1.2

1.5

0.38

0.28

nmol/l

0.26

201

Crohn disease (strict definition, require KELA)

498

1.07

0.14

1.5

0.52

0.43

nmol/l

0.40

407

Erythema nodosum

169

1.13

0.14

1.4

0.23

0.35

nmol/l

1.10

143

Benign neoplasm: Long bones of lower limb

217

1.11

0.14

1.7

1.5

0.26

0.36

nmol/l

0.74

182

Artrosis, including avohilmo

653

3631

0.98

0.14

1.4

0.33

0.41

nmol/l

1.82

502

2812

L01XX Other antineoplastic agents

1.18

0.14

1.2

1.5

0.27

0.21

nmol/l

—

Recurrent dislocation of patella

684

1.05

0.14

1.3

1.5

0.37

0.52

nmol/l

1.00

574

Poor fetal growth

230

2240

1.03

0.14

1.5

0.43

0.52

nmol/l

0.72

193

1851

Ulcerative rectosigmoiditis

557

1.06

0.14

1.5

0.30

0.39

nmol/l

0.67

442

Congenital malformations of the circulatory system

101

939

1.04

0.14

1.5

0.40

0.38

nmol/l

0.05

754

Personal history of certain other diseases

208

1.11

0.14

1.4

1.5

0.27

0.45

nmol/l

1.91

182

Other secondary gonarthrosis

160

1.13

0.14

1.4

0.71

0.29

nmol/l

—

120

Gonarthrosis [arthrosis of knee](FG)

428

2536

0.98

0.14

1.4

1.3

0.28

0.33

nmol/l

0.61

302

1864

Psoriasis

158

1631

0.97

0.14

1.4

0.26

0.37

nmol/l

2.38

112

1234

Seropositive rheumatoid arthritis

117

1210

0.96

0.14

1.4

0.29

0.38

nmol/l

1.16

899

Other maltreatment syndromes

189

1.11

0.13

1.6

1.5

0.29

0.31

nmol/l

0.10

147

Pyogenic arthritis

228

1.10

0.13

1.4

1.5

0.14

0.33

nmol/l

4.42

185

Early onset COPD

694

0.95

0.13

1.3

1.4

0.20

0.23

nmol/l

0.39

500

Gout, strict definition

267

1.09

0.13

1.1

1.4

0.13

0.16

nmol/l

0.68

210

Valvular operations

267

1.09

0.13

1.1

1.5

0.14

0.22

nmol/l

1.19

216

Other/unspecified enthesopathies, not elsewhere classified

374

1.07

0.13

1.1

1.5

0.29

0.30

nmol/l

0.07

294

Spondylopathies

500

3036

0.98

0.13

1.4

0.29

0.39

nmol/l

2.69

347

2316

COPD related to multimorbidity

663

0.95

0.12

1.4

0.15

0.19

nmol/l

1.73

475

Idiopathic gout

142

1.13

0.12

1.2

1.5

0.13

0.18

nmol/l

0.76

111

Fracture of lumbar spine and pelvis

745

1.05

0.12

1.3

1.5

0.48

0.36

nmol/l

0.50

580

Crohn disease (strict definition, require KELA, min 2 HDR)

492

1.06

0.12

1.4

1.5

0.53

0.43

nmol/l

0.43

401

Gastric ulcer

443

1.06

0.12

1.5

1.4

0.79

0.26

nmol/l

0.52

330

Other orthopaedic follow-up care

268

1.08

0.12

2.0

1.4

0.26

0.32

nmol/l

0.37

210

Mental and behavioural disorders due to psychoactive substance use

414

3771

1.02

0.12

1.4

1.5

0.30

0.38

nmol/l

2.12

308

2991

Other hammer toe(s) (acquired)

445

1.06

0.12

1.5

1.4

0.19

0.28

nmol/l

1.07

292

Colon adenocarcinoma

137

0.88

0.12

1.3

0.09

0.19

nmol/l

—

104

Pustulosis palmaris et plantaris

220

0.91

0.12

1.6

1.5

0.20

0.32

nmol/l

1.27

159

Other symptoms and signs involving the circulatory and respiratory systems

317

1.07

0.11

1.5

0.23

0.35

nmol/l

1.75

260

Dental caries, including avohilmo

551

2777

1.01

0.11

1.4

1.5

0.29

0.38

nmol/l

3.39

418

2207

Otitis externa, unspecified

782

0.96

0.11

1.3

1.5

0.55

0.40

nmol/l

0.23

633

Later onset COPD, excluding more controls

170

1.09

0.11

1.5

1.4

0.12

0.11

nmol/l

0.27

120

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

279

1.08

0.11

1.4

0.54

0.42

nmol/l

0.24

231

Later onset COPD

216

0.92

0.11

1.5

1.4

0.11

nmol/l

0.03

163

Otitis media, unspecified

118

1052

1.03

0.11

1.8

1.5

0.25

0.37

nmol/l

3.23

865

Otosclerosis

281

0.92

0.11

1.4

1.5

0.27

0.32

nmol/l

0.25

204

Arthropathies in other diseases classified elsewhere

157

0.89

0.11

1.4

0.36

0.34

nmol/l

—

126

Plantar fascial fibromatosis

602

1.05

0.11

1.3

1.4

0.39

0.36

nmol/l

0.14

467

Acute tubulo-interstitial nephritis

478

4183

0.99

0.11

1.4

1.5

0.38

0.41

nmol/l

0.40

353

3287

Car occupant injured in other and unspecified transport accidents

167

1713

0.97

0.11

1.3

1.5

0.44

0.43

nmol/l

0.04

136

1387

Bacterial pneumonia (organism specified)

222

1969

1.02

0.11

1.6

1.5

0.32

0.37

nmol/l

0.67

171

1522

Fall on and from stairs and steps

152

1561

0.97

0.11

1.4

0.26

0.40

nmol/l

3.19

113

1207

Superficial injury of head

145

1411

1.03

0.10

1.5

0.33

0.42

nmol/l

0.99

107

1100

Right hemicolectomy

115

1.13

0.10

1.3

1.5

0.38

0.28

nmol/l

0.22

Atrial septal defect, secundum type

182

1.10

0.10

2.0

1.4

0.75

0.33

nmol/l

0.34

148

Intrahepatic Cholestasis of Pregnancy (ICP)

110

1067

1.03

0.10

1.3

1.5

0.37

0.48

nmol/l

1.39

869

Bacterial meningitis

154

1.11

0.10

1.4

1.5

0.43

0.35

nmol/l

0.23

125

Pediculosis, acariasis and other infestations

339

1.06

0.10

1.6

1.5

0.30

0.35

nmol/l

0.34

277

Covid-19 suspected case

227

2225

1.02

0.10

1.5

0.53

0.44

nmol/l

0.37

192

1789

Early lumbar disc prolapse operation

107

1103

0.97

0.10

1.8

1.5

0.39

0.45

nmol/l

0.38

896

Maternal care for known or suspected malpresentation of fetus

370

2640

1.02

0.10

1.4

0.59

0.46

nmol/l

0.73

300

2121

Toxic effect of other and unspecified substances

106

1.14

0.10

1.4

1.6

0.18

0.36

nmol/l

—

Other disorders of urethra and urinary system

629

4487

1.01

0.10

1.4

0.39

0.43

nmol/l

0.29

487

3499

Childhood allergy (age < 16)

249

2014

1.02

0.09

1.8

1.6

0.40

0.44

nmol/l

0.26

219

1725

Respiratory tuberculosis, not confirmed

1.09

0.09

1.4

1.5

0.29

0.15

nmol/l

—

Reactive arthropathies, FINNGEN

418

1.05

0.09

1.4

0.36

0.40

nmol/l

0.13

327

Other gastritis (incl. Duodenitis)

851

1.03

0.09

1.5

1.4

0.32

0.31

nmol/l

0.04

633

Mental and behavioural disorders due to alcohol, excluding acute intoxication

240

2344

1.02

0.09

1.3

1.5

0.33

0.36

nmol/l

0.38

184

1855

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

145

0.89

0.09

1.5

0.31

0.36

nmol/l

0.19

123

Infliximab

145

1.11

0.09

1.3

1.5

0.29

0.35

nmol/l

—

121

Other bursopathies

497

1.05

0.09

1.1

1.5

0.39

0.30

nmol/l

0.49

386

HSIL lesion of the cervix uteri, vagina or vulva

300

3048

0.98

0.09

1.5

0.52

0.49

nmol/l

0.19

244

2461

Hydronephrosis

448

1.05

0.09

1.3

1.5

0.19

0.31

nmol/l

3.19

356

Golimumab

272

1.07

0.09

1.7

1.5

0.28

0.35

nmol/l

0.54

223

Other assisted single delivery

288

0.93

0.09

1.6

1.5

1.26

0.45

nmol/l

0.43

233

Ill-defined and unknown causes of mortality

126

1.11

0.09

1.1

1.5

0.28

0.20

nmol/l

—

Acute lymphadenitis

429

1.05

0.09

1.7

1.5

0.28

0.43

nmol/l

1.90

348

Other and unspecified urticaria

182

1783

1.02

0.09

1.4

1.5

0.40

0.43

nmol/l

0.16

140

1412

Viral pneumonia

616

1.04

0.09

1.5

0.28

0.38

nmol/l

0.93

503

Other arthrosis

285

1942

1.02

0.08

1.3

1.4

0.29

0.34

nmol/l

0.64

198

1427

Distal bite

377

0.95

0.08

1.2

1.6

0.19

0.30

nmol/l

3.05

310

Otitis externa

159

1556

1.02

0.08

1.3

1.4

0.48

0.40

nmol/l

0.24

118

1220

Gestational [pregnancy-induced] hypertension

381

3851

0.99

0.08

1.4

0.49

0.48

nmol/l

0.03

305

3072

Other ill-defined and unspecified causes of mortality

107

1.12

0.08

1.1

1.6

0.28

0.21

nmol/l

—

Polymorphous light eruption

1.04

0.08

1.5

0.29

0.33

nmol/l

—

Heart failure and antihypertensive medication

506

1.03

0.08

1.4

0.22

0.24

nmol/l

0.29

359

Chronic iridocyclitis

263

1.07

0.08

1.4

1.5

0.27

0.33

nmol/l

0.51

209

Sulfasalazine

196

1997

0.98

0.08

1.5

0.36

0.42

nmol/l

0.66

137

1562

Prolonged pregnancy

282

2504

0.98

0.08

1.4

1.5

0.57

0.46

nmol/l

0.87

229

2048

Left ventricular outflow tract obstruction, narrow definition

224

1.07

0.08

1.4

1.5

0.27

0.28

nmol/l

0.01

178

Benign neoplasm of urinary organs

146

1.10

0.08

1.3

1.4

0.16

0.30

nmol/l

2.01

112

Viral infections of the central nervous system

499

1.04

0.08

1.7

1.5

0.31

0.41

nmol/l

0.61

397

Oral lichen planus

1.14

0.08

1.1

1.5

0.12

0.31

nmol/l

—

Disorders of synovium and tendon in diseases classified elsewhere

1.05

0.08

1.3

1.4

0.19

0.33

nmol/l

—

Injury of nerves at forearm level

1.03

0.08

1.3

1.5

0.20

0.40

nmol/l

—

Viral agents as the cause of diseases classified to other chapters

166

1.09

0.07

1.2

1.4

0.32

0.37

nmol/l

0.19

137

Cardiomyopathy

480

1.04

0.07

1.8

1.5

0.17

0.24

nmol/l

1.29

372

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

313

1.06

0.07

1.4

0.34

0.37

nmol/l

0.09

265

Labour and delivery complicated by umbilical cord complications

579

1.04

0.07

1.3

1.4

0.75

0.40

nmol/l

1.06

449

Other predominantly sexually transmitted diseases, not elsewhere classified

212

2155

0.98

0.07

1.4

1.5

0.42

0.49

nmol/l

0.93

183

1752

Generalized skin eruption due to drugs and medicaments

225

1.07

0.07

1.5

0.23

0.32

nmol/l

0.76

179

Injuries to unspecified part of trunk, limb or body region

540

0.96

0.07

1.4

0.39

0.38

nmol/l

0.06

432

Other (seronegative) rheumatoid arthritis, wide

874

0.97

0.07

1.4

0.28

0.36

nmol/l

0.71

655

Malignant neoplasm of colon

225

1.07

0.07

1.5

1.4

0.21

0.26

nmol/l

0.29

178

Acute alcohol intoxication

132

1292

1.02

0.07

1.4

1.5

0.28

0.37

nmol/l

1.07

1017

Alcohol use disorder, ICD-based

226

2225

1.02

0.07

1.3

1.5

0.34

0.37

nmol/l

0.32

174

1755

Other specified/unspecified disorders of bone/cartilage

108

1.11

0.07

2.2

1.4

0.22

0.25

nmol/l

0.21

Stenosis and insufficiency of lacrimal passages

408

0.96

0.07

1.4

1.5

0.42

0.30

nmol/l

0.30

317

Gout, unspecified

343

1.05

0.07

1.2

1.4

0.17

0.20

nmol/l

0.47

265

Pregnancy, childbirth and the puerperium

288

1483

1.01

0.07

1.5

0.46

0.32

nmol/l

1.03

246

1185

Unspecified urinary incontinence

357

0.95

0.07

1.6

1.5

0.28

0.31

nmol/l

0.12

269

severe traumatic brain injury, does not include concussion

639

1.03

0.07

1.3

1.5

0.35

0.31

nmol/l

0.07

499

Reactive arthropathies

501

1.04

0.07

1.5

1.4

0.34

0.39

nmol/l

0.22

401

Dislocation, sprain and strain of joints and ligaments of knee

563

5233

0.99

0.07

1.4

1.5

0.33

0.43

nmol/l

2.82

459

4121

Open wound of lower leg

798

1.03

0.07

1.4

1.5

0.24

0.36

nmol/l

2.45

647

Myeloproliferative diseases (CML excluded)

214

0.93

0.07

1.5

0.26

0.28

nmol/l

0.10

165

Erysipelas

374

2886

0.99

0.06

1.4

0.28

0.35

nmol/l

0.88

261

2194

Chondrocostal junction syndrome [Tietze]

224

0.94

0.06

1.7

1.5

0.22

0.33

nmol/l

1.12

182

Biological medicines for asthma

132

0.91

0.06

2.1

1.4

0.24

0.35

nmol/l

—

108

Recurrent dislocation and subluxation of joint

579

0.97

0.06

1.3

1.4

0.27

0.40

nmol/l

1.74

473

Malignant neoplasm of head and neck

128

1.09

0.06

1.4

1.5

0.12

0.23

nmol/l

—

107

Superficial injury of thorax

771

0.97

0.06

1.3

1.5

0.45

0.35

nmol/l

0.27

614

Other peripheral vertigo

356

0.95

0.06

1.4

1.5

0.33

0.31

nmol/l

0.08

271

Congenital malformations of heart and great arteries

835

0.97

0.06

1.6

1.5

0.41

0.36

nmol/l

0.15

671

Vitamin deficiency, wide

246

1.06

0.06

1.3

1.5

0.25

0.33

nmol/l

0.63

195

Vitamin deficiency

246

1.06

0.06

1.3

1.5

0.25

0.33

nmol/l

0.63

195

Bilateral sagittal split ramus osteotomy operation

315

0.95

0.06

1.3

1.5

0.47

0.38

nmol/l

0.24

254

Delivery

404

2110

1.01

0.06

1.4

1.5

0.48

0.36

nmol/l

0.95

333

1684

Valvular heart disease excluding rheumatic fever

165

1211

0.98

0.06

1.4

0.40

0.29

nmol/l

0.56

115

905

Primary gonarthrosis, bilateral

153

1332

0.98

0.06

1.4

0.21

0.23

nmol/l

0.18

108

897

Hypertension, essential

619

3477

1.01

0.05

1.4

0.31

0.37

nmol/l

1.31

428

2667

Injuries to the abdomen, lower back, lumbar spine and pelvis

239

2393

0.99

0.05

1.4

1.5

0.37

0.42

nmol/l

0.46

187

1895

Struck by thrown, projected or falling objec

263

0.95

0.05

1.3

1.4

0.46

0.32

nmol/l

0.38

215

Malignant neoplasm of rectum

139

1.08

0.05

1.3

0.57

0.23

nmol/l

—

110

Embedded teeth, including avohilmo

115

1171

0.98

0.05

1.6

1.5

0.44

0.47

nmol/l

0.11

979

Acute alcohol intoxication, ICD10

119

1169

1.02

0.05

1.4

1.5

0.30

0.38

nmol/l

0.96

932

Viral meningitis

277

1.05

0.05

2.1

1.5

0.33

0.37

nmol/l

0.12

231

Gonarthrosis, primary, with knee surgery

167

1310

1.01

0.05

1.3

1.4

0.18

0.21

nmol/l

0.62

114

864

Acute and subacute iridocyclitis

113

1110

1.02

0.05

1.4

0.25

0.37

nmol/l

2.61

864

Psoriasis vulgaris

999

0.98

0.05

1.5

1.4

0.26

0.36

nmol/l

1.26

766

Other ulcerative colitis

396

1.04

0.05

1.3

1.5

0.36

0.40

nmol/l

0.17

316

208

1.06

0.05

1.5

1.7

0.19

0.22

nmol/l

0.35

173

Monoarthritis, not elsewhere classified

238

1.05

0.05

1.2

1.4

0.23

0.35

nmol/l

1.32

192

Superficial injury of shoulder and upper arm

644

1.03

0.05

1.1

1.5

0.27

0.36

nmol/l

0.96

517

Burns and corrosions of external body surface, specified by site

676

0.98

0.04

1.3

1.5

0.32

0.37

nmol/l

0.37

541

Generalized epilepsy

353

0.96

0.04

1.3

1.5

0.31

0.43

nmol/l

0.44

291

Other otitis externa (chronic)

363

0.96

0.04

1.4

1.5

0.35

0.36

nmol/l

0.04

281

Other congenital malformations of tongue, mouth and pharynx

139

1.07

0.04

1.5

1.6

0.34

nmol/l

0.03

121

Desensitization to allergens

605

0.97

0.04

1.5

0.52

0.42

nmol/l

0.23

496

Acute appendicitis, with complications

104

1058

0.98

0.04

1.5

1.4

0.36

nmol/l

0.01

798

Chronic kidney disease

692

0.98

0.04

1.4

0.18

0.28

nmol/l

2.34

518

Vulvovaginal ulceration/inflammation in other diseases

764

1.02

0.04

1.5

0.62

0.47

nmol/l

0.39

628

Seronegative rheumatoid arthritis

536

1.03

0.04

1.3

1.4

0.26

0.39

nmol/l

1.37

397

Ulcer of lower limb, not elsewhere classified

328

1.04

0.04

1.1

1.5

0.21

0.25

nmol/l

0.46

254

Viral infections of the central nervous system

453

0.97

0.04

1.8

1.4

0.34

0.41

nmol/l

0.32

356

Crushed, pushed or stepped on by crowd or human stampede

584

0.98

0.04

1.5

0.23

0.39

nmol/l

2.79

477

Lichen planus

453

0.97

0.04

1.4

1.5

0.23

0.29

nmol/l

0.51

331

Ulcerative proctitis

467

1.03

0.04

1.3

1.5

0.38

0.42

nmol/l

0.13

383

Atrial fibrillation and flutter

148

947

1.01

0.04

1.4

0.20

0.28

nmol/l

2.27

112

692

Caries of dentine, including avohilmo

624

3170

1.01

0.04

1.4

1.5

0.33

0.39

nmol/l

1.41

465

2538

Other disorders of the musculoskeletal system and connective tissue

614

0.98

0.04

1.3

1.4

0.25

0.35

nmol/l

1.12

465

Cholecystitis

467

1.03

0.04

1.5

1.4

0.48

0.36

nmol/l

0.35

363

Intermittent heterotropia

522

0.98

0.03

1.4

1.5

0.46

0.47

nmol/l

0.01

434

Ethmoidectomy

784

0.98

0.03

1.3

1.4

0.35

0.40

nmol/l

0.26

628

Divergent concomitant strabismus

538

1.02

0.03

1.3

1.5

0.62

0.42

nmol/l

0.32

422

Malignant neoplasm of prostate

222

0.97

0.03

1.2

1.4

0.12

nmol/l

0.07

184

Other sexually transmitted chlamydial diseases

923

0.99

0.03

1.5

0.31

0.50

nmol/l

3.82

784

Benign neoplasm: Skin of trunk

211

1.04

0.03

1.7

1.5

0.35

nmol/l

0.01

167

Carcinoma in situ of cervix uteri

141

1424

0.99

0.02

1.4

1.5

0.60

0.52

nmol/l

0.28

107

1182

Atrial fibrillation and flutter with reimbursement

482

1.02

0.02

1.4

0.18

0.21

nmol/l

0.62

337

Acute generalized exanthematous pustulosis

249

0.96

0.02

1.5

0.23

0.33

nmol/l

0.82

198

HSIL lesion of the cervix uteri

289

2907

0.99

0.02

1.5

0.54

0.50

nmol/l

0.25

235

2354

Asthma mixed form (mode)

279

0.97

0.02

1.4

0.29

0.38

nmol/l

0.50

227

Glaucoma

192

1640

1.01

0.02

1.4

0.21

0.29

nmol/l

2.51

137

1181

Muscle strain

212

1.04

0.02

1.0

1.6

0.22

0.35

nmol/l

1.94

176

Postpartum haemorrhage due to anatomy

202

2007

1.01

0.02

1.4

1.5

0.67

0.56

nmol/l

0.38

173

1684

Ankyloglossia

137

0.94

0.02

1.6

0.37

0.34

nmol/l

0.08

120

FESS (DNB20)

760

1.01

0.02

1.3

1.5

0.35

0.40

nmol/l

0.28

610

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

422

4184

1.00

0.02

1.5

0.37

0.43

nmol/l

1.02

339

3377

Crowding of teeth, including avohilmo

117

958

1.01

0.02

1.5

0.30

0.38

nmol/l

0.97

792

Injuries to the shoulder and upper arm

556

4464

1.00

0.02

1.4

1.5

0.28

0.36

nmol/l

2.53

418

3446

Pyogenic granuloma

103

1.07

0.02

1.6

1.5

0.17

0.37

nmol/l

1.83

Autoimmune diseases excluding thyroid diseases, strict definition

854

4686

1.00

0.01

1.4

0.37

0.40

nmol/l

0.49

646

3758

Other cataract

155

1181

0.99

0.01

1.4

0.26

0.27

nmol/l

0.13

113

831

Glomerular diseases

771

1.01

0.01

1.5

1.4

0.41

0.36

nmol/l

0.15

608

Carcinoma in situ of cervix uteri, endocervix

147

0.95

0.01

1.2

1.4

0.29

0.40

nmol/l

—

123

Iridocyclitis

131

1320

0.99

0.01

1.4

1.5

0.24

0.40

nmol/l

4.60

1024

Periapical abscess

297

2958

1.00

0.01

1.4

1.5

0.45

0.35

nmol/l

0.39

229

2256

Suppurative and unspecified otitis media

436

3851

1.00

0.01

1.6

1.5

0.33

0.46

nmol/l

4.47

352

3201

Focal brain injury

203

1.03

0.01

1.2

1.5

0.85

0.34

nmol/l

0.34

167

Malignant neoplasm of prostate, including Hilmo

233

1.02

0.01

1.2

1.4

0.12

nmol/l

0.04

194

Peripheral arterial reconstruction

213

1.03

0.01

1.0

1.4

0.12

0.17

nmol/l

1.71

159

Asthma mixed form (mode), excluding more controls

277

0.97

0.01

1.4

0.29

0.38

nmol/l

0.51

226

Myeloproliferative diseases

243

1.03

0.01

1.6

1.5

0.26

0.29

nmol/l

0.14

184

Other sexually transmitted chlamydial diseases

153

1521

1.01

0.01

1.5

1.6

0.33

0.47

nmol/l

2.67

133

1296

Degeneration of macula and posterior pole

757

1.01

0.01

1.5

1.4

0.29

0.20

nmol/l

0.33

509

Speech disturbances, not elsewhere classified

297

0.98

0.01

1.9

1.4

0.21

0.29

nmol/l

1.00

230

Myocardial infarction, unclassifiable

247

0.98

0.01

1.2

1.4

0.17

0.16

nmol/l

0.01

188

Other fall from one level to another

154

1547

0.99

0.01

1.4

1.5

0.34

0.39

nmol/l

0.32

121

1252

Open wound of head

285

2738

1.00

0.01

1.5

0.33

0.36

nmol/l

0.39

218

2121

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

114

1133

1.01

0.00

1.3

1.4

0.36

0.53

nmol/l

2.24

919

Pneumonitis due to solids and liquids

156

0.96

0.00

1.7

1.5

0.51

0.28

nmol/l

—

127

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

184

1.03

0.00

1.1

1.5

0.31

0.34

nmol/l

0.12

150

Postprocedural musculoskeletal disorders, not elsewhere classified

196

0.97

0.00

1.3

1.4

0.24

0.30

nmol/l

0.44

140

Non-rheumatic valve diseases

165

1195

1.00

0.00

1.4

0.40

0.29

nmol/l

0.57

115

895

Contact with other sharp object(s)

536

0.99

0.00

1.5

0.30

0.39

nmol/l

0.79

436

Injury of muscle and tendon at wrist and hand level

656

0.99

0.00

1.6

1.4

0.28

0.33

nmol/l

0.33

521

IBD patients in KELA-register

193

1924

1.00

0.00

1.4

1.5

0.44

0.43

nmol/l

0.05

157

1537

Primary open-angle glaucoma, strict

442

0.99

0.00

1.7

1.4

0.14

0.20

nmol/l

0.79

302

Lichen planus, including avohilmo

766

1.01

0.00

1.4

0.23

0.33

nmol/l

1.29

559

Bronchiectasis

165

1.03

0.00

1.4

0.36

0.26

nmol/l

0.27

125

Thyrotoxicosis with toxic multinodular goitre

195

1.03

0.00

1.4

0.33

0.27

nmol/l

—

146

Alcohol withdrawal state with delirium

151

0.99

0.00

1.1

1.5

0.13

0.24

nmol/l

—

120

Assault by bodily force

618

1.00

0.00

1.3

1.5

0.24

0.40

nmol/l

2.45

507

Pustular psoriasis

241

1.00

0.00

1.5

0.17

0.34

nmol/l

2.53

177

Early lumbar disc prolapse, operated

103

1028

1.00

0.00

1.8

1.5

0.40

0.44

nmol/l

0.26

841

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

141

0.99

0.00

1.4

1.5

0.48

0.29

nmol/l

—

112

Coxarthrosis, primary, with hip surgery

113

1062

1.00

0.00

1.2

1.4

0.18

0.20

nmol/l

0.59

704

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

110

1105

1.00

0.00

1.3

1.4

0.37

0.53

nmol/l

2.25

904

COPD-related respiratory insufficiency

184

0.98

0.00

1.0

1.4

0.18

0.22

nmol/l

0.38

139

Mental and behavioural disorders due to alcohol

308

2963

1.00

0.00

1.3

1.5

0.32

0.37

nmol/l

0.91

233

2353

Polypectomy (DHB20)

226

1.02

0.00

1.3

1.5

0.53

0.28

nmol/l

0.47

179

Other and unspecified injuries of wrist and hand

256

1.02

0.00

1.8

1.5

0.58

0.36

nmol/l

0.32

207

COPD (mode)

546

1.01

0.00

1.4

0.19

nmol/l

0.07

394

L04AC Interleukin inhibitors

408

1.00

0.00

1.4

1.5

0.37

0.36

nmol/l

0.02

324

Other osteochondropathies

442

1.00

0.00

1.6

1.4

0.32

0.40

nmol/l

0.36

347

Septal defects

418

1.01

0.00

1.7

1.5

0.52

0.32

nmol/l

0.41

340

Sequelae of injuries of neck and trunk

131

0.99

0.00

1.5

0.33

nmol/l

0.00

107

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

641

1.00

0.00

1.3

1.4

0.28

0.41

nmol/l

2.09

517

Ankylosing spondylitis

491

1.00

0.00

1.4

1.5

0.24

0.39

nmol/l

2.48

393

Abnormalities of forces of labour

136

1361

1.00

0.00

1.2

1.4

0.51

0.42

nmol/l

0.25

110

1003

Other disorders of amniotic fluid and membranes

235

2298

1.00

0.00

1.3

1.5

0.44

0.48

nmol/l

0.29

198

1865

Inflammatory bowel disease, strict (require KELA)

193

1929

1.00

0.00

1.4

1.5

0.44

0.43

nmol/l

0.05

157

1546

Granulomatous disorders of skin and subcutaneous tissue

173

0.98

0.00

1.4

1.5

0.34

0.38

nmol/l

0.18

140

Contusion of other and unspecified parts of foot

447

1.01

0.00

1.5

0.39

0.38

nmol/l

0.04

362

Infections of breast associated with childbirth

527

1.01

0.00

1.3

1.5

0.63

0.51

nmol/l

0.52

435

Other and unspecified nail disorders

105

1.05

0.00

1.6

1.5

0.32

0.36

nmol/l

0.15

Twin gestation

135

1353

1.00

0.00

1.9

1.4

0.46

0.47

nmol/l

0.05

110

1059

Other and unspecified disease of Bartholin gland

145

0.97

0.00

1.4

1.5

0.31

0.35

nmol/l

—

115

Contact with sharp glass

295

1.02

0.00

1.3

1.5

0.22

0.37

nmol/l

2.50

245

Use of anticholinesterases

272

1.01

0.00

1.5

1.4

0.13

nmol/l

0.10

192

N06DA Anticholinesterases

272

1.01

0.00

1.5

1.4

0.13

nmol/l

0.10

192

Congenital malformations of the respiratory system

0.93

0.00

1.3

1.5

0.17

0.27

nmol/l

—

Mononeuritis multiplex

0.00

-0.00

0.0

1.2

—

0.26

—

Intentional self-harm by crashing of motor vehicle

0.00

-0.00

0.0

1.4

—

0.27

—

Other abnormal findings in urine

0.89

-0.00

1.8

1.4

0.46

0.38

nmol/l

—

Rare circulating lymphoid malignancy

0.00

-0.00

0.0

1.4

—

0.36

—

Polydactyly

0.00

-0.00

0.0

1.6

—

0.22

—

Pectus carinatum

0.00

-0.00

0.0

1.6

—

0.46

—

Congenital malformations of the respiratory system

0.96

-0.00

1.3

1.5

0.20

0.26

nmol/l

—

Disorders resulting from impaired renal tubular function

110

1.00

-0.00

1.5

0.15

0.31

nmol/l

—

Thoracic root disorders

0.00

-0.00

0.0

1.7

—

0.32

—

Iliac crest spur

0.00

-0.00

0.0

1.6

—

0.25

—

Genetic anomalies of leukocytes

0.00

-0.00

0.0

1.7

—

0.17

—

Erythema annulare centrifugum

0.00

-0.00

0.0

2.6

—

0.33

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

-0.00

0.0

1.7

—

0.14

—

Acute mastoiditis

0.89

-0.00

1.0

1.4

0.29

0.41

nmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases

360

1.00

-0.00

1.3

1.4

0.24

0.43

nmol/l

2.13

282

Tympanosclerosis

0.00

-0.00

0.0

1.5

—

0.32

—

conjunctival degenerations and deposits

0.92

-0.00

1.7

1.3

0.21

0.37

nmol/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Estradiol (E2) [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS